NAD phosphorylation and dephosphorylation

MetaCyc:NADPHOS-DEPHOS-PWY

The native NAD phosphorylation and dephosphorylation pathway contains three core transformations: ATP-dependent NAD phosphorylation, NADP hydrolysis, and proton-coupled transhydrogenation. The E. coli evidence supports individual activities and condition-dependent nucleotide balancing, but does not identify the physiological cytosolic NADP phosphatase or establish a complete cycle in every strain. The broader native taxonomic range is curated pathway scope, not a measurement of flux in every listed organism. Soluble SthA is included as an opposing supporting redox activity, outside the three native member reactions. The exact directional reactions are RHEA:18630, NAD(1−)+ATP(4−)→NADP(3−)+ADP(3−)+H+; RHEA:28051, NADP(3−)+water→NAD(1−)+hydrogenphosphate(2−); and RHEA:47994, NADH(2−)+NADP(3−)+H+(outside)→NAD(1−)+NADPH(4−)+H+(inside). Each side has coefficient one. The two proton appearances are distinct transport sides and are not canceled. RHEA:11693 describes the supporting soluble NAD(1−)+NADPH(4−)→NADH(2−)+NADP(3−) reaction without proton transport. Compartments remain explicit in the source participants and edge descriptions; one shared proton chemical identity does not erase the transport. Frozen PathBank SMP0002093/PW002081 corroborates the three-event boundary: two BiochemicalReaction objects plus one TransportWithBiochemicalReaction. Its class-specific count of two does not mean that the transport event is absent. Its NAD, NADH, NADP, NADPH, ATP, ADP and phosphate references use CHEBI:15846,16908,18009,16474,15422,16761 and18367, respectively, rather than all of the exact Rhea charge forms. Those forms are not asserted to be exact chemical matches. The frozen diagram also assigns both transport protons to the same Inner_Membrane entity; it supplies structural context, not inside/outside topology or physical membrane localization of the nucleotide pools. NadK is a homohexamer in the native assembly and the 2001 purification, approximately180 kDa with approximately30-kDa subunits. The native assembly object CPLX0-682 has no direct name, so its display remains unnamed while its six-chain NadK interpretation is stated here. Endogenous MG1655 protein was purified3400-fold after growth at37°C for18 h. Its measured N terminus MDNHFKCIGI differs at residue2 from the deduced/current reference MNNHFKCIGI. The separately expressed pSK67 yfjB construct used pET14b NcoI/BamHI in BL21(DE3)pLysS, with empty SK45 as control; the vector name alone does not establish a retained His tag. The reference NadK is cytoplasmic by reviewed rule-based annotation, with an annotated proton-accepting residue73; the historical preparations are not assigned that exact sequence merely by accession. The 2001 purified-NadK assay used5 mM NAD and ATP,5 mM MgCl2,100 mM Tris at pH7.0 and37°C. At5 mM donor, reported relative activities were ATP100%, UTP109%, CTP60%, GTP56%, dATP42% and TTP40%. These alternate in-vitro donors do not redefine the native ATP core. Polyphosphate at1 mg/mL and the tested pyrophosphate, tripolyphosphate, trimetaphosphate, hexametaphosphate, metaphosphate, ADP, AMP, phosphoenolpyruvate, phosphocreatine, glucose6-phosphate and p-nitrophenylphosphate did not support the measured phosphorylation. NADH, ADP-ribose, adenosine, AMP, ADP and ATP were not phosphorylated as acceptors in experiments described as data not shown. Activity peaked near pH7.5 and60°C;65°C for10 min removed about half the activity. Replacing the divalent metal at1 mM gave relative NadK activities Mg100%, Mn242%, Zn104%, Ca85% and Co73%. FeCl2, CuCl2, NaCl, KCl, LiCl and no-metal conditions gave no detected activity in that replacement experiment. Failure to substitute for Mg is not inhibition of an Mg-containing assay. The supported metals are alternatives, not a claim that all occupy the hexamer simultaneously or that the fastest in-vitro metal is physiologically preferred. The 1987 NadK preparation came from an unspecified E. coli K12 substrain grown in forced-aerated glycerol minimal medium at37°C and harvested in late log phase. It was enriched93-fold and was explicitly not homogeneous. The general assay used 10 mM NAD and 10 mM ATP, 14 mM MgCl2 and 100 mM MOPS at pH 7.2. Table 2 instead used 4.0 mM NAD, found that roughly tenfold more NADH than NADPH was needed for similar inhibition, and reported additive inhibition when both were present. Separate saturation experiments varied NAD, using NADPH at 5–30 µM or NADH at 50–200 µM. NAD saturation became sigmoidal, with reported Hill coefficients1.8–2.1 for NADPH and1.7–2.0 for NADH; increasing NAD could overcome inhibition. These kinetic observations and native allosteric annotations do not locate a binding site experimentally. The abstract assigns Km1.9 mM to NAD and2.1 mM to ATP, whereas the Results reverse those assignments; both are retained as an internal discrepancy. In the 2001 preparation, NADPH at5 and10 µM left58% and24% activity, while NADH left68% and39%. NADP at50 and100 µM left83% and79%, contrasting with the absence of a significant NADP effect in the 1987 conditions. Quinolinate, nicotinate, nicotinamide, nicotinamide mononucleotide, ADP and AMP likewise had no significant effect in the earlier experiment. Varying adenylate energy charge from0 to1 at4 mM total adenylates, with or without15 µM NADPH, did not change the 1987 rate. Those negative findings are condition-limited and do not imply that adenylate composition never influences nucleotide metabolism. The 2001 NadK thiol-reagent experiment used a glucose6-phosphate dehydrogenase reporter instead of the inhibitor-sensitive isocitrate dehydrogenase reporter. DTT,2-mercaptoethanol and glutathione at1 mM left100% activity. PCMB at1,0.25 and0.1 mM gave no detected activity,33% and51%; HgCl2 gave no detected activity,35% and54%. HgCl2 remains the salt, not a free-mercury node. The unspecified PCMB salt/charge is retained as reagent prose rather than forced onto an acid or anion identity. Table3 reports its own kcat values55/125 and efficiencies22/38; these are not silently recalculated from another table. Failed recovery of a yfjB disruption, described as data not shown, suggested essentiality under those conditions rather than proving universal essentiality. The 2005 primary abstract and issuing NadK variant annotations distinguish R175G/H/Q/T, which gain NADH-kinase activity, from R175E/I/K, which do not. R175G also lowers the NAD-kinase Vmax. These variants are not assigned to the wild-type endpoint and do not contradict the negative wild-type acceptor assay. The full 2005 body was unavailable. The native physiological NADP-phosphatase object has no assigned gene. Purified alkaline phosphatase converted historical TPN to DPN in the 1962 source, supporting in-vitro NADP hydrolysis. That paper used GL, BAP, PV and HH preparations with AMP-based specific activities1230,1130,1130 and1060 units/mg, but the TPN sentence identifies neither a particular fraction nor an E. coli strain. Its standard assayA contained0.05 M Tris pH8.2,0.01 M substrate and0.2–1 enzyme units in0.5 mL for20 min at37°C; assayB used p-nitrophenylphosphate at4×10−4 M. No exact reference sequence, processing isozyme or particular fraction is retrospectively assigned to the TPN observation. Reviewed PhoA is periplasmic, with a1–21 signal peptide and a mature reference chain beginning at22. Its Ser124 annotation describes the phosphoserine catalytic intermediate. The reference binds two Zn ions and one Mg ion per subunit; these are per-chain capacities, not three coefficient-one ions assigned indiscriminately to a whole dimer. Isozymes1 and3 have identical-chain dimers, whereas isozyme2 combines the differently processed chains. DsbA-assisted folding and Iap-related N-terminal processing are protein-maturation context, not evidence for NADP-specific regulation. The native report of additional phosphite oxidation is a separate PhoA function, not another NADP-core reaction. Periplasmic localization and the native enzyme record’s physiological-relevance flag do not establish a cytosolic recycling loop. The 1962 PhoA inhibitor/activation observations largely concern p-nitrophenylphosphate or AMP, not NADP. They include strong cadmium inhibition, urea effects that depend on exposure time and can reverse, and substrate/salt-dependent stimulation; the text reports activating fluoride and p-hydroxymercuribenzoate conditions and more modest mercury/cobalt effects. Competitive phosphate inhibition is discussed with prior-work attribution. Mg plus phosphate can protect against heat inactivation, while concentrated NaCl can worsen it; KCl can block recovery and fluoride, urea or CuSO4 can slow recovery in their stated experiments. The flattened primary-table rendering does not justify invented precise row/column values, and none of these broad-substrate or renaturation results is relabeled a direct inhibition measurement of NADP turnover. The 2007 CysQ preparation was the GFP-free ASKA AG1 pCA24N construct, carrying N-terminal His6 plus TDPALRA and C-terminal GLCGR extensions. At37°C, pH8.0 and10 mM MgCl2 it hydrolyzed NADP and NADPH. Reported Km and kcat were2.70±0.53 mM and0.70±0.09 s−1 for NADP, and2.13±0.25 mM and1.45±0.18 s−1 for NADPH. The additional NADPH substrate activity is retained as assay context, not an extra member of the three-event core. PAP preference and the different optima led the authors to conclude that CysQ probably is not the physiological E. coli NADP phosphatase. CysQ NADP(H)ase activity was undetectable at pH6.4 or0.2 mM Mg, conditions more favorable to its PAPase. Matched Fbp and SuhB extracts were negative controls;15 mM NaCl,7.5 mM imidazole and2.5% glycerol carried with the preparation did not explain the activity. LiCl IC50 values were70 mM for NADP,60 mM for NADPH,10 mM for FBP,0.05 mM for3-PAP and0.15 mM for2-PAP; table dashes mean not determined. Reviewed CysQ calcium/lithium inhibition from the separate 2006 nucleotidase study is general protein context, not a calcium experiment on the 2007 NADP assay. Its annotated peripheral inner-membrane location is on the cytoplasmic side and still does not resolve the physiological catalyst. The 2007 archaeal comparisons used MJ0109, AF2372 and MJ0917 constructs in separately specified BL21/OrigamiB expression contexts and assays at85°C with20 mM Mg, pH8.5. Their activities are not assigned to E. coli CysQ or to one physiological E. coli loop. A later paper’s estimate of approximately140 NADP molecules dephosphorylated per cell per second is a citation to older work, not a firsthand reconstruction of that experiment. The 1971/1973 primary bodies and abstracts were unavailable; their bibliographic records and native/later-paper framing remain explicitly secondary evidence for the historical turnover claim. PntAB is a dimer of heterodimers: two PntA and two PntB chains in the native complex. The UniProt heterodimer description denotes the protomer and does not conflict with the α2β2 assembly. Its cytoplasmic nucleotide-binding domains dI and dIII handle NAD(H) and NADP(H), while membrane domain dII couples them to proton movement; FAD is not assigned as a Pnt cofactor. Native historical annotation gives AB (Re–Si) specificity, transferring the pro-R hydrogen of NADH and pro-S hydrogen of NADPH; this is not a new stereochemical measurement in the 2021 experiment. The 2021 pSA2-derived pET16b construct was expressed in THO C43(DE3) Δcyo ΔpntAB with an alpha N-terminal His6 tag and thrombin site. Tag cleavage was not reported. DDM-purified protein and proteoliposomes represent distinct preparations. The 2021 natural forward NADH/NADP and reverse NADPH/NAD assays used their stated regenerating systems; APAD-dependent reverse and cyclic assays were separate. The cyclic reaction does not carry net proton transport. Reported apparent Km values were NADPH4.1±1.2 µM, NAD108±12 µM, NADP37±7 µM and NADH6.8±1 µM. The source gives fixed NADH as50 µM in Methods but500 µM in Results; those descriptions are not silently reconciled. Reconstitution incorporated65±10% protein, with approximately75±5% of reverse-active and85±5% of cyclic-active sites facing outward. These are proteoliposome orientation estimates, not an inversion of cellular topology. Reverse Pnt hydride transfer generated a proton gradient and supported a co-reconstituted ATP synthase. The βH91A variant, no-enzyme controls and ionophores tested the coupling; ATP synthesis belongs to the separate ATP synthase, not the Pnt stoichiometry. An ATPase-generated proton motive force stimulated NADPH formation7±1.8-fold without ionophore,6.4±0.8-fold with valinomycin, and1.6±0.3-fold with CCCP plus valinomycin. The proposed gated-channel and dIII-flip mechanisms are mechanistic interpretations. Thermus thermophilus structural models and prior domain experiments do not become an experimental E. coli full-complex structure. Older Pnt inhibitor papers were available as primary abstracts and native annotations. DCCD inhibits transhydrogenation and proton pumping; NADH protects, while NADP and, less strongly, NADPH accelerate inhibition. In the 1993 αD232/E238/E240 mutant series, the proteins retained40–90% activity and proton pumping, while triple substitutions reduced DCCD sensitivity. Those historical residues/preparations are distinct from the 2021 βH91A construct. NBD chloride modifies βC147/260 and other residues; NADPH protects some domain modification, but an NBD–NADPH reaction product is itself strongly inhibitory. The adduct has no invented exact chemical identity here. The 1999 Pnt topology abstract used cysteine-free, His-tagged single-cysteine variants in intact cells and inside-out membranes, supporting four alpha and nine beta membrane spans in that experimental model. Native comments also preserve older nucleotide-affinity, cysteine-free and βD213 contexts. These are source-specific topology and kinetic studies, not measurements on the 2021 preparation. Reference-chain residue numbering, domain models, tags and assay directions remain distinct. Soluble SthA, also called UdhA, is represented as an octamer with reference P27306. The 1999 cloning abstract corrected an N-terminal genome-sequencing error; its older7–8-subunit interpretation is retained alongside the exact native octamer and the later approximately440-kDa SEC/DLS estimate. The 2022 K12 sthA construct carried a C-terminal His10 tag in pBXC3H and was expressed in MC1061; FAD was added during lysis before affinity and SEC purification. Reviewed capacity is one FAD per subunit, whereas a native historical comment reports measured occupancy0.76 mol FAD/subunit. Partial FAD loss during SEC is preparation-dependent. Native B-stereospecificity is explicitly not experimentally determined. The 2022 kinetic assay followed NADH/thioNADP transhydrogenation, opposite to the supporting physiological NADPH-to-NAD reaction. ThioNADP is a surrogate, not NADP. At5 mM, AMP, ADP and ATP raised wild-type activity to160.7±2.9%,171.1±7.2% and148.2±8.9%. Corresponding C45A values were454.9%,991.8% and363.1%; T50C values were222.9%,319.2% and177.4%. Each series uses its own no-adenylate baseline:8.66±0.83,0.55±0.10 and0.92±0.18 µmol/min/mg for wild type, C45A and T50C. Large mutant percentages therefore do not imply higher absolute mutant activity or restore the wild-type mechanism. Sodium and potassium phosphate inhibited the 2022 SthA surrogate assay, approaching residual activities of approximately20–25% and15% around50 mM. NaCl/KCl controls showed no significant change through50 mM, but500 mM left approximately70% and40%; high ionic strength is not universally inert. The hydrogenphosphate reference node denotes phosphate-buffer chemistry, not isolation of one protonation species. NADH above7 mM gave substrate inhibition with KI12.1±2.0 mM at0.5 mM thioNADP; thioNADP itself had KI0.59±0.26 mM. Neither observation establishes inhibition by natural NADP under all conditions. SthA can also oxidize NADH or NADPH with oxygen in uncoupled assays, releasing predominantly hydrogen peroxide with some superoxide. No-enzyme blanks and anaerobic persistence of reduced flavin constrain that interpretation. The wild-type coupled assay partitioned approximately98% to thioNADPH and2% to ROS; C45A gave62.3% hydride-transfer and37.1% peroxide-associated partitioning, while T50C gave89.2% and10.2%, at much lower total transfer rates. Reported flavin-reduction k_red/Kd were303±50 s−1/88±27 µM for wild type,710±160/300±100 for C45A and2200±400/227±61 for T50C. These mutant and side-activity observations do not add an oxygen-consuming core reaction or establish a universal cellular ROS flux. The 2022 paper distinguishes the reference P27306 sequence from AlphaFold model AF-B7M718-F1 and modeling with Thermus thermophilus lipoamide dehydrogenase2EQ7; these are not an experimental structure of the exact reference chain. A12-nucleotide sthA/oxyR overlap motivated a redox-stress hypothesis but did not demonstrate an OxyR→sthA regulatory edge. The 2011 purified fused-EcSTH primary abstract describes NADPH/thio-NAD activity, Km68.29 and133.2 µM, optimum35°C and pH7.5, stimulation by adenylates at2 mM, and inhibition by Mn, Co, Zn, Ni and Cu. After30 min preincubation, strong inhibition persisted only for Zn, Ni and Cu. Full Methods and the exact fusion sequence were unavailable. Its description of excess-NADPH product inhibition is preserved as the source’s terminology even though NADPH is the named assay substrate; it is not converted into a different reaction direction. These abstract-level results do not replace the 2022 salt controls or wild-type His10 preparation. In the 2004 MG1655 deletion/13C study (PMID:14660605), aerobic M9 cultures at37°C with5 g/L carbon source supported different physiological roles: PntAB supplied an estimated35–45% of biosynthetic NADPH during glucose growth, while loss of pntAB slowed growth and increased oxidative pentose-phosphate compensation. Soluble UdhA was important on acetate and in a pgi-deficient state with excess NADPH, rather than being required for ordinary glucose growth in that study. Some complementation results were described as data not shown. Crude-extract NADPH/APAD reverse assays measured enzyme capacity, not the same quantity as in-vivo redox flux. A 2004 redox-linked transcriptional interpretation (PMID:14660605) was later tested more directly: the 2016 study (PMID:27488847) found no correlation of transhydrogenase promoter activities with NADPH pools or formation/consumption fluxes across the tested perturbations. Paraquat at10 µM induced the zwf positive control without inducing pntAB or sthA. This narrows the earlier model under those conditions; it does not assert that every redox perturbation is transcriptionally inert. The 2016 regulatory screen compared BW25113 with62 Keio transcription-factor deletions using low-copy whole-intergenic gfpmut2 reporters containing50–100 bp flanks. M9 cultures contained5 g/L glucose, glycerol or succinate at37°C; mid-exponential OD-normalized activity was taken over OD6000.7–1.5. All screen rows retain growth rates and deviations; most had two biological replicates and selected validations three. These are conditional expression responses. Below-threshold differences are not proof of absence, and a deletion response alone does not demonstrate direct promoter binding. IHF-alpha deletion reduced pntAB reporter activity to approximately0.15,0.16 and0.12 of wild type on succinate, glycerol and glucose, respectively. The IHF reference is an alpha/beta heterodimer; native component slots have no explicit coefficients, so the source descriptions are retained without inventing new component counts. Lrp deletion gave pntAB ratios0.43,0.42 and0.22 and sthA ratios1.43,1.68 and1.83 in the same carbon-source order; the main interpretation emphasized activation/repression on glycerol and glucose. ArgP activation of pntAB was identified on glucose and Fur activation on succinate. The proteins’ exact promoter-bound assemblies or metal states were not measured in this reporter study. The aerobic 2016 ArcA-deletion experiment increased sthA expression on glucose, but did not detect ArcA activation of pntAB. This is distinct from the 2014 anaerobic MG1655 study: ArcA-8myc ChIP and ΔarcA expression comparisons in M9 with0.2% glucose and0.1% ammonium chloride, with or without20 mmol KNO3 at37°C, supported pntAB activation and sthA repression. Native PHOSPHO-ARCA remains the cited active state, mapped to reference ArcA with phosphoaspartate54. The original supplementary promoter-region peaks and occupancies are retained in the evidence ledger; modern coordinates are not substituted for that source genome version. With a20-amino-acid mixture, H-NS and CRP repressed the pntAB reporter; basal-medium results were different, including CRP-deletion glucose ratios0.53 for pntAB and0.57 for sthA and failure of that mutant to grow on glycerol or succinate. Supplementary mixture-condition pntAB activities were WT274.91±5.93, H-NS deletion630.91±16.85, CRP deletion499.85±29.74, IHF deletion139.95 and Lrp deletion319.20. TyrR deletion lowered sthA activity from WT801.20±167.35 to332.83±14.09 in this supplementary screen. This supports conditional expression effects, not a measured direct interaction or a universal sign. At5 mM single amino acid, leucine lowered pntAB and increased sthA reporter activity; lysine and histidine lowered pntAB, and methionine increased sthA. Valine prevented growth in that experiment and is not assigned an inhibitory promoter edge. Exact reference amino-acid charge forms identify the molecules without claiming that the medium contained an isolated ionic species. Exogenous cAMP reduced normalized pntAB activity by roughly50%, with only a marginal sthA decrease, after normalization to two constitutive reporters and verification of increased CRP activity. Native cAMP-bound CRP and the CRP dimer are represented, but the native component slots provide no ligand coefficient; direct pntA binding and occupancy were not measured. The 2019 Lrp source used MG1655 ATCC47076 versus lrp::kan in MOPS0.2% glycerol,37°C,200 rpm, with MIN log OD6000.15–0.25 and transition OD6001.8–2.2. Native located assertions assign Lrp activation of pntA in log phase and phoA in transition, and repression of sthA in log phase. The full primary Methods were inspected, but the exact per-gene supplementary data were unavailable, so these target-level statements remain native curated assertions. The His-tagged Lrp used to generate antibody is not a tag on the cellular ChIP endpoint. The 2017 Nac/CsiR study induced FLAG-tagged regulators from pT7-FLAG-4 in MG1655 in LB,1 mM IPTG for2 h from OD6000.2, with paired ChIP-seq and RNA-seq. Nac’s bound pntA row has peak1675942, coverage45, distance−15 and published normalized FC0.372191; this is not the raw4.3/13.24 ratio. Its cysQ row has peak4434633, coverage22, distance−145 and FC2.176844. Target assignment used the study’s proximity/operon framework, not promoter-specific site mutagenesis. Separate30°C nitrogen-depletion validation does not define these two rows or establish CysQ as the physiological NADP phosphatase. All16 selected-gene workbook rows are retained, including duplicate pntB operon annotations. CsiR, now called GlaR in the issuing reference, gave RNA-seq fold changes cysQ1.407187, nadK0.754291, phoA0.756034, pntA2.793539, pntB0.440537 and sthA0.587882; neither pntA nor pntB appeared in its bound-target sheet. Their opposite expression signs are preserved as potentially indirect responses. Corresponding Nac values were cysQ2.176844, nadK0.683302, phoA0.878483, pntA0.372191, pntB0.645038 and sthA0.879588. The ratios outside the bound Nac joins are quantitative context without invented statistical significance or blanket promoter-binding edges. Phosphorylated PhoB activates phoA through the exact native regulator→promoter PM00071→transcription-unit TU00052→phoA join. Its reference is P0AFJ5/phoB/b0399,229 residues, with phosphoaspartate53 and phosphorylation-dependent dimer orientation retained in the endpoint. P0A9I3 is GcvR and is explicitly rejected as PhoB. The 2013 acidic/aerobic versus microaerobic findings are available only through the primary abstract and native context, not full-body access. The 2019 phosphate-starvation reporter work (PMID:30765722) used MG1655 promoter fragments, BCD2/msfgfp and pSEVA234/237 plasmids in DH10B resting cells at30°C over0–50 mM phosphate; synthetic Pliar constructs and modeled phosphorylation/feedback rates are separate from measured native-promoter outputs. Spot42 represses sthA in MG1655-derived strains. The 2011 Northern experiment used NM525 Δspf GS0433 with IPTG-induced pSpot42; the translational-fusion experiment used PM1205 Δspf GS0434 with pBAD sthA-lacZ from its TSS through9–15 codons,0.2% arabinose and ±1 mM IPTG for1 h. The table reports a−4.2±0.5 expression change. RegionIII mutation and compensatory target mutation support direct RNA pairing. The 2012 follow-up (PMID:22388518) discusses multiple pairing regions, including I and III, without establishing simultaneous binding stoichiometry. Its nanC structural probing and Hfq-deletion experiments are not transferred to sthA; the sthA Hfq context in the earlier table retains that earlier source’s evidence level. Regulator reference annotations are retained separately from the pathway experiments. Lrp and ArgP have homodimer annotations; H-NS can form dimers and higher oligomers; TyrR changes between dimeric and tyrosine/ATP-associated higher assemblies. TyrR ATP binding enhances tyrosine affinity, but no particular TyrR assembly was measured at sthA. H-NS Lys121 hydroxyisobutyrylation, Fur His118 UMPylation, ArgP proteolysis, and GlaR glutarate relief of repression at glaH are known protein contexts, not demonstrated intermediates of the transhydrogenase reporter responses. Those unrelated target-specific mechanisms are not recursively imported as new pathway regulatory edges. The bounded iModulonDB check queried the six exact pathway loci and inspected ten selected module-member tables. None contained an exact target-locus match in that selection; alias/product substring matches were excluded. This is computational context and a bounded negative result, not global absence from iModulonDB or causal regulatory evidence. The Pseudomonas PathBank kinase/transhydrogenase definition with an unresolved protein and the archaeal phosphatases remain separate cross-source candidates, not organism-equivalent substitutes for the E. coli evidence.

Pathway type
cofactor metabolism
Organism scope

Read the source YAML

Pathway network

115 nodes · 102 asserted directed edges

Arrows show recorded subject → object relationships, not necessarily metabolic flow. Select a node for details or an arrow for evidence. Scroll, zoom or find a node to explore.

Pathway network: NAD phosphorylation and dephosphorylation 115 nodes · 102 asserted directed edges. Every arrow links to its evidence table row; nodes link to their component details. Isolated declared components are retained. CHEBI:57540 — consumes → RHEA:18630; RHEA:18630 substrates includes CHEBI:57540 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.; Evidence: RHEA:18630consumes CHEBI:30616 — consumes → RHEA:18630; RHEA:18630 substrates includes CHEBI:30616 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.; Evidence: RHEA:18630consumes RHEA:18630 — produces → CHEBI:456216; RHEA:18630 products includes CHEBI:456216 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.; Evidence: RHEA:18630produces RHEA:18630 — produces → CHEBI:58349; RHEA:18630 products includes CHEBI:58349 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.; Evidence: RHEA:18630produces RHEA:18630 — produces → CHEBI:15378; RHEA:18630 products includes CHEBI:15378 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.; Evidence: RHEA:18630produces CHEBI:58349 — consumes → RHEA:28051; RHEA:28051 substrates includes CHEBI:58349 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.; Evidence: RHEA:28051consumes CHEBI:15377 — consumes → RHEA:28051; RHEA:28051 substrates includes CHEBI:15377 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.; Evidence: RHEA:28051consumes RHEA:28051 — produces → CHEBI:43474; RHEA:28051 products includes CHEBI:43474 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.; Evidence: RHEA:28051produces RHEA:28051 — produces → CHEBI:57540; RHEA:28051 products includes CHEBI:57540 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.; Evidence: RHEA:28051produces CHEBI:57945 — consumes → RHEA:47994; RHEA:47994 substrates includes CHEBI:57945 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.; Evidence: RHEA:47994consumes CHEBI:58349 — consumes → RHEA:47994; RHEA:47994 substrates includes CHEBI:58349 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.; Evidence: RHEA:47994consumes CHEBI:15378 — consumes → RHEA:47994; RHEA:47994 substrates includes CHEBI:15378 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity. This is the proton outside.; Evidence: RHEA:47994consumes RHEA:47994 — produces → CHEBI:57540; RHEA:47994 products includes CHEBI:57540 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.; Evidence: RHEA:47994produces RHEA:47994 — produces → CHEBI:57783; RHEA:47994 products includes CHEBI:57783 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.; Evidence: RHEA:47994produces RHEA:47994 — produces → CHEBI:15378; RHEA:47994 products includes CHEBI:15378 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity. This is the proton inside.; Evidence: RHEA:47994produces CHEBI:57540 — consumes → RHEA:11693; RHEA:11693 substrates includes CHEBI:57540 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.; Evidence: RHEA:11693consumes CHEBI:57783 — consumes → RHEA:11693; RHEA:11693 substrates includes CHEBI:57783 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.; Evidence: RHEA:11693consumes RHEA:11693 — produces → CHEBI:57945; RHEA:11693 products includes CHEBI:57945 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.; Evidence: RHEA:11693produces RHEA:11693 — produces → CHEBI:58349; RHEA:11693 products includes CHEBI:58349 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.; Evidence: RHEA:11693produces RHEA:18630 — part_of → MetaCyc:NADPHOS-DEPHOS-PWY; The native pathway reaction-list includes NAD-KIN-RXN; the full definition has three core transformations. This is a curated boundary, not proof of complete physiological flux in every listed taxon.; Evidence: MetaCyc:NADPHOS-DEPHOS-PWYpart of RHEA:28051 — part_of → MetaCyc:NADPHOS-DEPHOS-PWY; The native pathway reaction-list includes RXN-5822; the full definition has three core transformations. This is a curated boundary, not proof of complete physiological flux in every listed taxon.; Evidence: MetaCyc:NADPHOS-DEPHOS-PWYpart of RHEA:47994 — part_of → MetaCyc:NADPHOS-DEPHOS-PWY; The native pathway reaction-list includes TRANS-RXN0-277; the full definition has three core transformations. This is a curated boundary, not proof of complete physiological flux in every listed taxon.; Evidence: MetaCyc:NADPHOS-DEPHOS-PWYpart of EcoCyc:CPLX0-682 — catalyzes → RHEA:18630; The exact native enzyme/reaction join supports this catalytic assembly. Evidence codes and cited preparations remain source-qualified.; Evidence: EcoCyc:NAD-KIN-ENZRXNcatalyzes EcoCyc:ALKAPHOSPHA-CPLX — catalyzes → RHEA:28051; The exact native enzyme/reaction join supports this catalytic assembly. Evidence codes and cited preparations remain source-qualified. Its physiological-relevance flag does not establish cytosolic PhoA localization or complete cellular recycling.; Evidence: EcoCyc:ENZRXN0-7742catalyzes EcoCyc:PYRNUTRANSHYDROGEN-CPLX — catalyzes → RHEA:47994; The exact native enzyme/reaction join supports this catalytic assembly. Evidence codes and cited preparations remain source-qualified.; Evidence: EcoCyc:PYRNUTRANSHYDROGEN-ENZRXNcatalyzes EcoCyc:UDHA-CPLX — catalyzes → RHEA:11693; The exact native enzyme/reaction join supports this catalytic assembly. Evidence codes and cited preparations remain source-qualified. SthA is supporting soluble redox chemistry, outside the three native core members.; Evidence: EcoCyc:UDHA-ENZRXNcatalyzes EcoCyc:CPLX0-682 — has_part → UniProtKB:P0A7B3; The native component specifies 6 copies of MONOMER0-541; this is assembly stoichiometry, not a claim that an isolated chain is fully catalytic.; Evidence: EcoCyc:CPLX0-682, EcoCyc:MONOMER0-541, UniProtKB:P0A7B3, Entrez:947092has part EcoCyc:ALKAPHOSPHA-CPLX — has_part → UniProtKB:P00634; The native component specifies 2 copies of ALKAPHOSPHA-MONOMER; this is assembly stoichiometry, not a claim that an isolated chain is fully catalytic.; Evidence: EcoCyc:ALKAPHOSPHA-CPLX, EcoCyc:ALKAPHOSPHA-MONOMER, UniProtKB:P00634, Entrez:945041has part EcoCyc:PYRNUTRANSHYDROGEN-CPLX — has_part → UniProtKB:P07001; The native component specifies 2 copies of PNTA-MONOMER; this is assembly stoichiometry, not a claim that an isolated chain is fully catalytic.; Evidence: EcoCyc:PYRNUTRANSHYDROGEN-CPLX, EcoCyc:PNTA-MONOMER, UniProtKB:P07001, Entrez:946628has part EcoCyc:PYRNUTRANSHYDROGEN-CPLX — has_part → UniProtKB:P0AB67; The native component specifies 2 copies of PNTB-MONOMER; this is assembly stoichiometry, not a claim that an isolated chain is fully catalytic.; Evidence: EcoCyc:PYRNUTRANSHYDROGEN-CPLX, EcoCyc:PNTB-MONOMER, UniProtKB:P0AB67, Entrez:946144has part EcoCyc:UDHA-CPLX — has_part → UniProtKB:P27306; The native component specifies 8 copies of UDHA-MONOMER; this is assembly stoichiometry, not a claim that an isolated chain is fully catalytic.; Evidence: EcoCyc:UDHA-CPLX, EcoCyc:UDHA-MONOMER, UniProtKB:P27306, Entrez:948461has part EcoCyc:CPLX0-682 — catalyzes → RHEA:18630; subject experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N terminus MDNHFKCIGI differs at residue2 from current MNNHFKCIGI. This is separate from recombinant pSK67/BL21 and1987 K12 preparations.; Evidence PMID:11488932: Methods identify endogenous MG1655 cultivation/purification and Results the homogeneous hexamer. (Retained primary rendering lines L148–L177; printed table/section as stated); Evidence PMID:11488932: Measured native N terminus differs from the deduced YfjB sequence at residue2; recombinant pSK67 and native preparations remain distinct. (Retained primary rendering lines L279–L284; printed table/section as stated); Purified native NadK is a hexamer and phosphorylates NAD with ATP; other tested acceptors including NADH were not phosphorylated in the reported experiment.; Evidence: PMID:11488932catalyzes EcoCyc:CPLX0-682 — catalyzes → RHEA:18630; subject experimental construct: 2001 pSK67 yfjB from MG1655 cloned into pET14b with NcoI/BamHI and expressed in BL21(DE3)pLysS; empty SK45 control. No retained His tag is inferred from the vector name; the native N-terminal discrepancy remains separate.; Evidence PMID:11488932: Cloning/expression/purification Methods identify pSK67 and BL21(DE3)pLysS, with SK45 vector-only control. (Retained primary rendering lines L158–L168; printed table/section as stated); Recombinant yfjB expression and purified product support NadK activity; SK67 cell extract is highly active compared with the SK45 control.; Evidence: PMID:11488932catalyzes EcoCyc:CPLX0-682 — has_cofactor → CHEBI:18420; subject experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N terminus MDNHFKCIGI differs at residue2 from current MNNHFKCIGI. This is separate from recombinant pSK67/BL21 and1987 K12 preparations.; Evidence PMID:11488932: Methods identify endogenous MG1655 cultivation/purification and Results the homogeneous hexamer. (Retained primary rendering lines L148–L177; printed table/section as stated); Evidence PMID:11488932: Measured native N terminus differs from the deduced YfjB sequence at residue2; recombinant pSK67 and native preparations remain distinct. (Retained primary rendering lines L279–L284; printed table/section as stated); Mg2+ supports NadK in the1-mM replacement-metal assay. This is an alternative assay cofactor, not simultaneous occupancy or a preferred cellular metal assignment.; Evidence: PMID:11488932has cofactor EcoCyc:CPLX0-682 — has_cofactor → CHEBI:29035; subject experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N terminus MDNHFKCIGI differs at residue2 from current MNNHFKCIGI. This is separate from recombinant pSK67/BL21 and1987 K12 preparations.; Evidence PMID:11488932: Methods identify endogenous MG1655 cultivation/purification and Results the homogeneous hexamer. (Retained primary rendering lines L148–L177; printed table/section as stated); Evidence PMID:11488932: Measured native N terminus differs from the deduced YfjB sequence at residue2; recombinant pSK67 and native preparations remain distinct. (Retained primary rendering lines L279–L284; printed table/section as stated); Mn2+ supports NadK in the1-mM replacement-metal assay. This is an alternative assay cofactor, not simultaneous occupancy or a preferred cellular metal assignment.; Evidence: PMID:11488932has cofactor EcoCyc:CPLX0-682 — has_cofactor → CHEBI:29105; subject experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N terminus MDNHFKCIGI differs at residue2 from current MNNHFKCIGI. This is separate from recombinant pSK67/BL21 and1987 K12 preparations.; Evidence PMID:11488932: Methods identify endogenous MG1655 cultivation/purification and Results the homogeneous hexamer. (Retained primary rendering lines L148–L177; printed table/section as stated); Evidence PMID:11488932: Measured native N terminus differs from the deduced YfjB sequence at residue2; recombinant pSK67 and native preparations remain distinct. (Retained primary rendering lines L279–L284; printed table/section as stated); Zn2+ supports NadK in the1-mM replacement-metal assay. This is an alternative assay cofactor, not simultaneous occupancy or a preferred cellular metal assignment.; Evidence: PMID:11488932has cofactor EcoCyc:CPLX0-682 — has_cofactor → CHEBI:29108; subject experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N terminus MDNHFKCIGI differs at residue2 from current MNNHFKCIGI. This is separate from recombinant pSK67/BL21 and1987 K12 preparations.; Evidence PMID:11488932: Methods identify endogenous MG1655 cultivation/purification and Results the homogeneous hexamer. (Retained primary rendering lines L148–L177; printed table/section as stated); Evidence PMID:11488932: Measured native N terminus differs from the deduced YfjB sequence at residue2; recombinant pSK67 and native preparations remain distinct. (Retained primary rendering lines L279–L284; printed table/section as stated); Ca2+ supports NadK in the1-mM replacement-metal assay. This is an alternative assay cofactor, not simultaneous occupancy or a preferred cellular metal assignment.; Evidence: PMID:11488932has cofactor EcoCyc:CPLX0-682 — has_cofactor → CHEBI:48828; subject experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N terminus MDNHFKCIGI differs at residue2 from current MNNHFKCIGI. This is separate from recombinant pSK67/BL21 and1987 K12 preparations.; Evidence PMID:11488932: Methods identify endogenous MG1655 cultivation/purification and Results the homogeneous hexamer. (Retained primary rendering lines L148–L177; printed table/section as stated); Evidence PMID:11488932: Measured native N terminus differs from the deduced YfjB sequence at residue2; recombinant pSK67 and native preparations remain distinct. (Retained primary rendering lines L279–L284; printed table/section as stated); Co2+ supports NadK in the1-mM replacement-metal assay. This is an alternative assay cofactor, not simultaneous occupancy or a preferred cellular metal assignment.; Evidence: PMID:11488932has cofactor CHEBI:57945 — inhibits → EcoCyc:CPLX0-682; object experimental construct: 1987 K12, unspecified substrain, forced-aerated glycerol minimal medium at37°C, late-log harvest;93-fold partially purified and not homogeneous. It is not asserted identical to the2001 native or modern MG1655 reference preparation.; Evidence PMID:3025169: Methods describe the K12 growth/purification and Results explicitly state that the93-fold preparation was not homogeneous. (PDF 1,2; Materials and methods; Results Properties); The exact native regulation gives an allosteric negative sign for NADH acting on NAD-KIN-ENZRXN.; Evidence: EcoCyc:REG0-7644, PMID:3025169inhibits CHEBI:57783 — inhibits → EcoCyc:CPLX0-682; object experimental construct: 1987 K12, unspecified substrain, forced-aerated glycerol minimal medium at37°C, late-log harvest;93-fold partially purified and not homogeneous. It is not asserted identical to the2001 native or modern MG1655 reference preparation.; Evidence PMID:3025169: Methods describe the K12 growth/purification and Results explicitly state that the93-fold preparation was not homogeneous. (PDF 1,2; Materials and methods; Results Properties); The exact native regulation gives an allosteric negative sign for NADPH acting on NAD-KIN-ENZRXN.; Evidence: EcoCyc:REG0-7643, PMID:3025169inhibits CHEBI:58349 — inhibits → EcoCyc:CPLX0-682; object experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N terminus MDNHFKCIGI differs at residue2 from current MNNHFKCIGI. This is separate from recombinant pSK67/BL21 and1987 K12 preparations.; Evidence PMID:11488932: Methods identify endogenous MG1655 cultivation/purification and Results the homogeneous hexamer. (Retained primary rendering lines L148–L177; printed table/section as stated); Evidence PMID:11488932: Measured native N terminus differs from the deduced YfjB sequence at residue2; recombinant pSK67 and native preparations remain distinct. (Retained primary rendering lines L279–L284; printed table/section as stated); The2001 NADP additions give slight inhibition:83% and79% relative activity at50 and100µM. The1987 preparation showed no significant effect under its conditions.; Evidence: PMID:11488932, PMID:3025169inhibits CHEBI:31823 — inhibits → EcoCyc:CPLX0-682; object experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N terminus MDNHFKCIGI differs at residue2 from current MNNHFKCIGI. This is separate from recombinant pSK67/BL21 and1987 K12 preparations.; Evidence PMID:11488932: Methods identify endogenous MG1655 cultivation/purification and Results the homogeneous hexamer. (Retained primary rendering lines L148–L177; printed table/section as stated); Evidence PMID:11488932: Measured native N terminus differs from the deduced YfjB sequence at residue2; recombinant pSK67 and native preparations remain distinct. (Retained primary rendering lines L279–L284; printed table/section as stated); HgCl2 inhibits the purified NadK assay. Glucose-6-phosphate dehydrogenase replaced the inhibitor-sensitive isocitrate reporter in this experiment; HgCl2 is not relabeled as free mercury ion.; Evidence: PMID:11488932inhibits EcoCyc:ALKAPHOSPHA-CPLX — catalyzes → RHEA:28051; subject experimental construct: 1962 purified E. coli alkaline phosphatase; strain unspecified. GL, BAP, PV and HH fractions were used in the paper, but the TPN-to-DPN sentence identifies no particular fraction. No exact native sequence or mature isozyme is assigned.; Evidence PMID:13906598: Methods distinguish four purified preparations, with reported specific activities. (Retained primary rendering lines L179–L194; printed table/section as stated); Evidence PMID:13906598: The substrate-specificity passage reports TPN conversion to DPN without naming a preparation for that observation. (Retained primary rendering lines L552–L562; printed table/section as stated); Purified alkaline phosphatase converts historical TPN to DPN; this supports NADP hydrolysis in vitro without identifying a cytosolic physiological recycling enzyme.; Evidence: PMID:13906598catalyzes UniProtKB:P00634 — has_cofactor → CHEBI:29105; The reviewed PhoA annotation gives 2 Zn2+ per subunit. Per-chain binding capacity is not an assumed coefficient for the whole dimer or every historical preparation.; Evidence: UniProtKB:P00634has cofactor UniProtKB:P00634 — has_cofactor → CHEBI:18420; The reviewed PhoA annotation gives 1 Mg2+ per subunit. Per-chain binding capacity is not an assumed coefficient for the whole dimer or every historical preparation.; Evidence: UniProtKB:P00634has cofactor UniProtKB:P00634 — located_in → GO:0042597; The issuing annotation places PhoA in the periplasm; this does not establish cytosolic NADP turnover.; Evidence: UniProtKB:P00634located in UniProtKB:P22255 — catalyzes → RHEA:28051; subject experimental construct: 2007 E. coli AG1 ASKA GFP-free pCA24N CysQ, N-terminal His6 plus TDPALRA and C-terminal GLCGR extensions;37°C, pH8.0,10mM MgCl2. This tagged assay protein is not an established physiological NADP phosphatase.; Evidence PMID:17616624: Methods specify AG1 ASKA pCA24N, both terminal extensions and purified-CysQ assay conditions. (PDF 2; Cloning and expression; Assays; Purification); Tagged CysQ hydrolyzes NADP in vitro, while kinetic preferences and conditions led the authors to reject its assignment as the physiological E. coli NADP phosphatase.; Evidence: PMID:17616624, UniProtKB:P22255, Entrez:948728catalyzes UniProtKB:P22255 — has_cofactor → CHEBI:18420; subject experimental construct: 2007 E. coli AG1 ASKA GFP-free pCA24N CysQ, N-terminal His6 plus TDPALRA and C-terminal GLCGR extensions;37°C, pH8.0,10mM MgCl2. This tagged assay protein is not an established physiological NADP phosphatase.; Evidence PMID:17616624: Methods specify AG1 ASKA pCA24N, both terminal extensions and purified-CysQ assay conditions. (PDF 2; Cloning and expression; Assays; Purification); CysQ NADP(H)ase activity is maximal at10mM MgCl2 in this assay and undetectable at0.2mM; its PAPase has different Mg dependence.; Evidence: PMID:17616624has cofactor CHEBI:48607 — inhibits → UniProtKB:P22255; object experimental construct: 2007 E. coli AG1 ASKA GFP-free pCA24N CysQ, N-terminal His6 plus TDPALRA and C-terminal GLCGR extensions;37°C, pH8.0,10mM MgCl2. This tagged assay protein is not an established physiological NADP phosphatase.; Evidence PMID:17616624: Methods specify AG1 ASKA pCA24N, both terminal extensions and purified-CysQ assay conditions. (PDF 2; Cloning and expression; Assays; Purification); LiCl inhibits CysQ in a substrate-dependent assay: IC50 values70mM for NADP,60mM for NADPH,10mM for FBP,0.05mM for3-PAP and0.15mM for2-PAP. Table dashes mean not determined.; Evidence: PMID:17616624inhibits EcoCyc:PYRNUTRANSHYDROGEN-CPLX — catalyzes → RHEA:47994; subject experimental construct: 2021 E. coli THO C43(DE3) Δcyo ΔpntAB, pET16b/pSA2-derived PntAB with alpha N-terminal His6 and thrombin site; cleavage is not reported. DDM-purified protein and oriented proteoliposomes are distinct assay states, not native topology measurements.; Evidence PMID:34707181: Cloning, expression and purification Methods specify the THO host, alpha His6/thrombin construct and detergent purification. (XPath /article/body/sec[2]/sec[1] | /article/body/sec[2]/sec[2]); Natural NADH/NADP forward assays support proton-coupled transhydrogenation; reverse and cyclic APAD assays are separate, and the cyclic reaction has no net proton transport.; Evidence: PMID:34707181catalyzes UniProtKB:P07001 — located_in → GO:0005886; The issuing subcellular-location annotation places this reference PntAB subunit in the inner membrane as a multi-pass membrane protein.; Evidence: UniProtKB:P07001, UniProtKB:P07001, PMID:34707181located in UniProtKB:P0AB67 — located_in → GO:0005886; The issuing subcellular-location annotation places this reference PntAB subunit in the inner membrane as a multi-pass membrane protein.; Evidence: UniProtKB:P0AB67, UniProtKB:P0AB67, PMID:34707181located in CHEBI:53090 — inhibits → EcoCyc:PYRNUTRANSHYDROGEN-CPLX; object experimental construct: Historical purified E. coli transhydrogenase assays; full older bodies unavailable. The primary abstract and exact native regulation support inhibition, with preparation, cysteine variants and nucleotide-dependent protection retained separately.; Evidence PMID:3891338: The primary abstract reports inhibition of E. coli transhydrogenase by the named reagent; this is abstract-level preparation evidence, not access to full Methods. (resultList.result[id='3891338' and source='MED'].abstractText); The exact native regulation identifies the reagent, a negative sign and the PntAB enzymatic reaction.; Evidence: EcoCyc:REG0-8848, PMID:3891338inhibits CHEBI:78878 — inhibits → EcoCyc:PYRNUTRANSHYDROGEN-CPLX; object experimental construct: Historical purified E. coli transhydrogenase assays; full older bodies unavailable. The primary abstract and exact native regulation support inhibition, with preparation, cysteine variants and nucleotide-dependent protection retained separately.; Evidence PMID:10556628: The primary abstract reports inhibition of E. coli transhydrogenase by the named reagent; this is abstract-level preparation evidence, not access to full Methods. (resultList.result[id='10556628' and source='MED'].abstractText); The exact native regulation identifies the reagent, a negative sign and the PntAB enzymatic reaction.; Evidence: EcoCyc:REG0-9666, PMID:10556628inhibits EcoCyc:UDHA-CPLX — has_part → UniProtKB:P27306; subject experimental construct: 2022 K12 sthA in pBXC3H_SthA, C-terminal His10, expressed in MC1061; FAD added during lysis, affinity plus SEC purification. Wild-type sequence construct is distinct from C45A/T50C and the AF-B7M718-F1 structural model.; Evidence PMID:35933012: Results specify C-terminal His10 and Methods the MC1061 expression/purification with FAD-containing lysis buffer. (XPath /article/body/sec[1]/sec[1]/p[1] | /article/body/sec[3]/sec[2]/p); SEC and DLS support an approximately440-kDa octamer for the purified2022 construct; this does not establish filamentous assemblies reported for other species.; Evidence: PMID:35933012has part UniProtKB:P27306 — has_cofactor → CHEBI:57692; The issuing SthA annotation identifies one FAD per subunit as cofactor capacity.; Evidence: UniProtKB:P27306, EcoCyc:UDHA-ENZRXN, PMID:35933012has cofactor UniProtKB:P27306 — located_in → GO:0005829; The issuing reference places soluble SthA in the cytoplasm; unlike PntAB its redox reaction is not coupled to membrane proton translocation.; Evidence: UniProtKB:P27306located in CHEBI:456215 — activates → EcoCyc:UDHA-CPLX; object experimental construct: 2022 K12 sthA in pBXC3H_SthA, C-terminal His10, expressed in MC1061; FAD added during lysis, affinity plus SEC purification. Wild-type sequence construct is distinct from C45A/T50C and the AF-B7M718-F1 structural model.; Evidence PMID:35933012: Results specify C-terminal His10 and Methods the MC1061 expression/purification with FAD-containing lysis buffer. (XPath /article/body/sec[1]/sec[1]/p[1] | /article/body/sec[3]/sec[2]/p); At5mM, AMP increases the rate of NADH/thioNADP transhydrogenation by the2022 construct; this is an assay activation, not an additional phosphoryl donor.; Evidence: PMID:35933012, DOI:10.1016/j.jbc.2022.102304activates CHEBI:456216 — activates → EcoCyc:UDHA-CPLX; object experimental construct: 2022 K12 sthA in pBXC3H_SthA, C-terminal His10, expressed in MC1061; FAD added during lysis, affinity plus SEC purification. Wild-type sequence construct is distinct from C45A/T50C and the AF-B7M718-F1 structural model.; Evidence PMID:35933012: Results specify C-terminal His10 and Methods the MC1061 expression/purification with FAD-containing lysis buffer. (XPath /article/body/sec[1]/sec[1]/p[1] | /article/body/sec[3]/sec[2]/p); At5mM, ADP increases the rate of NADH/thioNADP transhydrogenation by the2022 construct; this is an assay activation, not an additional phosphoryl donor.; Evidence: PMID:35933012, DOI:10.1016/j.jbc.2022.102304activates CHEBI:30616 — activates → EcoCyc:UDHA-CPLX; object experimental construct: 2022 K12 sthA in pBXC3H_SthA, C-terminal His10, expressed in MC1061; FAD added during lysis, affinity plus SEC purification. Wild-type sequence construct is distinct from C45A/T50C and the AF-B7M718-F1 structural model.; Evidence PMID:35933012: Results specify C-terminal His10 and Methods the MC1061 expression/purification with FAD-containing lysis buffer. (XPath /article/body/sec[1]/sec[1]/p[1] | /article/body/sec[3]/sec[2]/p); At5mM, ATP increases the rate of NADH/thioNADP transhydrogenation by the2022 construct; this is an assay activation, not an additional phosphoryl donor.; Evidence: PMID:35933012, DOI:10.1016/j.jbc.2022.102304activates CHEBI:43474 — inhibits → EcoCyc:UDHA-CPLX; object experimental construct: 2022 K12 sthA in pBXC3H_SthA, C-terminal His10, expressed in MC1061; FAD added during lysis, affinity plus SEC purification. Wild-type sequence construct is distinct from C45A/T50C and the AF-B7M718-F1 structural model.; Evidence PMID:35933012: Results specify C-terminal His10 and Methods the MC1061 expression/purification with FAD-containing lysis buffer. (XPath /article/body/sec[1]/sec[1]/p[1] | /article/body/sec[3]/sec[2]/p); Sodium and potassium phosphate suppress NADH/thioNADP activity, leveling off around50mM. The reference phosphate node represents the buffer species; exact assay protonation is not isolated.; Evidence: PMID:35933012, DOI:10.1016/j.jbc.2022.102304inhibits CHEBI:57945 — inhibits → EcoCyc:UDHA-CPLX; object experimental construct: 2022 K12 sthA in pBXC3H_SthA, C-terminal His10, expressed in MC1061; FAD added during lysis, affinity plus SEC purification. Wild-type sequence construct is distinct from C45A/T50C and the AF-B7M718-F1 structural model.; Evidence PMID:35933012: Results specify C-terminal His10 and Methods the MC1061 expression/purification with FAD-containing lysis buffer. (XPath /article/body/sec[1]/sec[1]/p[1] | /article/body/sec[3]/sec[2]/p); With thioNADP fixed at0.5mM, NADH above7mM causes substrate inhibition; fitted KI12.1±2.0mM. This is not inhibition at every NADH concentration.; Evidence: PMID:35933012inhibits CHEBI:29035 — inhibits → EcoCyc:UDHA-CPLX; object experimental construct: 2011 purified fused E. coli STH; exact fusion sequence and full Methods were unavailable. The primary abstract measures NADPH/thio-NAD activity and reports time-dependent metal effects; this is distinct from2022 C-terminal His10 SthA.; Evidence PMID:21545646: The primary abstract specifies a fused purified EcSTH protein, NADPH/thio-NAD kinetics and time-dependent divalent-metal effects. (resultList.result[id='21545646' and source='MED'].abstractText); Mn2+ inhibits the2011 fused-SthA assay. After30min preincubation only Zn2+, Ni2+ and Cu2+ retain strong inhibition; exact metal salt and full experimental details were unavailable.; Evidence: PMID:21545646inhibits CHEBI:48828 — inhibits → EcoCyc:UDHA-CPLX; object experimental construct: 2011 purified fused E. coli STH; exact fusion sequence and full Methods were unavailable. The primary abstract measures NADPH/thio-NAD activity and reports time-dependent metal effects; this is distinct from2022 C-terminal His10 SthA.; Evidence PMID:21545646: The primary abstract specifies a fused purified EcSTH protein, NADPH/thio-NAD kinetics and time-dependent divalent-metal effects. (resultList.result[id='21545646' and source='MED'].abstractText); Co2+ inhibits the2011 fused-SthA assay. After30min preincubation only Zn2+, Ni2+ and Cu2+ retain strong inhibition; exact metal salt and full experimental details were unavailable.; Evidence: PMID:21545646inhibits CHEBI:29105 — inhibits → EcoCyc:UDHA-CPLX; object experimental construct: 2011 purified fused E. coli STH; exact fusion sequence and full Methods were unavailable. The primary abstract measures NADPH/thio-NAD activity and reports time-dependent metal effects; this is distinct from2022 C-terminal His10 SthA.; Evidence PMID:21545646: The primary abstract specifies a fused purified EcSTH protein, NADPH/thio-NAD kinetics and time-dependent divalent-metal effects. (resultList.result[id='21545646' and source='MED'].abstractText); Zn2+ inhibits the2011 fused-SthA assay. After30min preincubation only Zn2+, Ni2+ and Cu2+ retain strong inhibition; exact metal salt and full experimental details were unavailable.; Evidence: PMID:21545646inhibits CHEBI:49786 — inhibits → EcoCyc:UDHA-CPLX; object experimental construct: 2011 purified fused E. coli STH; exact fusion sequence and full Methods were unavailable. The primary abstract measures NADPH/thio-NAD activity and reports time-dependent metal effects; this is distinct from2022 C-terminal His10 SthA.; Evidence PMID:21545646: The primary abstract specifies a fused purified EcSTH protein, NADPH/thio-NAD kinetics and time-dependent divalent-metal effects. (resultList.result[id='21545646' and source='MED'].abstractText); Ni2+ inhibits the2011 fused-SthA assay. After30min preincubation only Zn2+, Ni2+ and Cu2+ retain strong inhibition; exact metal salt and full experimental details were unavailable.; Evidence: PMID:21545646inhibits CHEBI:29036 — inhibits → EcoCyc:UDHA-CPLX; object experimental construct: 2011 purified fused E. coli STH; exact fusion sequence and full Methods were unavailable. The primary abstract measures NADPH/thio-NAD activity and reports time-dependent metal effects; this is distinct from2022 C-terminal His10 SthA.; Evidence PMID:21545646: The primary abstract specifies a fused purified EcSTH protein, NADPH/thio-NAD kinetics and time-dependent divalent-metal effects. (resultList.result[id='21545646' and source='MED'].abstractText); Cu2+ inhibits the2011 fused-SthA assay. After30min preincubation only Zn2+, Ni2+ and Cu2+ retain strong inhibition; exact metal salt and full experimental details were unavailable.; Evidence: PMID:21545646inhibits EcoCyc:PC00027 — has_part → UniProtKB:P0A6X7; The native IHF complex contains the stated chain; native component slots give no coefficient, while the reviewed chain describes the alpha/beta heterodimer.; Evidence: EcoCyc:PC00027, EcoCyc:PD00347, UniProtKB:P0A6X7has part EcoCyc:PC00027 — has_part → UniProtKB:P0A6Y1; The native IHF complex contains the stated chain; native component slots give no coefficient, while the reviewed chain describes the alpha/beta heterodimer.; Evidence: EcoCyc:PC00027, EcoCyc:PD00348, UniProtKB:P0A6Y1has part EcoCyc:CPLX0-226 — has_part → EcoCyc:PC00004; The native cAMP-bound CRP complex contains the exact PC00004 CRP assembly; native component slots give no coefficient.; Evidence: EcoCyc:CPLX0-226has part EcoCyc:CPLX0-226 — has_part → CHEBI:58165; The native complex contains CAMP; no ligand coefficient is given in this component slot.; Evidence: EcoCyc:CPLX0-226, UniProtKB:P0ACJ8has part EcoCyc:PC00004 — has_part → UniProtKB:P0ACJ8; The native CRP assembly contains its reference protein chain; stoichiometry is source-local.; Evidence: EcoCyc:PC00004, UniProtKB:P0ACJ8, UniProtKB:P0ACJ8has part CHEBI:58165 — activates → UniProtKB:P0ACJ8; cAMP binding stabilizes the active DNA-binding conformation of CRP. This general allosteric annotation alone does not establish binding to the pntA promoter.; Evidence: UniProtKB:P0ACJ8activates EcoCyc:PC00027 — activates → Entrez:946628; subject experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein. IHF alpha deletion probes the heterodimer.; Evidence PMID:27488847: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity. (PDF 3,4; Methods: strain/growth, reporter construction and calculations); Loss of IHF alpha reduces pntAB reporter activity on succinate, glycerol and glucose. The source infers IHF activation; direct promoter binding is not demonstrated by this reporter experiment.; Evidence: PMID:27488847, Entrez:946628activates UniProtKB:P0ACJ0 — activates → Entrez:946628; subject experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein. ; Evidence PMID:27488847: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity. (PDF 3,4; Methods: strain/growth, reporter construction and calculations); Lrp deletion reduces pntAB promoter activity, with activation identified on glycerol and glucose; the full succinate result is retained in the supplementary screen.; Evidence: PMID:27488847, Entrez:946628, UniProtKB:P0ACJ0, UniProtKB:P0ACJ0activates UniProtKB:P0ACJ0 — inhibits → Entrez:948461; subject experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein. ; Evidence PMID:27488847: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity. (PDF 3,4; Methods: strain/growth, reporter construction and calculations); Lrp deletion increases sthA/udhA reporter activity on glycerol and glucose; this condition-specific repression is distinct from promoter occupancy.; Evidence: PMID:27488847, Entrez:948461, UniProtKB:P0ACJ0inhibits UniProtKB:P0A8S1 — activates → Entrez:946628; subject experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein. ; Evidence PMID:27488847: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity. (PDF 3,4; Methods: strain/growth, reporter construction and calculations); ArgP deletion lowers pntAB reporter activity on glucose. Direct promoter binding remains unshown in this study.; Evidence: PMID:27488847, Entrez:946628, UniProtKB:P0A8S1, UniProtKB:P0A8S1activates UniProtKB:P0A9A9 — activates → Entrez:946628; subject experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein. ; Evidence PMID:27488847: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity. (PDF 3,4; Methods: strain/growth, reporter construction and calculations); Fur deletion lowers pntAB reporter activity on succinate. This is a condition-limited expression inference, without direct promoter binding or measured Fur metal occupancy.; Evidence: PMID:27488847, Entrez:946628, UniProtKB:P0A9A9, UniProtKB:P0A9A9activates UniProtKB:P0A9Q1 — inhibits → Entrez:948461; subject experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein. ; Evidence PMID:27488847: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity. (PDF 3,4; Methods: strain/growth, reporter construction and calculations); ArcA deletion increases sthA/udhA reporter activity on glucose. The study detects no ArcA activation of pntAB in its aerobic conditions; phosphorylation state is not directly measured here.; Evidence: PMID:27488847, Entrez:948461, UniProtKB:P0A9Q1inhibits UniProtKB:P0ACF8 — inhibits → Entrez:946628; subject experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein. ; Evidence PMID:27488847: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity. (PDF 3,4; Methods: strain/growth, reporter construction and calculations); H-NS deletion increases pntAB promoter activity in glucose plus20 amino acids. Basal-medium outcomes differ; this is conditional repression without a demonstrated direct promoter interaction.; Evidence: PMID:27488847, Entrez:946628, UniProtKB:P0ACF8, UniProtKB:P0ACF8inhibits EcoCyc:CPLX0-226 — inhibits → Entrez:946628; subject experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein. cAMP occupancy and stoichiometry were unmeasured.; Evidence PMID:27488847: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity. (PDF 3,4; Methods: strain/growth, reporter construction and calculations); CRP deletion increases pntAB reporter activity with20 amino acids. The active cAMP-bound reference complex is inferred from known CRP biology; the study does not directly measure pntA promoter binding.; Evidence: PMID:27488847, Entrez:946628inhibits UniProtKB:P07604 — activates → Entrez:948461; subject experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein. ; Evidence PMID:27488847: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity. (PDF 3,4; Methods: strain/growth, reporter construction and calculations); In the amino-acid mixture screen, deleting TyrR lowers sthA reporter activity. This supplementary observation is expression-level evidence; no direct binding or defined TyrR oligomer was established.; Evidence: PMID:27488847, Entrez:948461, UniProtKB:P07604, DOI:10.1099/mic.0.000346activates CHEBI:57427 — inhibits → Entrez:946628; Leucine addition reduces pntAB reporter activity. WT BW25113 received5mM single amino acid in M9 glucose; this is a reporter response, not direct chemical binding to the gene or proven action through one regulator.; Evidence: PMID:27488847, Entrez:946628inhibits CHEBI:57427 — activates → Entrez:948461; Leucine addition increases sthA/udhA reporter activity. WT BW25113 received5mM single amino acid in M9 glucose; this is a reporter response, not direct chemical binding to the gene or proven action through one regulator.; Evidence: PMID:27488847, Entrez:948461activates CHEBI:32551 — inhibits → Entrez:946628; Lysine addition reduces pntAB reporter activity. WT BW25113 received5mM single amino acid in M9 glucose; this is a reporter response, not direct chemical binding to the gene or proven action through one regulator.; Evidence: PMID:27488847, Entrez:946628inhibits CHEBI:57595 — inhibits → Entrez:946628; Histidine addition reduces pntAB reporter activity. WT BW25113 received5mM single amino acid in M9 glucose; this is a reporter response, not direct chemical binding to the gene or proven action through one regulator.; Evidence: PMID:27488847, Entrez:946628inhibits CHEBI:57844 — activates → Entrez:948461; Methionine addition increases sthA/udhA reporter activity. WT BW25113 received5mM single amino acid in M9 glucose; this is a reporter response, not direct chemical binding to the gene or proven action through one regulator.; Evidence: PMID:27488847, Entrez:948461activates CHEBI:58165 — inhibits → Entrez:946628; Extracellular cAMP lowers pntAB promoter activity after normalization to two constitutive reporters; growth effects are controlled and CRP activity rises. This does not demonstrate direct pntA promoter binding.; Evidence: PMID:27488847inhibits UniProtKB:P0ACJ0 — activates → Entrez:945041; subject experimental construct: 2019 native Lrp in MG1655 ATCC47076 versus lrp::kan, MOPS0.2% glycerol,37°C,200rpm; MIN transition, OD6001.8–2.2. The antibody preparation is not a His tag on cellular Lrp. Exact per-gene supplementary data were unavailable; the target claim uses native annotation.; Evidence PMID:30420454: Methods specify MG1655 ATCC47076, lrp::kan, MIN medium, phase-specific harvest and antibody-based ChIP/RNA-seq. (PDF 16,17; Materials and methods); The exact native regulation reports this sign and gene target under the stated2019 phase-specific condition. This is a located curated assertion, not a claim to have read unavailable target supplementary rows.; Evidence: EcoCyc:REG0-15526, EcoCyc:PD00353, Entrez:945041activates UniProtKB:P0ACJ0 — activates → Entrez:946628; subject experimental construct: 2019 native Lrp in MG1655 ATCC47076 versus lrp::kan, MOPS0.2% glycerol,37°C,200rpm; MIN log, OD6000.15–0.25. The antibody preparation is not a His tag on cellular Lrp. Exact per-gene supplementary data were unavailable; the target claim uses native annotation.; Evidence PMID:30420454: Methods specify MG1655 ATCC47076, lrp::kan, MIN medium, phase-specific harvest and antibody-based ChIP/RNA-seq. (PDF 16,17; Materials and methods); The exact native regulation reports this sign and gene target under the stated2019 phase-specific condition. This is a located curated assertion, not a claim to have read unavailable target supplementary rows.; Evidence: EcoCyc:REG0-15529, EcoCyc:PD00353, Entrez:946628activates UniProtKB:P0ACJ0 — inhibits → Entrez:948461; subject experimental construct: 2019 native Lrp in MG1655 ATCC47076 versus lrp::kan, MOPS0.2% glycerol,37°C,200rpm; MIN log, OD6000.15–0.25. The antibody preparation is not a His tag on cellular Lrp. Exact per-gene supplementary data were unavailable; the target claim uses native annotation.; Evidence PMID:30420454: Methods specify MG1655 ATCC47076, lrp::kan, MIN medium, phase-specific harvest and antibody-based ChIP/RNA-seq. (PDF 16,17; Materials and methods); The exact native regulation reports this sign and gene target under the stated2019 phase-specific condition. This is a located curated assertion, not a claim to have read unavailable target supplementary rows.; Evidence: EcoCyc:REG0-15570, EcoCyc:PD00353, Entrez:948461inhibits UniProtKB:P0A9Q1 — activates → Entrez:946628; subject molecular state: Phosphorylated ArcA (native PHOSPHO-ARCA), mapped to reference P0A9Q1. The2014 binding preparation is ArcA-8myc in MG1655; expression comparisons use ΔarcA in anaerobic M9 glucose/ammonium±20mmol KNO3 at37°C. No active deletion protein is asserted.; Evidence EcoCyc:PHOSPHO-ARCA: The exact source state points to unmodified ARCA-MONOMER; state identity remains explicit rather than being treated as unmodified reference protein. (XPath /ptools-xml/Protein/unmodified-form); Evidence PMID:24699140: Methods specify ArcA-8myc, MG1655 derivatives, ΔarcA and anaerobic media with/without nitrate. (XPath /article/body/sec[4]/sec[1]/p); Evidence UniProtKB:P0A9Q1: The issuing ArcA reference has phosphoaspartate54; the active modified state is distinguished from the unmodified reference sequence. (entry[primaryAccession='P0A9Q1'].features[type='Modified residue']); Evidence UniProtKB:P0A9Q1: The issuing ArcA reference has phosphoaspartate54; the active modified state is distinguished from the unmodified reference sequence. (entry[primaryAccession='P0A9Q1'].features[type='Modified residue']); The native ArcA regulation records the exact sign, PHOSPHO-ARCA regulator and target gene under anaerobic source conditions.; Evidence: EcoCyc:REG0-14088, EcoCyc:REG0-14089, PMID:24699140, EcoCyc:ARCA-MONOMER, Entrez:946628, DOI:10.1371/journal.pgen.1004264.s009, DOI:10.1371/journal.pgen.1004264.s010activates UniProtKB:P0A9Q1 — inhibits → Entrez:948461; subject molecular state: Phosphorylated ArcA (native PHOSPHO-ARCA), mapped to reference P0A9Q1. The2014 binding preparation is ArcA-8myc in MG1655; expression comparisons use ΔarcA in anaerobic M9 glucose/ammonium±20mmol KNO3 at37°C. No active deletion protein is asserted.; Evidence EcoCyc:PHOSPHO-ARCA: The exact source state points to unmodified ARCA-MONOMER; state identity remains explicit rather than being treated as unmodified reference protein. (XPath /ptools-xml/Protein/unmodified-form); Evidence PMID:24699140: Methods specify ArcA-8myc, MG1655 derivatives, ΔarcA and anaerobic media with/without nitrate. (XPath /article/body/sec[4]/sec[1]/p); Evidence UniProtKB:P0A9Q1: The issuing ArcA reference has phosphoaspartate54; the active modified state is distinguished from the unmodified reference sequence. (entry[primaryAccession='P0A9Q1'].features[type='Modified residue']); Evidence UniProtKB:P0A9Q1: The issuing ArcA reference has phosphoaspartate54; the active modified state is distinguished from the unmodified reference sequence. (entry[primaryAccession='P0A9Q1'].features[type='Modified residue']); The native ArcA regulation records the exact sign, PHOSPHO-ARCA regulator and target gene under anaerobic source conditions.; Evidence: EcoCyc:REG0-14101, EcoCyc:REG0-14102, EcoCyc:REG0-14103, PMID:24699140, EcoCyc:ARCA-MONOMER, Entrez:948461, DOI:10.1371/journal.pgen.1004264.s009, DOI:10.1371/journal.pgen.1004264.s010inhibits UniProtKB:Q47005 — inhibits → Entrez:946628; subject experimental construct: 2017 pT7-FLAG-4 inducible FLAG-Nac in MG1655, LB,1mM IPTG for2h from OD6000.2; ChIP-seq and RNA-seq. The30°C nitrogen-depletion validation was separate and does not define these pntA/cysQ rows.; Evidence PMID:28061857: Primary Methods specify the inducible FLAG construct, host, LB induction and matched RNA-seq experiment. (XPath /article/body/sec[2]/sec[2]/p | /article/body/sec[2]/sec[4]/p); Nac-bound pntA row: peak1675942, coverage45, distance−15, published normalized FC0.372191; raw4.3/13.24 is not that normalized value.; Evidence: DOI:10.1186/s12918-016-0376-y, EcoCyc:G7072-MONOMER, Entrez:946628inhibits UniProtKB:Q47005 — activates → Entrez:948728; subject experimental construct: 2017 pT7-FLAG-4 inducible FLAG-Nac in MG1655, LB,1mM IPTG for2h from OD6000.2; ChIP-seq and RNA-seq. The30°C nitrogen-depletion validation was separate and does not define these pntA/cysQ rows.; Evidence PMID:28061857: Primary Methods specify the inducible FLAG construct, host, LB induction and matched RNA-seq experiment. (XPath /article/body/sec[2]/sec[2]/p | /article/body/sec[2]/sec[4]/p); Nac-bound cysQ row: peak4434633, coverage22, distance−145, published normalized FC2.176844. The row supports a condition-qualified binding/expression join.; Evidence: DOI:10.1186/s12918-016-0376-y, EcoCyc:G7072-MONOMER, Entrez:948728activates EcoCyc:SPF-RNA — inhibits → Entrez:948461; Spot42 represses sthA mRNA/translation in MG1655-derived NM525Δspf GS0433 Northern and PM1205Δspf GS0434 pBAD sthA-lacZ experiments. The fusion spans the TSS through9–15 codons;0.2% arabinose±1mM IPTG for1h, with regionIII and compensatory target mutants. This RNA construct context is explicit prose because endpoint qualifiers are restricted to proteins/complexes.; Evidence: EcoCyc:REG0-11863, PMID:21292161, PMID:21292161, Entrez:948461inhibits UniProtKB:P0AFJ5 — activates → Entrez:945041; subject molecular state: Phosphorylated PhoB (native PHOSPHO-PHOB), mapped to P0AFJ5 reference chain; phosphorylation-dependent dimer orientation is required for the active DNA-binding state. It is not an unmodified monomer or a synthetic-promoter preparation.; Evidence EcoCyc:PHOSPHO-PHOB: The native state identifies unmodified PHOB-MONOMER and explains phosphorylation-dependent dimer orientation and activation. (XPath /ptools-xml/Protein/unmodified-form | /ptools-xml/Protein/comment); Evidence UniProtKB:P0AFJ5: The issuing PhoB reference has phosphoaspartate53, supporting the stated phosphorylated endpoint; this is not an unmodified chain. (entry[primaryAccession='P0AFJ5'].features[type='Modified residue']); The native regulation identifies phosphorylated PhoB activating PM00071.; Evidence: EcoCyc:REG0-4617, EcoCyc:PM00071, EcoCyc:TU00052, EcoCyc:PHOB-MONOMER, Entrez:945041, UniProtKB:P0AFJ5activates UniProtKB:P0A7B3 — located_in → GO:0005829; The issuing NadK annotation places the reference protein in the cytoplasm, by rule-based inference rather than direct localization of every historical preparation.; Evidence: UniProtKB:P0A7B3located in UniProtKB:P22255 — located_in → GO:0005886; The issuing CysQ annotation describes a peripheral inner-membrane protein on the cytoplasmic side. This reference localization does not establish physiological NADP phosphatase function.; Evidence: UniProtKB:P22255located in CHEBI:29108 — inhibits → UniProtKB:P22255; The reviewed CysQ annotation reports calcium inhibition from the2006 bisphosphate-nucleotidase study. This is general enzyme context, not a measured calcium effect on the2007 NADP assay.; Evidence: UniProtKB:P22255inhibits UniProtKB:P37338 — activates → Entrez:946628; subject experimental construct: 2017 pT7-FLAG-4 induced CsiR in MG1655, LB,1mM IPTG for2h from OD6000.2. These RNA-seq rows are expression-only; neither pntA nor pntB occurs in the bound-target sheet. The current reference is GlaR/P37338.; Evidence PMID:28061857: The primary Methods identify FLAG-tagged inducible regulators and paired transcript measurements. (XPath /article/body/sec[2]/sec[2]/p | /article/body/sec[2]/sec[4]/p); Induced CsiR gives pntA normalized FC2.793539; no pntA bound-target row was found. The edge denotes a potentially indirect expression response.; Evidence: DOI:10.1186/s12918-016-0376-y, UniProtKB:P37338, Entrez:946628activates UniProtKB:P37338 — inhibits → Entrez:946144; subject experimental construct: 2017 pT7-FLAG-4 induced CsiR in MG1655, LB,1mM IPTG for2h from OD6000.2. These RNA-seq rows are expression-only; neither pntA nor pntB occurs in the bound-target sheet. The current reference is GlaR/P37338.; Evidence PMID:28061857: The primary Methods identify FLAG-tagged inducible regulators and paired transcript measurements. (XPath /article/body/sec[2]/sec[2]/p | /article/body/sec[2]/sec[4]/p); Induced CsiR gives pntB normalized FC0.440537, opposite to pntA; no pntB bound-target row was found. The edge denotes a potentially indirect expression response.; Evidence: DOI:10.1186/s12918-016-0376-y, UniProtKB:P37338, Entrez:946144inhibits NAD(1-); CHEBI:57540; Declared type: small_molecule small molecule NAD(1-) ATP(4-); CHEBI:30616; Declared type: small_molecule small molecule ATP(4-) ADP(3-); CHEBI:456216; Declared type: small_molecule small molecule ADP(3-) NADP(3-); CHEBI:58349; Declared type: small_molecule small molecule NADP(3-) hydron; CHEBI:15378; Declared type: small_molecule small molecule hydron water; CHEBI:15377; Declared type: small_molecule small molecule water hydrogenphosphate; CHEBI:43474; Declared type: small_molecule small molecule hydrogenphosphate NADH(2-); CHEBI:57945; Declared type: small_molecule small molecule NADH(2-) NADPH(4-); CHEBI:57783; Declared type: small_molecule small molecule NADPH(4-) adenosine 5'-monophosphate(2-); CHEBI:456215; Declared type: small_molecule small molecule adenosine 5'-monophosphate(2-) mercury dichloride; CHEBI:31823; Declared type: small_molecule small molecule mercury dichloride lithium chloride; CHEBI:48607; Declared type: small_molecule small molecule lithium chloride 1,3-dicyclohexylcarbodiimide; CHEBI:53090; Declared type: small_molecule small molecule 1,3-dicyclohexylcarbodiimide 4-chloro-7-nitrobenzofurazan; CHEBI:78878; Declared type: small_molecule small molecule 4-chloro-7-nitrobenzofurazan L-leucine zwitterion; CHEBI:57427; Declared type: small_molecule small molecule L-leucine zwitterion L-lysinium(1+); CHEBI:32551; Declared type: small_molecule small molecule L-lysinium(1+) L-histidine zwitterion; CHEBI:57595; Declared type: small_molecule small molecule L-histidine zwitterion L-methionine zwitterion; CHEBI:57844; Declared type: small_molecule small molecule L-methionine zwitterion 3',5'-cyclic AMP(1-); CHEBI:58165; Declared type: small_molecule small molecule 3',5'-cyclic AMP(1-) magnesium(2+); CHEBI:18420; Declared type: cofactor cofactor magnesium(2+) manganese(2+); CHEBI:29035; Declared type: cofactor cofactor manganese(2+) zinc(2+); CHEBI:29105; Declared type: cofactor cofactor zinc(2+) calcium(2+); CHEBI:29108; Declared type: cofactor cofactor calcium(2+) cobalt(2+); CHEBI:48828; Declared type: cofactor cofactor cobalt(2+) FAD(3-); CHEBI:57692; Declared type: cofactor cofactor FAD(3-) iron(2+); CHEBI:29033; Declared type: small_molecule small molecule iron(2+) copper(2+); CHEBI:29036; Declared type: small_molecule small molecule copper(2+) NAD kinase; UniProtKB:P0A7B3; Declared type: protein protein NAD kinase Alkaline phosphatase; UniProtKB:P00634; Declared type: protein protein Alkaline phosphatase NAD(P) transhydrogenase subunit alpha; UniProtKB:P07001; Declared type: protein protein NAD(P) transhydrogenase subunit alpha NAD(P) transhydrogenase subunit beta; UniProtKB:P0AB67; Declared type: protein protein NAD(P) transhydrogenase subunit beta Soluble pyridine nucleotide transhydrogenase; UniProtKB:P27306; Declared type: protein protein Soluble pyridine nucleotide transhydrogenase 3'(2'),5'-bisphosphate nucleotidase CysQ; UniProtKB:P22255; Declared type: protein protein 3'(2'),5'-bisphosphate nucleotidase CysQ Aerobic respiration control protein ArcA; UniProtKB:P0A9Q1; Declared type: protein protein Aerobic respiration control protein ArcA Phosphate regulon transcriptional regulatory protein PhoB; UniProtKB:P0AFJ5; Declared type: protein protein Phosphate regulon transcriptional regulatory protein PhoB Leucine-responsive regulatory protein; UniProtKB:P0ACJ0; Declared type: protein protein Leucine-responsive regulatory protein Nitrogen assimilation regulatory protein nac; UniProtKB:Q47005; Declared type: protein protein Nitrogen assimilation regulatory protein nac DNA-binding transcriptional dual regulator CRP; UniProtKB:P0ACJ8; Declared type: protein protein DNA-binding transcriptional dual regulator CRP Integration host factor subunit alpha; UniProtKB:P0A6X7; Declared type: protein protein Integration host factor subunit alpha Integration host factor subunit beta; UniProtKB:P0A6Y1; Declared type: protein protein Integration host factor subunit beta DNA-binding protein H-NS; UniProtKB:P0ACF8; Declared type: protein protein DNA-binding protein H-NS HTH-type transcriptional regulator ArgP; UniProtKB:P0A8S1; Declared type: protein protein HTH-type transcriptional regulator ArgP Ferric uptake regulation protein; UniProtKB:P0A9A9; Declared type: protein protein Ferric uptake regulation protein HTH-type transcriptional regulatory protein TyrR; UniProtKB:P07604; Declared type: protein protein HTH-type transcriptional regulatory protein TyrR HTH-type transcriptional repressor GlaR; UniProtKB:P37338; Declared type: protein protein HTH-type transcriptional repressor GlaR unnamed protein complex CPLX0-682; EcoCyc:CPLX0-682; Declared type: complex complex unnamed protein complex CPLX0-682 alkaline phosphatase; EcoCyc:ALKAPHOSPHA-CPLX; Declared type: complex complex alkaline phosphatase PntAB; EcoCyc:PYRNUTRANSHYDROGEN-CPLX; Declared type: complex complex PntAB soluble pyridine nucleotide transhydrogenase; EcoCyc:UDHA-CPLX; Declared type: complex complex soluble pyridine nucleotide transhydrogenase DNA-binding transcriptional dual regulator IHF; EcoCyc:PC00027; Declared type: complex complex DNA-binding transcriptional dual regulator IHF CRP-cyclic-AMP DNA-binding transcriptional dual regulator; EcoCyc:CPLX0-226; Declared type: complex complex CRP-cyclic-AMP DNA-binding transcriptional dual regulator small regulatory RNA Spot 42; EcoCyc:SPF-RNA; Declared type: rna rna small regulatory RNA Spot 42 phoA; Entrez:945041; Declared type: gene gene phoA pntA; Entrez:946628; Declared type: gene gene pntA pntB; Entrez:946144; Declared type: gene gene pntB sthA; Entrez:948461; Declared type: gene gene sthA cysQ; Entrez:948728; Declared type: gene gene cysQ cytosol; GO:0005829; Declared type: cellular_component cellular component cytosol plasma membrane; GO:0005886; Declared type: cellular_component cellular component plasma membrane periplasmic space; GO:0042597; Declared type: cellular_component cellular component periplasmic space nickel(2+); CHEBI:49786; Declared type: small_molecule small molecule nickel(2+) DNA-binding transcriptional dual regulator CRP; EcoCyc:PC00004; Declared type: complex complex DNA-binding transcriptional dual regulator CRP NAD(+) + ATP => ADP + NADP(+) + H(+); RHEA:18630; Declared type: molecular_activity; Source reaction direction: left_to_right molecular activity NAD(+) + ATP => ADP + NADP(+) + H(+) NADP(+) + H2O => phosphate + NAD(+); RHEA:28051; Declared type: molecular_activity; Source reaction direction: left_to_right molecular activity NADP(+) + H2O => phosphate + NAD(+) NADH + NADP(+) + H(+)(out) => NAD(+) + NADPH + H(+)(in); RHEA:47994; Declared type: molecular_activity; Source reaction direction: right_to_left molecular activity NADH + NADP(+) + H(+)(out) => NAD(+) + NADPH + H(+)(in) NAD(+) + NADPH => NADH + NADP(+); RHEA:11693; Declared type: molecular_activity; Source reaction direction: left_to_right molecular activity NAD(+) + NADPH => NADH + NADP(+) NAD phosphorylation and dephosphorylation; MetaCyc:NADPHOS-DEPHOS-PWY; Declared type: pathway pathway NAD phosphorylation and dephosphorylation unnamed protein complex CPLX0-682; EcoCyc:CPLX0-682; Declared type: complex; experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N terminus MDNHFKCIGI differs at residue2 from current MNNHFKCIGI. This is separate from recombinant pSK67/BL21 and1987 K12 preparations.; Evidence PMID:11488932: Methods identify endogenous MG1655 cultivation/purification and Results the homogeneous hexamer. (Retained primary rendering lines L148–L177; printed table/section as stated); Evidence PMID:11488932: Measured native N terminus differs from the deduced YfjB sequence at residue2; recombinant pSK67 and native preparations remain distinct. (Retained primary rendering lines L279–L284; printed table/section as stated) experimental construct unnamed protein complex CPLX0-682 [experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N…] unnamed protein complex CPLX0-682; EcoCyc:CPLX0-682; Declared type: complex; experimental construct: 2001 pSK67 yfjB from MG1655 cloned into pET14b with NcoI/BamHI and expressed in BL21(DE3)pLysS; empty SK45 control. No retained His tag is inferred from the vector name; the native N-terminal discrepancy remains separate.; Evidence PMID:11488932: Cloning/expression/purification Methods identify pSK67 and BL21(DE3)pLysS, with SK45 vector-only control. (Retained primary rendering lines L158–L168; printed table/section as stated) experimental construct unnamed protein complex CPLX0-682 [experimental construct: 2001 pSK67 yfjB from MG1655 cloned into pET14b with NcoI/BamHI and expressed in BL21(DE3)pLysS;…] unnamed protein complex CPLX0-682; EcoCyc:CPLX0-682; Declared type: complex; experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N terminus MDNHFKCIGI differs at residue2 from current MNNHFKCIGI. This is separate from recombinant pSK67/BL21 and1987 K12 preparations.; Evidence PMID:11488932: Methods identify endogenous MG1655 cultivation/purification and Results the homogeneous hexamer. (Retained primary rendering lines L148–L177; printed table/section as stated); Evidence PMID:11488932: Measured native N terminus differs from the deduced YfjB sequence at residue2; recombinant pSK67 and native preparations remain distinct. (Retained primary rendering lines L279–L284; printed table/section as stated) experimental construct unnamed protein complex CPLX0-682 [experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N…] unnamed protein complex CPLX0-682; EcoCyc:CPLX0-682; Declared type: complex; experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N terminus MDNHFKCIGI differs at residue2 from current MNNHFKCIGI. This is separate from recombinant pSK67/BL21 and1987 K12 preparations.; Evidence PMID:11488932: Methods identify endogenous MG1655 cultivation/purification and Results the homogeneous hexamer. (Retained primary rendering lines L148–L177; printed table/section as stated); Evidence PMID:11488932: Measured native N terminus differs from the deduced YfjB sequence at residue2; recombinant pSK67 and native preparations remain distinct. (Retained primary rendering lines L279–L284; printed table/section as stated) experimental construct unnamed protein complex CPLX0-682 [experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N…] unnamed protein complex CPLX0-682; EcoCyc:CPLX0-682; Declared type: complex; experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N terminus MDNHFKCIGI differs at residue2 from current MNNHFKCIGI. This is separate from recombinant pSK67/BL21 and1987 K12 preparations.; Evidence PMID:11488932: Methods identify endogenous MG1655 cultivation/purification and Results the homogeneous hexamer. (Retained primary rendering lines L148–L177; printed table/section as stated); Evidence PMID:11488932: Measured native N terminus differs from the deduced YfjB sequence at residue2; recombinant pSK67 and native preparations remain distinct. (Retained primary rendering lines L279–L284; printed table/section as stated) experimental construct unnamed protein complex CPLX0-682 [experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N…] unnamed protein complex CPLX0-682; EcoCyc:CPLX0-682; Declared type: complex; experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N terminus MDNHFKCIGI differs at residue2 from current MNNHFKCIGI. This is separate from recombinant pSK67/BL21 and1987 K12 preparations.; Evidence PMID:11488932: Methods identify endogenous MG1655 cultivation/purification and Results the homogeneous hexamer. (Retained primary rendering lines L148–L177; printed table/section as stated); Evidence PMID:11488932: Measured native N terminus differs from the deduced YfjB sequence at residue2; recombinant pSK67 and native preparations remain distinct. (Retained primary rendering lines L279–L284; printed table/section as stated) experimental construct unnamed protein complex CPLX0-682 [experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N…] unnamed protein complex CPLX0-682; EcoCyc:CPLX0-682; Declared type: complex; experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N terminus MDNHFKCIGI differs at residue2 from current MNNHFKCIGI. This is separate from recombinant pSK67/BL21 and1987 K12 preparations.; Evidence PMID:11488932: Methods identify endogenous MG1655 cultivation/purification and Results the homogeneous hexamer. (Retained primary rendering lines L148–L177; printed table/section as stated); Evidence PMID:11488932: Measured native N terminus differs from the deduced YfjB sequence at residue2; recombinant pSK67 and native preparations remain distinct. (Retained primary rendering lines L279–L284; printed table/section as stated) experimental construct unnamed protein complex CPLX0-682 [experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N…] unnamed protein complex CPLX0-682; EcoCyc:CPLX0-682; Declared type: complex; experimental construct: 1987 K12, unspecified substrain, forced-aerated glycerol minimal medium at37°C, late-log harvest;93-fold partially purified and not homogeneous. It is not asserted identical to the2001 native or modern MG1655 reference preparation.; Evidence PMID:3025169: Methods describe the K12 growth/purification and Results explicitly state that the93-fold preparation was not homogeneous. (PDF 1,2; Materials and methods; Results Properties) experimental construct unnamed protein complex CPLX0-682 [experimental construct: 1987 K12, unspecified substrain, forced-aerated glycerol minimal medium at37°C, late- log…] unnamed protein complex CPLX0-682; EcoCyc:CPLX0-682; Declared type: complex; experimental construct: 1987 K12, unspecified substrain, forced-aerated glycerol minimal medium at37°C, late-log harvest;93-fold partially purified and not homogeneous. It is not asserted identical to the2001 native or modern MG1655 reference preparation.; Evidence PMID:3025169: Methods describe the K12 growth/purification and Results explicitly state that the93-fold preparation was not homogeneous. (PDF 1,2; Materials and methods; Results Properties) experimental construct unnamed protein complex CPLX0-682 [experimental construct: 1987 K12, unspecified substrain, forced-aerated glycerol minimal medium at37°C, late- log…] unnamed protein complex CPLX0-682; EcoCyc:CPLX0-682; Declared type: complex; experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N terminus MDNHFKCIGI differs at residue2 from current MNNHFKCIGI. This is separate from recombinant pSK67/BL21 and1987 K12 preparations.; Evidence PMID:11488932: Methods identify endogenous MG1655 cultivation/purification and Results the homogeneous hexamer. (Retained primary rendering lines L148–L177; printed table/section as stated); Evidence PMID:11488932: Measured native N terminus differs from the deduced YfjB sequence at residue2; recombinant pSK67 and native preparations remain distinct. (Retained primary rendering lines L279–L284; printed table/section as stated) experimental construct unnamed protein complex CPLX0-682 [experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N…] unnamed protein complex CPLX0-682; EcoCyc:CPLX0-682; Declared type: complex; experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N terminus MDNHFKCIGI differs at residue2 from current MNNHFKCIGI. This is separate from recombinant pSK67/BL21 and1987 K12 preparations.; Evidence PMID:11488932: Methods identify endogenous MG1655 cultivation/purification and Results the homogeneous hexamer. (Retained primary rendering lines L148–L177; printed table/section as stated); Evidence PMID:11488932: Measured native N terminus differs from the deduced YfjB sequence at residue2; recombinant pSK67 and native preparations remain distinct. (Retained primary rendering lines L279–L284; printed table/section as stated) experimental construct unnamed protein complex CPLX0-682 [experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N…] alkaline phosphatase; EcoCyc:ALKAPHOSPHA-CPLX; Declared type: complex; experimental construct: 1962 purified E. coli alkaline phosphatase; strain unspecified. GL, BAP, PV and HH fractions were used in the paper, but the TPN-to-DPN sentence identifies no particular fraction. No exact native sequence or mature isozyme is assigned.; Evidence PMID:13906598: Methods distinguish four purified preparations, with reported specific activities. (Retained primary rendering lines L179–L194; printed table/section as stated); Evidence PMID:13906598: The substrate-specificity passage reports TPN conversion to DPN without naming a preparation for that observation. (Retained primary rendering lines L552–L562; printed table/section as stated) experimental construct alkaline phosphatase [experimental construct: 1962 purified E. coli alkaline phosphatase; strain unspecified. GL, BAP, PV and HH fractions were…] 3'(2'),5'-bisphosphate nucleotidase CysQ; UniProtKB:P22255; Declared type: protein; experimental construct: 2007 E. coli AG1 ASKA GFP-free pCA24N CysQ, N-terminal His6 plus TDPALRA and C-terminal GLCGR extensions;37°C, pH8.0,10mM MgCl2. This tagged assay protein is not an established physiological NADP phosphatase.; Evidence PMID:17616624: Methods specify AG1 ASKA pCA24N, both terminal extensions and purified-CysQ assay conditions. (PDF 2; Cloning and expression; Assays; Purification) experimental construct 3'(2'),5'-bisphosphate nucleotidase CysQ [experimental construct: 2007 E. coli AG1 ASKA GFP- free pCA24N CysQ, N-terminal His6 plus TDPALRA and C-terminal GLCGR…] 3'(2'),5'-bisphosphate nucleotidase CysQ; UniProtKB:P22255; Declared type: protein; experimental construct: 2007 E. coli AG1 ASKA GFP-free pCA24N CysQ, N-terminal His6 plus TDPALRA and C-terminal GLCGR extensions;37°C, pH8.0,10mM MgCl2. This tagged assay protein is not an established physiological NADP phosphatase.; Evidence PMID:17616624: Methods specify AG1 ASKA pCA24N, both terminal extensions and purified-CysQ assay conditions. (PDF 2; Cloning and expression; Assays; Purification) experimental construct 3'(2'),5'-bisphosphate nucleotidase CysQ [experimental construct: 2007 E. coli AG1 ASKA GFP- free pCA24N CysQ, N-terminal His6 plus TDPALRA and C-terminal GLCGR…] 3'(2'),5'-bisphosphate nucleotidase CysQ; UniProtKB:P22255; Declared type: protein; experimental construct: 2007 E. coli AG1 ASKA GFP-free pCA24N CysQ, N-terminal His6 plus TDPALRA and C-terminal GLCGR extensions;37°C, pH8.0,10mM MgCl2. This tagged assay protein is not an established physiological NADP phosphatase.; Evidence PMID:17616624: Methods specify AG1 ASKA pCA24N, both terminal extensions and purified-CysQ assay conditions. (PDF 2; Cloning and expression; Assays; Purification) experimental construct 3'(2'),5'-bisphosphate nucleotidase CysQ [experimental construct: 2007 E. coli AG1 ASKA GFP- free pCA24N CysQ, N-terminal His6 plus TDPALRA and C-terminal GLCGR…] PntAB; EcoCyc:PYRNUTRANSHYDROGEN-CPLX; Declared type: complex; experimental construct: 2021 E. coli THO C43(DE3) Δcyo ΔpntAB, pET16b/pSA2-derived PntAB with alpha N-terminal His6 and thrombin site; cleavage is not reported. DDM-purified protein and oriented proteoliposomes are distinct assay states, not native topology measurements.; Evidence PMID:34707181: Cloning, expression and purification Methods specify the THO host, alpha His6/thrombin construct and detergent purification. (XPath /article/body/sec[2]/sec[1] | /article/body/sec[2]/sec[2]) experimental construct PntAB [experimental construct: 2021 E. coli THO C43(DE3) Δcyo ΔpntAB, pET16b/pSA2-derived PntAB with alpha N-terminal His6 and…] PntAB; EcoCyc:PYRNUTRANSHYDROGEN-CPLX; Declared type: complex; experimental construct: Historical purified E. coli transhydrogenase assays; full older bodies unavailable. The primary abstract and exact native regulation support inhibition, with preparation, cysteine variants and nucleotide-dependent protection retained separately.; Evidence PMID:3891338: The primary abstract reports inhibition of E. coli transhydrogenase by the named reagent; this is abstract-level preparation evidence, not access to full Methods. (resultList.result[id='3891338' and source='MED'].abstractText) experimental construct PntAB [experimental construct: Historical purified E. coli transhydrogenase assays; full older bodies unavailable. The primary…] PntAB; EcoCyc:PYRNUTRANSHYDROGEN-CPLX; Declared type: complex; experimental construct: Historical purified E. coli transhydrogenase assays; full older bodies unavailable. The primary abstract and exact native regulation support inhibition, with preparation, cysteine variants and nucleotide-dependent protection retained separately.; Evidence PMID:10556628: The primary abstract reports inhibition of E. coli transhydrogenase by the named reagent; this is abstract-level preparation evidence, not access to full Methods. (resultList.result[id='10556628' and source='MED'].abstractText) experimental construct PntAB [experimental construct: Historical purified E. coli transhydrogenase assays; full older bodies unavailable. The primary…] soluble pyridine nucleotide transhydrogenase; EcoCyc:UDHA-CPLX; Declared type: complex; experimental construct: 2022 K12 sthA in pBXC3H_SthA, C-terminal His10, expressed in MC1061; FAD added during lysis, affinity plus SEC purification. Wild-type sequence construct is distinct from C45A/T50C and the AF-B7M718-F1 structural model.; Evidence PMID:35933012: Results specify C-terminal His10 and Methods the MC1061 expression/purification with FAD-containing lysis buffer. (XPath /article/body/sec[1]/sec[1]/p[1] | /article/body/sec[3]/sec[2]/p) experimental construct soluble pyridine nucleotide transhydrogenase [experimental construct: 2022 K12 sthA in pBXC3H_SthA, C-terminal His10, expressed in MC1061; FAD added during lysis,…] soluble pyridine nucleotide transhydrogenase; EcoCyc:UDHA-CPLX; Declared type: complex; experimental construct: 2022 K12 sthA in pBXC3H_SthA, C-terminal His10, expressed in MC1061; FAD added during lysis, affinity plus SEC purification. Wild-type sequence construct is distinct from C45A/T50C and the AF-B7M718-F1 structural model.; Evidence PMID:35933012: Results specify C-terminal His10 and Methods the MC1061 expression/purification with FAD-containing lysis buffer. (XPath /article/body/sec[1]/sec[1]/p[1] | /article/body/sec[3]/sec[2]/p) experimental construct soluble pyridine nucleotide transhydrogenase [experimental construct: 2022 K12 sthA in pBXC3H_SthA, C-terminal His10, expressed in MC1061; FAD added during lysis,…] soluble pyridine nucleotide transhydrogenase; EcoCyc:UDHA-CPLX; Declared type: complex; experimental construct: 2022 K12 sthA in pBXC3H_SthA, C-terminal His10, expressed in MC1061; FAD added during lysis, affinity plus SEC purification. Wild-type sequence construct is distinct from C45A/T50C and the AF-B7M718-F1 structural model.; Evidence PMID:35933012: Results specify C-terminal His10 and Methods the MC1061 expression/purification with FAD-containing lysis buffer. (XPath /article/body/sec[1]/sec[1]/p[1] | /article/body/sec[3]/sec[2]/p) experimental construct soluble pyridine nucleotide transhydrogenase [experimental construct: 2022 K12 sthA in pBXC3H_SthA, C-terminal His10, expressed in MC1061; FAD added during lysis,…] soluble pyridine nucleotide transhydrogenase; EcoCyc:UDHA-CPLX; Declared type: complex; experimental construct: 2022 K12 sthA in pBXC3H_SthA, C-terminal His10, expressed in MC1061; FAD added during lysis, affinity plus SEC purification. Wild-type sequence construct is distinct from C45A/T50C and the AF-B7M718-F1 structural model.; Evidence PMID:35933012: Results specify C-terminal His10 and Methods the MC1061 expression/purification with FAD-containing lysis buffer. (XPath /article/body/sec[1]/sec[1]/p[1] | /article/body/sec[3]/sec[2]/p) experimental construct soluble pyridine nucleotide transhydrogenase [experimental construct: 2022 K12 sthA in pBXC3H_SthA, C-terminal His10, expressed in MC1061; FAD added during lysis,…] soluble pyridine nucleotide transhydrogenase; EcoCyc:UDHA-CPLX; Declared type: complex; experimental construct: 2022 K12 sthA in pBXC3H_SthA, C-terminal His10, expressed in MC1061; FAD added during lysis, affinity plus SEC purification. Wild-type sequence construct is distinct from C45A/T50C and the AF-B7M718-F1 structural model.; Evidence PMID:35933012: Results specify C-terminal His10 and Methods the MC1061 expression/purification with FAD-containing lysis buffer. (XPath /article/body/sec[1]/sec[1]/p[1] | /article/body/sec[3]/sec[2]/p) experimental construct soluble pyridine nucleotide transhydrogenase [experimental construct: 2022 K12 sthA in pBXC3H_SthA, C-terminal His10, expressed in MC1061; FAD added during lysis,…] soluble pyridine nucleotide transhydrogenase; EcoCyc:UDHA-CPLX; Declared type: complex; experimental construct: 2022 K12 sthA in pBXC3H_SthA, C-terminal His10, expressed in MC1061; FAD added during lysis, affinity plus SEC purification. Wild-type sequence construct is distinct from C45A/T50C and the AF-B7M718-F1 structural model.; Evidence PMID:35933012: Results specify C-terminal His10 and Methods the MC1061 expression/purification with FAD-containing lysis buffer. (XPath /article/body/sec[1]/sec[1]/p[1] | /article/body/sec[3]/sec[2]/p) experimental construct soluble pyridine nucleotide transhydrogenase [experimental construct: 2022 K12 sthA in pBXC3H_SthA, C-terminal His10, expressed in MC1061; FAD added during lysis,…] soluble pyridine nucleotide transhydrogenase; EcoCyc:UDHA-CPLX; Declared type: complex; experimental construct: 2011 purified fused E. coli STH; exact fusion sequence and full Methods were unavailable. The primary abstract measures NADPH/thio-NAD activity and reports time-dependent metal effects; this is distinct from2022 C-terminal His10 SthA.; Evidence PMID:21545646: The primary abstract specifies a fused purified EcSTH protein, NADPH/thio-NAD kinetics and time-dependent divalent-metal effects. (resultList.result[id='21545646' and source='MED'].abstractText) experimental construct soluble pyridine nucleotide transhydrogenase [experimental construct: 2011 purified fused E. coli STH; exact fusion sequence and full Methods were unavailable. The…] soluble pyridine nucleotide transhydrogenase; EcoCyc:UDHA-CPLX; Declared type: complex; experimental construct: 2011 purified fused E. coli STH; exact fusion sequence and full Methods were unavailable. The primary abstract measures NADPH/thio-NAD activity and reports time-dependent metal effects; this is distinct from2022 C-terminal His10 SthA.; Evidence PMID:21545646: The primary abstract specifies a fused purified EcSTH protein, NADPH/thio-NAD kinetics and time-dependent divalent-metal effects. (resultList.result[id='21545646' and source='MED'].abstractText) experimental construct soluble pyridine nucleotide transhydrogenase [experimental construct: 2011 purified fused E. coli STH; exact fusion sequence and full Methods were unavailable. The…] soluble pyridine nucleotide transhydrogenase; EcoCyc:UDHA-CPLX; Declared type: complex; experimental construct: 2011 purified fused E. coli STH; exact fusion sequence and full Methods were unavailable. The primary abstract measures NADPH/thio-NAD activity and reports time-dependent metal effects; this is distinct from2022 C-terminal His10 SthA.; Evidence PMID:21545646: The primary abstract specifies a fused purified EcSTH protein, NADPH/thio-NAD kinetics and time-dependent divalent-metal effects. (resultList.result[id='21545646' and source='MED'].abstractText) experimental construct soluble pyridine nucleotide transhydrogenase [experimental construct: 2011 purified fused E. coli STH; exact fusion sequence and full Methods were unavailable. The…] soluble pyridine nucleotide transhydrogenase; EcoCyc:UDHA-CPLX; Declared type: complex; experimental construct: 2011 purified fused E. coli STH; exact fusion sequence and full Methods were unavailable. The primary abstract measures NADPH/thio-NAD activity and reports time-dependent metal effects; this is distinct from2022 C-terminal His10 SthA.; Evidence PMID:21545646: The primary abstract specifies a fused purified EcSTH protein, NADPH/thio-NAD kinetics and time-dependent divalent-metal effects. (resultList.result[id='21545646' and source='MED'].abstractText) experimental construct soluble pyridine nucleotide transhydrogenase [experimental construct: 2011 purified fused E. coli STH; exact fusion sequence and full Methods were unavailable. The…] soluble pyridine nucleotide transhydrogenase; EcoCyc:UDHA-CPLX; Declared type: complex; experimental construct: 2011 purified fused E. coli STH; exact fusion sequence and full Methods were unavailable. The primary abstract measures NADPH/thio-NAD activity and reports time-dependent metal effects; this is distinct from2022 C-terminal His10 SthA.; Evidence PMID:21545646: The primary abstract specifies a fused purified EcSTH protein, NADPH/thio-NAD kinetics and time-dependent divalent-metal effects. (resultList.result[id='21545646' and source='MED'].abstractText) experimental construct soluble pyridine nucleotide transhydrogenase [experimental construct: 2011 purified fused E. coli STH; exact fusion sequence and full Methods were unavailable. The…] DNA-binding transcriptional dual regulator IHF; EcoCyc:PC00027; Declared type: complex; experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein. IHF alpha deletion probes the heterodimer.; Evidence PMID:27488847: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity. (PDF 3,4; Methods: strain/growth, reporter construction and calculations) experimental construct DNA-binding transcriptional dual regulator IHF [experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional…] Leucine-responsive regulatory protein; UniProtKB:P0ACJ0; Declared type: protein; experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein. ; Evidence PMID:27488847: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity. (PDF 3,4; Methods: strain/growth, reporter construction and calculations) experimental construct Leucine-responsive regulatory protein [experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional…] Leucine-responsive regulatory protein; UniProtKB:P0ACJ0; Declared type: protein; experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein. ; Evidence PMID:27488847: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity. (PDF 3,4; Methods: strain/growth, reporter construction and calculations) experimental construct Leucine-responsive regulatory protein [experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional…] HTH-type transcriptional regulator ArgP; UniProtKB:P0A8S1; Declared type: protein; experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein. ; Evidence PMID:27488847: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity. (PDF 3,4; Methods: strain/growth, reporter construction and calculations) experimental construct HTH-type transcriptional regulator ArgP [experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole- intergenic gfpmut2 transcriptional…] Ferric uptake regulation protein; UniProtKB:P0A9A9; Declared type: protein; experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein. ; Evidence PMID:27488847: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity. (PDF 3,4; Methods: strain/growth, reporter construction and calculations) experimental construct Ferric uptake regulation protein [experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole- intergenic gfpmut2 transcriptional…] Aerobic respiration control protein ArcA; UniProtKB:P0A9Q1; Declared type: protein; experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein. ; Evidence PMID:27488847: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity. (PDF 3,4; Methods: strain/growth, reporter construction and calculations) experimental construct Aerobic respiration control protein ArcA [experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole- intergenic gfpmut2 transcriptional…] DNA-binding protein H-NS; UniProtKB:P0ACF8; Declared type: protein; experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein. ; Evidence PMID:27488847: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity. (PDF 3,4; Methods: strain/growth, reporter construction and calculations) experimental construct DNA-binding protein H-NS [experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional…] CRP-cyclic-AMP DNA-binding transcriptional dual regulator; EcoCyc:CPLX0-226; Declared type: complex; experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein. cAMP occupancy and stoichiometry were unmeasured.; Evidence PMID:27488847: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity. (PDF 3,4; Methods: strain/growth, reporter construction and calculations) experimental construct CRP-cyclic-AMP DNA-binding transcriptional dual regulator [experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole- intergenic gfpmut2 transcriptional…] HTH-type transcriptional regulatory protein TyrR; UniProtKB:P07604; Declared type: protein; experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein. ; Evidence PMID:27488847: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity. (PDF 3,4; Methods: strain/growth, reporter construction and calculations) experimental construct HTH-type transcriptional regulatory protein TyrR [experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional…] Leucine-responsive regulatory protein; UniProtKB:P0ACJ0; Declared type: protein; experimental construct: 2019 native Lrp in MG1655 ATCC47076 versus lrp::kan, MOPS0.2% glycerol,37°C,200rpm; MIN transition, OD6001.8–2.2. The antibody preparation is not a His tag on cellular Lrp. Exact per-gene supplementary data were unavailable; the target claim uses native annotation.; Evidence PMID:30420454: Methods specify MG1655 ATCC47076, lrp::kan, MIN medium, phase-specific harvest and antibody-based ChIP/RNA-seq. (PDF 16,17; Materials and methods) experimental construct Leucine-responsive regulatory protein [experimental construct: 2019 native Lrp in MG1655 ATCC47076 versus lrp::kan, MOPS0.2% glycerol,37°C,200rpm; MIN transition,…] Leucine-responsive regulatory protein; UniProtKB:P0ACJ0; Declared type: protein; experimental construct: 2019 native Lrp in MG1655 ATCC47076 versus lrp::kan, MOPS0.2% glycerol,37°C,200rpm; MIN log, OD6000.15–0.25. The antibody preparation is not a His tag on cellular Lrp. Exact per-gene supplementary data were unavailable; the target claim uses native annotation.; Evidence PMID:30420454: Methods specify MG1655 ATCC47076, lrp::kan, MIN medium, phase-specific harvest and antibody-based ChIP/RNA-seq. (PDF 16,17; Materials and methods) experimental construct Leucine-responsive regulatory protein [experimental construct: 2019 native Lrp in MG1655 ATCC47076 versus lrp::kan, MOPS0.2% glycerol,37°C,200rpm; MIN log,…] Leucine-responsive regulatory protein; UniProtKB:P0ACJ0; Declared type: protein; experimental construct: 2019 native Lrp in MG1655 ATCC47076 versus lrp::kan, MOPS0.2% glycerol,37°C,200rpm; MIN log, OD6000.15–0.25. The antibody preparation is not a His tag on cellular Lrp. Exact per-gene supplementary data were unavailable; the target claim uses native annotation.; Evidence PMID:30420454: Methods specify MG1655 ATCC47076, lrp::kan, MIN medium, phase-specific harvest and antibody-based ChIP/RNA-seq. (PDF 16,17; Materials and methods) experimental construct Leucine-responsive regulatory protein [experimental construct: 2019 native Lrp in MG1655 ATCC47076 versus lrp::kan, MOPS0.2% glycerol,37°C,200rpm; MIN log,…] Aerobic respiration control protein ArcA; UniProtKB:P0A9Q1; Declared type: protein; molecular state: Phosphorylated ArcA (native PHOSPHO-ARCA), mapped to reference P0A9Q1. The2014 binding preparation is ArcA-8myc in MG1655; expression comparisons use ΔarcA in anaerobic M9 glucose/ammonium±20mmol KNO3 at37°C. No active deletion protein is asserted.; Evidence EcoCyc:PHOSPHO-ARCA: The exact source state points to unmodified ARCA-MONOMER; state identity remains explicit rather than being treated as unmodified reference protein. (XPath /ptools-xml/Protein/unmodified-form); Evidence PMID:24699140: Methods specify ArcA-8myc, MG1655 derivatives, ΔarcA and anaerobic media with/without nitrate. (XPath /article/body/sec[4]/sec[1]/p); Evidence UniProtKB:P0A9Q1: The issuing ArcA reference has phosphoaspartate54; the active modified state is distinguished from the unmodified reference sequence. (entry[primaryAccession='P0A9Q1'].features[type='Modified residue']); Evidence UniProtKB:P0A9Q1: The issuing ArcA reference has phosphoaspartate54; the active modified state is distinguished from the unmodified reference sequence. (entry[primaryAccession='P0A9Q1'].features[type='Modified residue']) molecular state Aerobic respiration control protein ArcA [molecular state: Phosphorylated ArcA (native PHOSPHO-ARCA), mapped to reference P0A9Q1. The2014 binding preparation…] Aerobic respiration control protein ArcA; UniProtKB:P0A9Q1; Declared type: protein; molecular state: Phosphorylated ArcA (native PHOSPHO-ARCA), mapped to reference P0A9Q1. The2014 binding preparation is ArcA-8myc in MG1655; expression comparisons use ΔarcA in anaerobic M9 glucose/ammonium±20mmol KNO3 at37°C. No active deletion protein is asserted.; Evidence EcoCyc:PHOSPHO-ARCA: The exact source state points to unmodified ARCA-MONOMER; state identity remains explicit rather than being treated as unmodified reference protein. (XPath /ptools-xml/Protein/unmodified-form); Evidence PMID:24699140: Methods specify ArcA-8myc, MG1655 derivatives, ΔarcA and anaerobic media with/without nitrate. (XPath /article/body/sec[4]/sec[1]/p); Evidence UniProtKB:P0A9Q1: The issuing ArcA reference has phosphoaspartate54; the active modified state is distinguished from the unmodified reference sequence. (entry[primaryAccession='P0A9Q1'].features[type='Modified residue']); Evidence UniProtKB:P0A9Q1: The issuing ArcA reference has phosphoaspartate54; the active modified state is distinguished from the unmodified reference sequence. (entry[primaryAccession='P0A9Q1'].features[type='Modified residue']) molecular state Aerobic respiration control protein ArcA [molecular state: Phosphorylated ArcA (native PHOSPHO-ARCA), mapped to reference P0A9Q1. The2014 binding preparation…] Nitrogen assimilation regulatory protein nac; UniProtKB:Q47005; Declared type: protein; experimental construct: 2017 pT7-FLAG-4 inducible FLAG-Nac in MG1655, LB,1mM IPTG for2h from OD6000.2; ChIP-seq and RNA-seq. The30°C nitrogen-depletion validation was separate and does not define these pntA/cysQ rows.; Evidence PMID:28061857: Primary Methods specify the inducible FLAG construct, host, LB induction and matched RNA-seq experiment. (XPath /article/body/sec[2]/sec[2]/p | /article/body/sec[2]/sec[4]/p) experimental construct Nitrogen assimilation regulatory protein nac [experimental construct: 2017 pT7-FLAG-4 inducible FLAG-Nac in MG1655, LB,1mM IPTG for2h from OD6000.2; ChIP-seq and RNA-…] Nitrogen assimilation regulatory protein nac; UniProtKB:Q47005; Declared type: protein; experimental construct: 2017 pT7-FLAG-4 inducible FLAG-Nac in MG1655, LB,1mM IPTG for2h from OD6000.2; ChIP-seq and RNA-seq. The30°C nitrogen-depletion validation was separate and does not define these pntA/cysQ rows.; Evidence PMID:28061857: Primary Methods specify the inducible FLAG construct, host, LB induction and matched RNA-seq experiment. (XPath /article/body/sec[2]/sec[2]/p | /article/body/sec[2]/sec[4]/p) experimental construct Nitrogen assimilation regulatory protein nac [experimental construct: 2017 pT7-FLAG-4 inducible FLAG-Nac in MG1655, LB,1mM IPTG for2h from OD6000.2; ChIP-seq and RNA-…] Phosphate regulon transcriptional regulatory protein PhoB; UniProtKB:P0AFJ5; Declared type: protein; molecular state: Phosphorylated PhoB (native PHOSPHO-PHOB), mapped to P0AFJ5 reference chain; phosphorylation-dependent dimer orientation is required for the active DNA-binding state. It is not an unmodified monomer or a synthetic-promoter preparation.; Evidence EcoCyc:PHOSPHO-PHOB: The native state identifies unmodified PHOB-MONOMER and explains phosphorylation-dependent dimer orientation and activation. (XPath /ptools-xml/Protein/unmodified-form | /ptools-xml/Protein/comment); Evidence UniProtKB:P0AFJ5: The issuing PhoB reference has phosphoaspartate53, supporting the stated phosphorylated endpoint; this is not an unmodified chain. (entry[primaryAccession='P0AFJ5'].features[type='Modified residue']) molecular state Phosphate regulon transcriptional regulatory protein PhoB [molecular state: Phosphorylated PhoB (native PHOSPHO-PHOB), mapped to P0AFJ5 reference chain; phosphorylation-…] HTH-type transcriptional repressor GlaR; UniProtKB:P37338; Declared type: protein; experimental construct: 2017 pT7-FLAG-4 induced CsiR in MG1655, LB,1mM IPTG for2h from OD6000.2. These RNA-seq rows are expression-only; neither pntA nor pntB occurs in the bound-target sheet. The current reference is GlaR/P37338.; Evidence PMID:28061857: The primary Methods identify FLAG-tagged inducible regulators and paired transcript measurements. (XPath /article/body/sec[2]/sec[2]/p | /article/body/sec[2]/sec[4]/p) experimental construct HTH-type transcriptional repressor GlaR [experimental construct: 2017 pT7-FLAG-4 induced CsiR in MG1655, LB,1mM IPTG for2h from OD6000.2. These RNA-seq rows are…] HTH-type transcriptional repressor GlaR; UniProtKB:P37338; Declared type: protein; experimental construct: 2017 pT7-FLAG-4 induced CsiR in MG1655, LB,1mM IPTG for2h from OD6000.2. These RNA-seq rows are expression-only; neither pntA nor pntB occurs in the bound-target sheet. The current reference is GlaR/P37338.; Evidence PMID:28061857: The primary Methods identify FLAG-tagged inducible regulators and paired transcript measurements. (XPath /article/body/sec[2]/sec[2]/p | /article/body/sec[2]/sec[4]/p) experimental construct HTH-type transcriptional repressor GlaR [experimental construct: 2017 pT7-FLAG-4 induced CsiR in MG1655, LB,1mM IPTG for2h from OD6000.2. These RNA-seq rows are…]

Components and activities

Declared biological components and source reaction directions
NodeKind or roleSource direction
Escherichia coli
NCBITaxon:562
taxon
NAD(1-)
CHEBI:57540
small molecule
ATP(4-)
CHEBI:30616
small molecule
ADP(3-)
CHEBI:456216
small molecule
NADP(3-)
CHEBI:58349
small molecule
hydron
CHEBI:15378
small molecule
water
CHEBI:15377
small molecule
hydrogenphosphate
CHEBI:43474
small molecule
NADH(2-)
CHEBI:57945
small molecule
NADPH(4-)
CHEBI:57783
small molecule
adenosine 5'-monophosphate(2-)
CHEBI:456215
small molecule
mercury dichloride
CHEBI:31823
small molecule
lithium chloride
CHEBI:48607
small molecule
1,3-dicyclohexylcarbodiimide
CHEBI:53090
small molecule
4-chloro-7-nitrobenzofurazan
CHEBI:78878
small molecule
L-leucine zwitterion
CHEBI:57427
small molecule
L-lysinium(1+)
CHEBI:32551
small molecule
L-histidine zwitterion
CHEBI:57595
small molecule
L-methionine zwitterion
CHEBI:57844
small molecule
3',5'-cyclic AMP(1-)
CHEBI:58165
small molecule
magnesium(2+)
CHEBI:18420
cofactor
manganese(2+)
CHEBI:29035
cofactor
zinc(2+)
CHEBI:29105
cofactor
calcium(2+)
CHEBI:29108
cofactor
cobalt(2+)
CHEBI:48828
cofactor
FAD(3-)
CHEBI:57692
cofactor
iron(2+)
CHEBI:29033
small molecule
copper(2+)
CHEBI:29036
small molecule
NAD kinase
UniProtKB:P0A7B3
protein
Alkaline phosphatase
UniProtKB:P00634
protein
NAD(P) transhydrogenase subunit alpha
UniProtKB:P07001
protein
NAD(P) transhydrogenase subunit beta
UniProtKB:P0AB67
protein
Soluble pyridine nucleotide transhydrogenase
UniProtKB:P27306
protein
3'(2'),5'-bisphosphate nucleotidase CysQ
UniProtKB:P22255
protein
Aerobic respiration control protein ArcA
UniProtKB:P0A9Q1
protein
Phosphate regulon transcriptional regulatory protein PhoB
UniProtKB:P0AFJ5
protein
Leucine-responsive regulatory protein
UniProtKB:P0ACJ0
protein
Nitrogen assimilation regulatory protein nac
UniProtKB:Q47005
protein
DNA-binding transcriptional dual regulator CRP
UniProtKB:P0ACJ8
protein
Integration host factor subunit alpha
UniProtKB:P0A6X7
protein
Integration host factor subunit beta
UniProtKB:P0A6Y1
protein
DNA-binding protein H-NS
UniProtKB:P0ACF8
protein
HTH-type transcriptional regulator ArgP
UniProtKB:P0A8S1
protein
Ferric uptake regulation protein
UniProtKB:P0A9A9
protein
HTH-type transcriptional regulatory protein TyrR
UniProtKB:P07604
protein
HTH-type transcriptional repressor GlaR
UniProtKB:P37338
protein
unnamed protein complex CPLX0-682
EcoCyc:CPLX0-682
complex
alkaline phosphatase
EcoCyc:ALKAPHOSPHA-CPLX
complex
PntAB
EcoCyc:PYRNUTRANSHYDROGEN-CPLX
complex
soluble pyridine nucleotide transhydrogenase
EcoCyc:UDHA-CPLX
complex
DNA-binding transcriptional dual regulator IHF
EcoCyc:PC00027
complex
CRP-cyclic-AMP DNA-binding transcriptional dual regulator
EcoCyc:CPLX0-226
complex
small regulatory RNA Spot 42
EcoCyc:SPF-RNA
rna
phoA
Entrez:945041
gene
pntA
Entrez:946628
gene
pntB
Entrez:946144
gene
sthA
Entrez:948461
gene
cysQ
Entrez:948728
gene
cytosol
GO:0005829
cellular component
plasma membrane
GO:0005886
cellular component
periplasmic space
GO:0042597
cellular component
nickel(2+)
CHEBI:49786
small molecule
DNA-binding transcriptional dual regulator CRP
EcoCyc:PC00004
complex
NAD(+) + ATP => ADP + NADP(+) + H(+)
RHEA:18630
molecular activityleft to right
NADP(+) + H2O => phosphate + NAD(+)
RHEA:28051
molecular activityleft to right
NADH + NADP(+) + H(+)(out) => NAD(+) + NADPH + H(+)(in)
RHEA:47994
molecular activityright to left
NAD(+) + NADPH => NADH + NADP(+)
RHEA:11693
molecular activityleft to right

Mechanistic edges

Mechanistic edges and their cited evidence
SubjectPredicate and descriptionObjectEvidence
NAD(1-)
CHEBI:57540
consumes

RHEA:18630 substrates includes CHEBI:57540 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

NAD(+) + ATP => ADP + NADP(+) + H(+)
RHEA:18630
  • RHEA:18630

    Source assertion: RHEA:18630 substrates includes CHEBI:57540 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

    Source locationRHEA:18630 rh:substrates; http://rdf.rhea-db.org/Participant_18629_compound_3484 rh:compound http://rdf.rhea-db.org/Compound_3484; rh:contains1
ATP(4-)
CHEBI:30616
consumes

RHEA:18630 substrates includes CHEBI:30616 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

NAD(+) + ATP => ADP + NADP(+) + H(+)
RHEA:18630
  • RHEA:18630

    Source assertion: RHEA:18630 substrates includes CHEBI:30616 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

    Source locationRHEA:18630 rh:substrates; http://rdf.rhea-db.org/Participant_18629_compound_6372 rh:compound http://rdf.rhea-db.org/Compound_6372; rh:contains1
NAD(+) + ATP => ADP + NADP(+) + H(+)
RHEA:18630
produces

RHEA:18630 products includes CHEBI:456216 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

ADP(3-)
CHEBI:456216
  • RHEA:18630

    Source assertion: RHEA:18630 products includes CHEBI:456216 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

    Source locationRHEA:18630 rh:products; http://rdf.rhea-db.org/Participant_18629_compound_2710 rh:compound http://rdf.rhea-db.org/Compound_2710; rh:contains1
NAD(+) + ATP => ADP + NADP(+) + H(+)
RHEA:18630
produces

RHEA:18630 products includes CHEBI:58349 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

NADP(3-)
CHEBI:58349
  • RHEA:18630

    Source assertion: RHEA:18630 products includes CHEBI:58349 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

    Source locationRHEA:18630 rh:products; http://rdf.rhea-db.org/Participant_18629_compound_5188 rh:compound http://rdf.rhea-db.org/Compound_5188; rh:contains1
NAD(+) + ATP => ADP + NADP(+) + H(+)
RHEA:18630
produces

RHEA:18630 products includes CHEBI:15378 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

hydron
CHEBI:15378
  • RHEA:18630

    Source assertion: RHEA:18630 products includes CHEBI:15378 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

    Source locationRHEA:18630 rh:products; http://rdf.rhea-db.org/Participant_18629_compound_3249 rh:compound http://rdf.rhea-db.org/Compound_3249; rh:contains1
NADP(3-)
CHEBI:58349
consumes

RHEA:28051 substrates includes CHEBI:58349 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

NADP(+) + H2O => phosphate + NAD(+)
RHEA:28051
  • RHEA:28051

    Source assertion: RHEA:28051 substrates includes CHEBI:58349 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

    Source locationRHEA:28051 rh:substrates; http://rdf.rhea-db.org/Participant_28050_compound_5188 rh:compound http://rdf.rhea-db.org/Compound_5188; rh:contains1
water
CHEBI:15377
consumes

RHEA:28051 substrates includes CHEBI:15377 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

NADP(+) + H2O => phosphate + NAD(+)
RHEA:28051
  • RHEA:28051

    Source assertion: RHEA:28051 substrates includes CHEBI:15377 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

    Source locationRHEA:28051 rh:substrates; http://rdf.rhea-db.org/Participant_28050_compound_1283 rh:compound http://rdf.rhea-db.org/Compound_1283; rh:contains1
NADP(+) + H2O => phosphate + NAD(+)
RHEA:28051
produces

RHEA:28051 products includes CHEBI:43474 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

hydrogenphosphate
CHEBI:43474
  • RHEA:28051

    Source assertion: RHEA:28051 products includes CHEBI:43474 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

    Source locationRHEA:28051 rh:products; http://rdf.rhea-db.org/Participant_28050_compound_5518 rh:compound http://rdf.rhea-db.org/Compound_5518; rh:contains1
NADP(+) + H2O => phosphate + NAD(+)
RHEA:28051
produces

RHEA:28051 products includes CHEBI:57540 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

NAD(1-)
CHEBI:57540
  • RHEA:28051

    Source assertion: RHEA:28051 products includes CHEBI:57540 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

    Source locationRHEA:28051 rh:products; http://rdf.rhea-db.org/Participant_28050_compound_3484 rh:compound http://rdf.rhea-db.org/Compound_3484; rh:contains1
NADH(2-)
CHEBI:57945
consumes

RHEA:47994 substrates includes CHEBI:57945 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

NADH + NADP(+) + H(+)(out) => NAD(+) + NADPH + H(+)(in)
RHEA:47994
  • RHEA:47994

    Source assertion: RHEA:47994 substrates includes CHEBI:57945 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

    Source locationRHEA:47994 rh:substrates; http://rdf.rhea-db.org/Participant_47992_compound_1650 rh:compound http://rdf.rhea-db.org/Compound_1650; rh:contains1
NADP(3-)
CHEBI:58349
consumes

RHEA:47994 substrates includes CHEBI:58349 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

NADH + NADP(+) + H(+)(out) => NAD(+) + NADPH + H(+)(in)
RHEA:47994
  • RHEA:47994

    Source assertion: RHEA:47994 substrates includes CHEBI:58349 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

    Source locationRHEA:47994 rh:substrates; http://rdf.rhea-db.org/Participant_47992_compound_5188 rh:compound http://rdf.rhea-db.org/Compound_5188; rh:contains1
hydron
CHEBI:15378
consumes

RHEA:47994 substrates includes CHEBI:15378 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity. This is the proton outside.

NADH + NADP(+) + H(+)(out) => NAD(+) + NADPH + H(+)(in)
RHEA:47994
  • RHEA:47994

    Source assertion: RHEA:47994 substrates includes CHEBI:15378 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity. This is the proton outside.

    Source locationRHEA:47994 rh:substrates; http://rdf.rhea-db.org/Participant_47992_compound_3249_out rh:compound http://rdf.rhea-db.org/Compound_3249; rh:contains1
NADH + NADP(+) + H(+)(out) => NAD(+) + NADPH + H(+)(in)
RHEA:47994
produces

RHEA:47994 products includes CHEBI:57540 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

NAD(1-)
CHEBI:57540
  • RHEA:47994

    Source assertion: RHEA:47994 products includes CHEBI:57540 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

    Source locationRHEA:47994 rh:products; http://rdf.rhea-db.org/Participant_47992_compound_3484 rh:compound http://rdf.rhea-db.org/Compound_3484; rh:contains1
NADH + NADP(+) + H(+)(out) => NAD(+) + NADPH + H(+)(in)
RHEA:47994
produces

RHEA:47994 products includes CHEBI:57783 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

NADPH(4-)
CHEBI:57783
  • RHEA:47994

    Source assertion: RHEA:47994 products includes CHEBI:57783 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

    Source locationRHEA:47994 rh:products; http://rdf.rhea-db.org/Participant_47992_compound_3438 rh:compound http://rdf.rhea-db.org/Compound_3438; rh:contains1
NADH + NADP(+) + H(+)(out) => NAD(+) + NADPH + H(+)(in)
RHEA:47994
produces

RHEA:47994 products includes CHEBI:15378 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity. This is the proton inside.

hydron
CHEBI:15378
  • RHEA:47994

    Source assertion: RHEA:47994 products includes CHEBI:15378 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity. This is the proton inside.

    Source locationRHEA:47994 rh:products; http://rdf.rhea-db.org/Participant_47992_compound_3249_in rh:compound http://rdf.rhea-db.org/Compound_3249; rh:contains1
NAD(1-)
CHEBI:57540
consumes

RHEA:11693 substrates includes CHEBI:57540 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

NAD(+) + NADPH => NADH + NADP(+)
RHEA:11693
  • RHEA:11693

    Source assertion: RHEA:11693 substrates includes CHEBI:57540 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

    Source locationRHEA:11693 rh:substrates; http://rdf.rhea-db.org/Participant_11692_compound_3484 rh:compound http://rdf.rhea-db.org/Compound_3484; rh:contains1
NADPH(4-)
CHEBI:57783
consumes

RHEA:11693 substrates includes CHEBI:57783 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

NAD(+) + NADPH => NADH + NADP(+)
RHEA:11693
  • RHEA:11693

    Source assertion: RHEA:11693 substrates includes CHEBI:57783 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

    Source locationRHEA:11693 rh:substrates; http://rdf.rhea-db.org/Participant_11692_compound_3438 rh:compound http://rdf.rhea-db.org/Compound_3438; rh:contains1
NAD(+) + NADPH => NADH + NADP(+)
RHEA:11693
produces

RHEA:11693 products includes CHEBI:57945 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

NADH(2-)
CHEBI:57945
  • RHEA:11693

    Source assertion: RHEA:11693 products includes CHEBI:57945 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

    Source locationRHEA:11693 rh:products; http://rdf.rhea-db.org/Participant_11692_compound_1650 rh:compound http://rdf.rhea-db.org/Compound_1650; rh:contains1
NAD(+) + NADPH => NADH + NADP(+)
RHEA:11693
produces

RHEA:11693 products includes CHEBI:58349 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

NADP(3-)
CHEBI:58349
  • RHEA:11693

    Source assertion: RHEA:11693 products includes CHEBI:58349 with coefficient 1; the issuing participant and containsN chain establish the exact charge form and multiplicity.

    Source locationRHEA:11693 rh:products; http://rdf.rhea-db.org/Participant_11692_compound_5188 rh:compound http://rdf.rhea-db.org/Compound_5188; rh:contains1
NAD(+) + ATP => ADP + NADP(+) + H(+)
RHEA:18630
part_of

The native pathway reaction-list includes NAD-KIN-RXN; the full definition has three core transformations. This is a curated boundary, not proof of complete physiological flux in every listed taxon.

MetaCyc:NADPHOS-DEPHOS-PWY
  • MetaCyc:NADPHOS-DEPHOS-PWY

    Source assertion: The native pathway reaction-list includes NAD-KIN-RXN; the full definition has three core transformations. This is a curated boundary, not proof of complete physiological flux in every listed taxon.

    Source locationXPath /ptools-xml/Pathway/reaction-list/Reaction[@frameid="NAD-KIN-RXN"]
NADP(+) + H2O => phosphate + NAD(+)
RHEA:28051
part_of

The native pathway reaction-list includes RXN-5822; the full definition has three core transformations. This is a curated boundary, not proof of complete physiological flux in every listed taxon.

MetaCyc:NADPHOS-DEPHOS-PWY
  • MetaCyc:NADPHOS-DEPHOS-PWY

    Source assertion: The native pathway reaction-list includes RXN-5822; the full definition has three core transformations. This is a curated boundary, not proof of complete physiological flux in every listed taxon.

    Source locationXPath /ptools-xml/Pathway/reaction-list/Reaction[@frameid="RXN-5822"]
NADH + NADP(+) + H(+)(out) => NAD(+) + NADPH + H(+)(in)
RHEA:47994
part_of

The native pathway reaction-list includes TRANS-RXN0-277; the full definition has three core transformations. This is a curated boundary, not proof of complete physiological flux in every listed taxon.

MetaCyc:NADPHOS-DEPHOS-PWY
  • MetaCyc:NADPHOS-DEPHOS-PWY

    Source assertion: The native pathway reaction-list includes TRANS-RXN0-277; the full definition has three core transformations. This is a curated boundary, not proof of complete physiological flux in every listed taxon.

    Source locationXPath /ptools-xml/Pathway/reaction-list/Reaction[@frameid="TRANS-RXN0-277"]
unnamed protein complex CPLX0-682
EcoCyc:CPLX0-682
catalyzes

The exact native enzyme/reaction join supports this catalytic assembly. Evidence codes and cited preparations remain source-qualified.

NAD(+) + ATP => ADP + NADP(+) + H(+)
RHEA:18630
  • EcoCyc:NAD-KIN-ENZRXN

    Source assertion: The exact native enzyme/reaction join supports this catalytic assembly. Evidence codes and cited preparations remain source-qualified.

    Source locationXPath /ptools-xml/Enzymatic-Reaction/enzyme | /ptools-xml/Enzymatic-Reaction/reaction | /ptools-xml/Enzymatic-Reaction/evidence
alkaline phosphatase
EcoCyc:ALKAPHOSPHA-CPLX
catalyzes

The exact native enzyme/reaction join supports this catalytic assembly. Evidence codes and cited preparations remain source-qualified. Its physiological-relevance flag does not establish cytosolic PhoA localization or complete cellular recycling.

NADP(+) + H2O => phosphate + NAD(+)
RHEA:28051
  • EcoCyc:ENZRXN0-7742

    Source assertion: The exact native enzyme/reaction join supports this catalytic assembly. Evidence codes and cited preparations remain source-qualified. Its physiological-relevance flag does not establish cytosolic PhoA localization or complete cellular recycling.

    Source locationXPath /ptools-xml/Enzymatic-Reaction/enzyme | /ptools-xml/Enzymatic-Reaction/reaction | /ptools-xml/Enzymatic-Reaction/evidence
PntAB
EcoCyc:PYRNUTRANSHYDROGEN-CPLX
catalyzes

The exact native enzyme/reaction join supports this catalytic assembly. Evidence codes and cited preparations remain source-qualified.

NADH + NADP(+) + H(+)(out) => NAD(+) + NADPH + H(+)(in)
RHEA:47994
  • EcoCyc:PYRNUTRANSHYDROGEN-ENZRXN

    Source assertion: The exact native enzyme/reaction join supports this catalytic assembly. Evidence codes and cited preparations remain source-qualified.

    Source locationXPath /ptools-xml/Enzymatic-Reaction/enzyme | /ptools-xml/Enzymatic-Reaction/reaction | /ptools-xml/Enzymatic-Reaction/evidence
soluble pyridine nucleotide transhydrogenase
EcoCyc:UDHA-CPLX
catalyzes

The exact native enzyme/reaction join supports this catalytic assembly. Evidence codes and cited preparations remain source-qualified. SthA is supporting soluble redox chemistry, outside the three native core members.

NAD(+) + NADPH => NADH + NADP(+)
RHEA:11693
  • EcoCyc:UDHA-ENZRXN

    Source assertion: The exact native enzyme/reaction join supports this catalytic assembly. Evidence codes and cited preparations remain source-qualified. SthA is supporting soluble redox chemistry, outside the three native core members.

    Source locationXPath /ptools-xml/Enzymatic-Reaction/enzyme | /ptools-xml/Enzymatic-Reaction/reaction | /ptools-xml/Enzymatic-Reaction/evidence
unnamed protein complex CPLX0-682
EcoCyc:CPLX0-682
has_part

The native component specifies 6 copies of MONOMER0-541; this is assembly stoichiometry, not a claim that an isolated chain is fully catalytic.

NAD kinase
UniProtKB:P0A7B3
  • EcoCyc:CPLX0-682

    Source assertion: The native component specifies 6 copies of MONOMER0-541; this is assembly stoichiometry, not a claim that an isolated chain is fully catalytic.

    Source locationXPath /ptools-xml/Protein/component[Protein[@frameid="MONOMER0-541"]]
  • EcoCyc:MONOMER0-541

    Source assertion: The exact native chain cross-reference grounds UniProtKB:P0A7B3. Historical preparations and tagged variants require their separate qualifications.

    Source locationXPath /ptools-xml/Protein/dblink[dblink-db="UNIPROT" and dblink-oid="P0A7B3"]
  • UniProtKB:P0A7B3

    Source assertion: The issuing reference chain identifies the b2615 locus in E. coli K-12; this is an identity join, not separate proof of catalytic or regulatory activity.

    Source locationentry[primaryAccession='P0A7B3'].genes,organism,sequence
  • Entrez:947092

    Source assertion: Entrez:947092 identifies b2615 in MG1655 taxon511145. This grounds the reference gene-to-chain join, not the exact sequence of every experimental preparation.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
alkaline phosphatase
EcoCyc:ALKAPHOSPHA-CPLX
has_part

The native component specifies 2 copies of ALKAPHOSPHA-MONOMER; this is assembly stoichiometry, not a claim that an isolated chain is fully catalytic.

Alkaline phosphatase
UniProtKB:P00634
  • EcoCyc:ALKAPHOSPHA-CPLX

    Source assertion: The native component specifies 2 copies of ALKAPHOSPHA-MONOMER; this is assembly stoichiometry, not a claim that an isolated chain is fully catalytic.

    Source locationXPath /ptools-xml/Protein/component[Protein[@frameid="ALKAPHOSPHA-MONOMER"]]
  • EcoCyc:ALKAPHOSPHA-MONOMER

    Source assertion: The exact native chain cross-reference grounds UniProtKB:P00634. Historical preparations and tagged variants require their separate qualifications.

    Source locationXPath /ptools-xml/Protein/dblink[dblink-db="UNIPROT" and dblink-oid="P00634"]
  • UniProtKB:P00634

    Source assertion: The issuing reference chain identifies the b0383 locus in E. coli K-12; this is an identity join, not separate proof of catalytic or regulatory activity.

    Source locationentry[primaryAccession='P00634'].genes,organism,sequence
  • Entrez:945041

    Source assertion: Entrez:945041 identifies b0383 in MG1655 taxon511145. This grounds the reference gene-to-chain join, not the exact sequence of every experimental preparation.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
PntAB
EcoCyc:PYRNUTRANSHYDROGEN-CPLX
has_part

The native component specifies 2 copies of PNTA-MONOMER; this is assembly stoichiometry, not a claim that an isolated chain is fully catalytic.

NAD(P) transhydrogenase subunit alpha
UniProtKB:P07001
  • EcoCyc:PYRNUTRANSHYDROGEN-CPLX

    Source assertion: The native component specifies 2 copies of PNTA-MONOMER; this is assembly stoichiometry, not a claim that an isolated chain is fully catalytic.

    Source locationXPath /ptools-xml/Protein/component[Protein[@frameid="PNTA-MONOMER"]]
  • EcoCyc:PNTA-MONOMER

    Source assertion: The exact native chain cross-reference grounds UniProtKB:P07001. Historical preparations and tagged variants require their separate qualifications.

    Source locationXPath /ptools-xml/Protein/dblink[dblink-db="UNIPROT" and dblink-oid="P07001"]
  • UniProtKB:P07001

    Source assertion: The issuing reference chain identifies the b1603 locus in E. coli K-12; this is an identity join, not separate proof of catalytic or regulatory activity.

    Source locationentry[primaryAccession='P07001'].genes,organism,sequence
  • Entrez:946628

    Source assertion: Entrez:946628 identifies b1603 in MG1655 taxon511145. This grounds the reference gene-to-chain join, not the exact sequence of every experimental preparation.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
PntAB
EcoCyc:PYRNUTRANSHYDROGEN-CPLX
has_part

The native component specifies 2 copies of PNTB-MONOMER; this is assembly stoichiometry, not a claim that an isolated chain is fully catalytic.

NAD(P) transhydrogenase subunit beta
UniProtKB:P0AB67
  • EcoCyc:PYRNUTRANSHYDROGEN-CPLX

    Source assertion: The native component specifies 2 copies of PNTB-MONOMER; this is assembly stoichiometry, not a claim that an isolated chain is fully catalytic.

    Source locationXPath /ptools-xml/Protein/component[Protein[@frameid="PNTB-MONOMER"]]
  • EcoCyc:PNTB-MONOMER

    Source assertion: The exact native chain cross-reference grounds UniProtKB:P0AB67. Historical preparations and tagged variants require their separate qualifications.

    Source locationXPath /ptools-xml/Protein/dblink[dblink-db="UNIPROT" and dblink-oid="P0AB67"]
  • UniProtKB:P0AB67

    Source assertion: The issuing reference chain identifies the b1602 locus in E. coli K-12; this is an identity join, not separate proof of catalytic or regulatory activity.

    Source locationentry[primaryAccession='P0AB67'].genes,organism,sequence
  • Entrez:946144

    Source assertion: Entrez:946144 identifies b1602 in MG1655 taxon511145. This grounds the reference gene-to-chain join, not the exact sequence of every experimental preparation.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
soluble pyridine nucleotide transhydrogenase
EcoCyc:UDHA-CPLX
has_part

The native component specifies 8 copies of UDHA-MONOMER; this is assembly stoichiometry, not a claim that an isolated chain is fully catalytic.

Soluble pyridine nucleotide transhydrogenase
UniProtKB:P27306
  • EcoCyc:UDHA-CPLX

    Source assertion: The native component specifies 8 copies of UDHA-MONOMER; this is assembly stoichiometry, not a claim that an isolated chain is fully catalytic.

    Source locationXPath /ptools-xml/Protein/component[Protein[@frameid="UDHA-MONOMER"]]
  • EcoCyc:UDHA-MONOMER

    Source assertion: The exact native chain cross-reference grounds UniProtKB:P27306. Historical preparations and tagged variants require their separate qualifications.

    Source locationXPath /ptools-xml/Protein/dblink[dblink-db="UNIPROT" and dblink-oid="P27306"]
  • UniProtKB:P27306

    Source assertion: The issuing reference chain identifies the b3962 locus in E. coli K-12; this is an identity join, not separate proof of catalytic or regulatory activity.

    Source locationentry[primaryAccession='P27306'].genes,organism,sequence
  • Entrez:948461

    Source assertion: Entrez:948461 identifies b3962 in MG1655 taxon511145. This grounds the reference gene-to-chain join, not the exact sequence of every experimental preparation.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
unnamed protein complex CPLX0-682
EcoCyc:CPLX0-682

experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N terminus MDNHFKCIGI differs at residue2 from current MNNHFKCIGI. This is separate from recombinant pSK67/BL21 and1987 K12 preparations.

Qualification evidence
  • PMID:11488932

    Source assertion: Methods identify endogenous MG1655 cultivation/purification and Results the homogeneous hexamer.

    Source locationRetained primary rendering lines L148–L177; printed table/section as stated
  • PMID:11488932

    Source assertion: Measured native N terminus differs from the deduced YfjB sequence at residue2; recombinant pSK67 and native preparations remain distinct.

    Source locationRetained primary rendering lines L279–L284; printed table/section as stated
catalyzes

Purified native NadK is a hexamer and phosphorylates NAD with ATP; other tested acceptors including NADH were not phosphorylated in the reported experiment.

NAD(+) + ATP => ADP + NADP(+) + H(+)
RHEA:18630
  • PMID:11488932

    Source assertion: Purified native NadK is a hexamer and phosphorylates NAD with ATP; other tested acceptors including NADH were not phosphorylated in the reported experiment.

    Source locationRetained primary rendering lines L177–L205; printed table/section as stated
unnamed protein complex CPLX0-682
EcoCyc:CPLX0-682

experimental construct: 2001 pSK67 yfjB from MG1655 cloned into pET14b with NcoI/BamHI and expressed in BL21(DE3)pLysS; empty SK45 control. No retained His tag is inferred from the vector name; the native N-terminal discrepancy remains separate.

Qualification evidence
  • PMID:11488932

    Source assertion: Cloning/expression/purification Methods identify pSK67 and BL21(DE3)pLysS, with SK45 vector-only control.

    Source locationRetained primary rendering lines L158–L168; printed table/section as stated
catalyzes

Recombinant yfjB expression and purified product support NadK activity; SK67 cell extract is highly active compared with the SK45 control.

NAD(+) + ATP => ADP + NADP(+) + H(+)
RHEA:18630
  • PMID:11488932

    Source assertion: Recombinant yfjB expression and purified product support NadK activity; SK67 cell extract is highly active compared with the SK45 control.

    Source locationRetained primary rendering lines L280–L284; printed table/section as stated
unnamed protein complex CPLX0-682
EcoCyc:CPLX0-682

experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N terminus MDNHFKCIGI differs at residue2 from current MNNHFKCIGI. This is separate from recombinant pSK67/BL21 and1987 K12 preparations.

Qualification evidence
  • PMID:11488932

    Source assertion: Methods identify endogenous MG1655 cultivation/purification and Results the homogeneous hexamer.

    Source locationRetained primary rendering lines L148–L177; printed table/section as stated
  • PMID:11488932

    Source assertion: Measured native N terminus differs from the deduced YfjB sequence at residue2; recombinant pSK67 and native preparations remain distinct.

    Source locationRetained primary rendering lines L279–L284; printed table/section as stated
has_cofactor

Mg2+ supports NadK in the1-mM replacement-metal assay. This is an alternative assay cofactor, not simultaneous occupancy or a preferred cellular metal assignment.

magnesium(2+)
CHEBI:18420
  • PMID:11488932

    Source assertion: Mg2+ supports NadK in the1-mM replacement-metal assay. This is an alternative assay cofactor, not simultaneous occupancy or a preferred cellular metal assignment.

    Source locationRetained primary rendering lines L238–L252; printed table/section as stated
unnamed protein complex CPLX0-682
EcoCyc:CPLX0-682

experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N terminus MDNHFKCIGI differs at residue2 from current MNNHFKCIGI. This is separate from recombinant pSK67/BL21 and1987 K12 preparations.

Qualification evidence
  • PMID:11488932

    Source assertion: Methods identify endogenous MG1655 cultivation/purification and Results the homogeneous hexamer.

    Source locationRetained primary rendering lines L148–L177; printed table/section as stated
  • PMID:11488932

    Source assertion: Measured native N terminus differs from the deduced YfjB sequence at residue2; recombinant pSK67 and native preparations remain distinct.

    Source locationRetained primary rendering lines L279–L284; printed table/section as stated
has_cofactor

Mn2+ supports NadK in the1-mM replacement-metal assay. This is an alternative assay cofactor, not simultaneous occupancy or a preferred cellular metal assignment.

manganese(2+)
CHEBI:29035
  • PMID:11488932

    Source assertion: Mn2+ supports NadK in the1-mM replacement-metal assay. This is an alternative assay cofactor, not simultaneous occupancy or a preferred cellular metal assignment.

    Source locationRetained primary rendering lines L238–L252; printed table/section as stated
unnamed protein complex CPLX0-682
EcoCyc:CPLX0-682

experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N terminus MDNHFKCIGI differs at residue2 from current MNNHFKCIGI. This is separate from recombinant pSK67/BL21 and1987 K12 preparations.

Qualification evidence
  • PMID:11488932

    Source assertion: Methods identify endogenous MG1655 cultivation/purification and Results the homogeneous hexamer.

    Source locationRetained primary rendering lines L148–L177; printed table/section as stated
  • PMID:11488932

    Source assertion: Measured native N terminus differs from the deduced YfjB sequence at residue2; recombinant pSK67 and native preparations remain distinct.

    Source locationRetained primary rendering lines L279–L284; printed table/section as stated
has_cofactor

Zn2+ supports NadK in the1-mM replacement-metal assay. This is an alternative assay cofactor, not simultaneous occupancy or a preferred cellular metal assignment.

zinc(2+)
CHEBI:29105
  • PMID:11488932

    Source assertion: Zn2+ supports NadK in the1-mM replacement-metal assay. This is an alternative assay cofactor, not simultaneous occupancy or a preferred cellular metal assignment.

    Source locationRetained primary rendering lines L238–L252; printed table/section as stated
unnamed protein complex CPLX0-682
EcoCyc:CPLX0-682

experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N terminus MDNHFKCIGI differs at residue2 from current MNNHFKCIGI. This is separate from recombinant pSK67/BL21 and1987 K12 preparations.

Qualification evidence
  • PMID:11488932

    Source assertion: Methods identify endogenous MG1655 cultivation/purification and Results the homogeneous hexamer.

    Source locationRetained primary rendering lines L148–L177; printed table/section as stated
  • PMID:11488932

    Source assertion: Measured native N terminus differs from the deduced YfjB sequence at residue2; recombinant pSK67 and native preparations remain distinct.

    Source locationRetained primary rendering lines L279–L284; printed table/section as stated
has_cofactor

Ca2+ supports NadK in the1-mM replacement-metal assay. This is an alternative assay cofactor, not simultaneous occupancy or a preferred cellular metal assignment.

calcium(2+)
CHEBI:29108
  • PMID:11488932

    Source assertion: Ca2+ supports NadK in the1-mM replacement-metal assay. This is an alternative assay cofactor, not simultaneous occupancy or a preferred cellular metal assignment.

    Source locationRetained primary rendering lines L238–L252; printed table/section as stated
unnamed protein complex CPLX0-682
EcoCyc:CPLX0-682

experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N terminus MDNHFKCIGI differs at residue2 from current MNNHFKCIGI. This is separate from recombinant pSK67/BL21 and1987 K12 preparations.

Qualification evidence
  • PMID:11488932

    Source assertion: Methods identify endogenous MG1655 cultivation/purification and Results the homogeneous hexamer.

    Source locationRetained primary rendering lines L148–L177; printed table/section as stated
  • PMID:11488932

    Source assertion: Measured native N terminus differs from the deduced YfjB sequence at residue2; recombinant pSK67 and native preparations remain distinct.

    Source locationRetained primary rendering lines L279–L284; printed table/section as stated
has_cofactor

Co2+ supports NadK in the1-mM replacement-metal assay. This is an alternative assay cofactor, not simultaneous occupancy or a preferred cellular metal assignment.

cobalt(2+)
CHEBI:48828
  • PMID:11488932

    Source assertion: Co2+ supports NadK in the1-mM replacement-metal assay. This is an alternative assay cofactor, not simultaneous occupancy or a preferred cellular metal assignment.

    Source locationRetained primary rendering lines L238–L252; printed table/section as stated
NADH(2-)
CHEBI:57945
inhibits

The exact native regulation gives an allosteric negative sign for NADH acting on NAD-KIN-ENZRXN.

unnamed protein complex CPLX0-682
EcoCyc:CPLX0-682

experimental construct: 1987 K12, unspecified substrain, forced-aerated glycerol minimal medium at37°C, late-log harvest;93-fold partially purified and not homogeneous. It is not asserted identical to the2001 native or modern MG1655 reference preparation.

Qualification evidence
  • PMID:3025169

    Source assertion: Methods describe the K12 growth/purification and Results explicitly state that the93-fold preparation was not homogeneous.

    Source locationPDF 1,2; Materials and methods; Results Properties
  • EcoCyc:REG0-7644

    Source assertion: The exact native regulation gives an allosteric negative sign for NADH acting on NAD-KIN-ENZRXN.

    Source locationXPath /ptools-xml/Regulation/mode | /ptools-xml/Regulation/regulator | /ptools-xml/Regulation/regulated-entity | /ptools-xml/Regulation/mechanism
  • PMID:3025169

    Source assertion: NADH inhibits the1987 preparation and changes NAD saturation to a sigmoidal curve; combined reduced-nucleotide effects are additive.

    Source locationPDF 2,3,4; Table2; Figures1–2; Results
NADPH(4-)
CHEBI:57783
inhibits

The exact native regulation gives an allosteric negative sign for NADPH acting on NAD-KIN-ENZRXN.

unnamed protein complex CPLX0-682
EcoCyc:CPLX0-682

experimental construct: 1987 K12, unspecified substrain, forced-aerated glycerol minimal medium at37°C, late-log harvest;93-fold partially purified and not homogeneous. It is not asserted identical to the2001 native or modern MG1655 reference preparation.

Qualification evidence
  • PMID:3025169

    Source assertion: Methods describe the K12 growth/purification and Results explicitly state that the93-fold preparation was not homogeneous.

    Source locationPDF 1,2; Materials and methods; Results Properties
  • EcoCyc:REG0-7643

    Source assertion: The exact native regulation gives an allosteric negative sign for NADPH acting on NAD-KIN-ENZRXN.

    Source locationXPath /ptools-xml/Regulation/mode | /ptools-xml/Regulation/regulator | /ptools-xml/Regulation/regulated-entity | /ptools-xml/Regulation/mechanism
  • PMID:3025169

    Source assertion: NADPH inhibits the1987 preparation and changes NAD saturation to a sigmoidal curve; combined reduced-nucleotide effects are additive.

    Source locationPDF 2,3,4; Table2; Figures1–2; Results
NADP(3-)
CHEBI:58349
inhibits

The2001 NADP additions give slight inhibition:83% and79% relative activity at50 and100µM. The1987 preparation showed no significant effect under its conditions.

unnamed protein complex CPLX0-682
EcoCyc:CPLX0-682

experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N terminus MDNHFKCIGI differs at residue2 from current MNNHFKCIGI. This is separate from recombinant pSK67/BL21 and1987 K12 preparations.

Qualification evidence
  • PMID:11488932

    Source assertion: Methods identify endogenous MG1655 cultivation/purification and Results the homogeneous hexamer.

    Source locationRetained primary rendering lines L148–L177; printed table/section as stated
  • PMID:11488932

    Source assertion: Measured native N terminus differs from the deduced YfjB sequence at residue2; recombinant pSK67 and native preparations remain distinct.

    Source locationRetained primary rendering lines L279–L284; printed table/section as stated
  • PMID:11488932

    Source assertion: The 2001 NADP additions give slight inhibition: 83% and 79% relative activity at 50 and 100 µM.

    Source locationRetained primary rendering lines L253–L264; printed table/section as stated
  • PMID:3025169

    Source assertion: The separate 1987, 93-fold partially purified K12 preparation showed no significant NADP effect under its assay conditions; Table 2 reports 102%, 96% and 96% relative activity at 0.05, 0.10 and 0.20 mM NADP. This comparison does not describe the 2001 endpoint preparation.

    Source locationPDF pages 1–2 (printed pp. 184–185): p. 1 Materials and methods, Growth conditions (K12); p. 2 Results, Properties of NAD kinase (93-fold, nonhomogeneous), Table 2 NADP rows and adjacent Regulation of NAD kinase
mercury dichloride
CHEBI:31823
inhibits

HgCl2 inhibits the purified NadK assay. Glucose-6-phosphate dehydrogenase replaced the inhibitor-sensitive isocitrate reporter in this experiment; HgCl2 is not relabeled as free mercury ion.

unnamed protein complex CPLX0-682
EcoCyc:CPLX0-682

experimental construct: 2001 endogenous MG1655 NadK, purified 3400-fold, approximately180-kDa hexamer/30-kDa chain; N terminus MDNHFKCIGI differs at residue2 from current MNNHFKCIGI. This is separate from recombinant pSK67/BL21 and1987 K12 preparations.

Qualification evidence
  • PMID:11488932

    Source assertion: Methods identify endogenous MG1655 cultivation/purification and Results the homogeneous hexamer.

    Source locationRetained primary rendering lines L148–L177; printed table/section as stated
  • PMID:11488932

    Source assertion: Measured native N terminus differs from the deduced YfjB sequence at residue2; recombinant pSK67 and native preparations remain distinct.

    Source locationRetained primary rendering lines L279–L284; printed table/section as stated
  • PMID:11488932

    Source assertion: HgCl2 inhibits the purified NadK assay. Glucose-6-phosphate dehydrogenase replaced the inhibitor-sensitive isocitrate reporter in this experiment; HgCl2 is not relabeled as free mercury ion.

    Source locationRetained primary rendering lines L253–L273; printed table/section as stated
alkaline phosphatase
EcoCyc:ALKAPHOSPHA-CPLX

experimental construct: 1962 purified E. coli alkaline phosphatase; strain unspecified. GL, BAP, PV and HH fractions were used in the paper, but the TPN-to-DPN sentence identifies no particular fraction. No exact native sequence or mature isozyme is assigned.

Qualification evidence
  • PMID:13906598

    Source assertion: Methods distinguish four purified preparations, with reported specific activities.

    Source locationRetained primary rendering lines L179–L194; printed table/section as stated
  • PMID:13906598

    Source assertion: The substrate-specificity passage reports TPN conversion to DPN without naming a preparation for that observation.

    Source locationRetained primary rendering lines L552–L562; printed table/section as stated
catalyzes

Purified alkaline phosphatase converts historical TPN to DPN; this supports NADP hydrolysis in vitro without identifying a cytosolic physiological recycling enzyme.

NADP(+) + H2O => phosphate + NAD(+)
RHEA:28051
  • PMID:13906598

    Source assertion: Purified alkaline phosphatase converts historical TPN to DPN; this supports NADP hydrolysis in vitro without identifying a cytosolic physiological recycling enzyme.

    Source locationRetained primary rendering lines L552–L562; printed table/section as stated
Alkaline phosphatase
UniProtKB:P00634
has_cofactor

The reviewed PhoA annotation gives 2 Zn2+ per subunit. Per-chain binding capacity is not an assumed coefficient for the whole dimer or every historical preparation.

zinc(2+)
CHEBI:29105
  • UniProtKB:P00634

    Source assertion: The reviewed PhoA annotation gives 2 Zn2+ per subunit. Per-chain binding capacity is not an assumed coefficient for the whole dimer or every historical preparation.

    Source locationentry[primaryAccession='P00634'].comments[commentType='COFACTOR']
Alkaline phosphatase
UniProtKB:P00634
has_cofactor

The reviewed PhoA annotation gives 1 Mg2+ per subunit. Per-chain binding capacity is not an assumed coefficient for the whole dimer or every historical preparation.

magnesium(2+)
CHEBI:18420
  • UniProtKB:P00634

    Source assertion: The reviewed PhoA annotation gives 1 Mg2+ per subunit. Per-chain binding capacity is not an assumed coefficient for the whole dimer or every historical preparation.

    Source locationentry[primaryAccession='P00634'].comments[commentType='COFACTOR']
Alkaline phosphatase
UniProtKB:P00634
located_in

The issuing annotation places PhoA in the periplasm; this does not establish cytosolic NADP turnover.

periplasmic space
GO:0042597
  • UniProtKB:P00634

    Source assertion: The issuing annotation places PhoA in the periplasm; this does not establish cytosolic NADP turnover.

    Source locationentry[primaryAccession='P00634'].comments[commentType='SUBCELLULAR LOCATION']
3'(2'),5'-bisphosphate nucleotidase CysQ
UniProtKB:P22255

experimental construct: 2007 E. coli AG1 ASKA GFP-free pCA24N CysQ, N-terminal His6 plus TDPALRA and C-terminal GLCGR extensions;37°C, pH8.0,10mM MgCl2. This tagged assay protein is not an established physiological NADP phosphatase.

Qualification evidence
  • PMID:17616624

    Source assertion: Methods specify AG1 ASKA pCA24N, both terminal extensions and purified-CysQ assay conditions.

    Source locationPDF 2; Cloning and expression; Assays; Purification
catalyzes

Tagged CysQ hydrolyzes NADP in vitro, while kinetic preferences and conditions led the authors to reject its assignment as the physiological E. coli NADP phosphatase.

NADP(+) + H2O => phosphate + NAD(+)
RHEA:28051
  • PMID:17616624

    Source assertion: Tagged CysQ hydrolyzes NADP in vitro, while kinetic preferences and conditions led the authors to reject its assignment as the physiological E. coli NADP phosphatase.

    Source locationPDF 3,4,5; Tables1–2; Results and Discussion
  • UniProtKB:P22255

    Source assertion: The issuing reference chain identifies the b4214 locus in E. coli K-12; this is an identity join, not separate proof of catalytic or regulatory activity.

    Source locationentry[primaryAccession='P22255'].genes,organism,sequence
  • Entrez:948728

    Source assertion: Entrez:948728 identifies b4214 in MG1655 taxon511145. This grounds the reference gene-to-chain join, not the exact sequence of every experimental preparation.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
3'(2'),5'-bisphosphate nucleotidase CysQ
UniProtKB:P22255

experimental construct: 2007 E. coli AG1 ASKA GFP-free pCA24N CysQ, N-terminal His6 plus TDPALRA and C-terminal GLCGR extensions;37°C, pH8.0,10mM MgCl2. This tagged assay protein is not an established physiological NADP phosphatase.

Qualification evidence
  • PMID:17616624

    Source assertion: Methods specify AG1 ASKA pCA24N, both terminal extensions and purified-CysQ assay conditions.

    Source locationPDF 2; Cloning and expression; Assays; Purification
has_cofactor

CysQ NADP(H)ase activity is maximal at10mM MgCl2 in this assay and undetectable at0.2mM; its PAPase has different Mg dependence.

magnesium(2+)
CHEBI:18420
  • PMID:17616624

    Source assertion: CysQ NADP(H)ase activity is maximal at10mM MgCl2 in this assay and undetectable at0.2mM; its PAPase has different Mg dependence.

    Source locationPDF 2,4; Assays; Properties of CysQ
lithium chloride
CHEBI:48607
inhibits

LiCl inhibits CysQ in a substrate-dependent assay: IC50 values70mM for NADP,60mM for NADPH,10mM for FBP,0.05mM for3-PAP and0.15mM for2-PAP. Table dashes mean not determined.

3'(2'),5'-bisphosphate nucleotidase CysQ
UniProtKB:P22255

experimental construct: 2007 E. coli AG1 ASKA GFP-free pCA24N CysQ, N-terminal His6 plus TDPALRA and C-terminal GLCGR extensions;37°C, pH8.0,10mM MgCl2. This tagged assay protein is not an established physiological NADP phosphatase.

Qualification evidence
  • PMID:17616624

    Source assertion: Methods specify AG1 ASKA pCA24N, both terminal extensions and purified-CysQ assay conditions.

    Source locationPDF 2; Cloning and expression; Assays; Purification
  • PMID:17616624

    Source assertion: LiCl inhibits CysQ in a substrate-dependent assay: IC50 values70mM for NADP,60mM for NADPH,10mM for FBP,0.05mM for3-PAP and0.15mM for2-PAP. Table dashes mean not determined.

    Source locationPDF 2,4; Assays; Table3
PntAB
EcoCyc:PYRNUTRANSHYDROGEN-CPLX

experimental construct: 2021 E. coli THO C43(DE3) Δcyo ΔpntAB, pET16b/pSA2-derived PntAB with alpha N-terminal His6 and thrombin site; cleavage is not reported. DDM-purified protein and oriented proteoliposomes are distinct assay states, not native topology measurements.

Qualification evidence
  • PMID:34707181

    Source assertion: Cloning, expression and purification Methods specify the THO host, alpha His6/thrombin construct and detergent purification.

    Source locationXPath /article/body/sec[2]/sec[1] | /article/body/sec[2]/sec[2]
catalyzes

Natural NADH/NADP forward assays support proton-coupled transhydrogenation; reverse and cyclic APAD assays are separate, and the cyclic reaction has no net proton transport.

NADH + NADP(+) + H(+)(out) => NAD(+) + NADPH + H(+)(in)
RHEA:47994
  • PMID:34707181

    Source assertion: Natural NADH/NADP forward assays support proton-coupled transhydrogenation; reverse and cyclic APAD assays are separate, and the cyclic reaction has no net proton transport.

    Source locationXPath /article/body/sec[1]/p[2] | /article/body/sec[1]/p[4] | /article/body/sec[2]/sec[3]/p[1] | /article/body/sec[2]/sec[6]/p | /article/body/sec[3]/sec[2]/p[3] | /article/body/sec[3]/sec[2]/table-wrap/caption/p | /article/body/sec[3]/sec[4]/p[2] | /article/body/sec[3]/sec[5]/p | /article/body/sec[3]/sec[6]/fig/caption/p | /article/body/sec[3]/sec[7]/p[2] | /article/body/sec[4]/p[1] | /article/body/sec[4]/p[3]
NAD(P) transhydrogenase subunit alpha
UniProtKB:P07001
located_in

The issuing subcellular-location annotation places this reference PntAB subunit in the inner membrane as a multi-pass membrane protein.

plasma membrane
GO:0005886
  • UniProtKB:P07001

    Source assertion: The issuing subcellular-location annotation places this reference PntAB subunit in the inner membrane as a multi-pass membrane protein.

    Source locationentry[primaryAccession='P07001'].comments[commentType='SUBCELLULAR LOCATION']
  • UniProtKB:P07001

    Source assertion: The separate issuing topological-domain features locate the alpha N-terminal or beta C-terminal soluble domain on the cytoplasmic side; these are annotation-based topology assignments.

    Source locationentry[primaryAccession='P07001'].features[type='Topological domain']
  • PMID:34707181

    Source assertion: The2021 Introduction and Figure1 explain cytoplasmic dI/NAD(H) and dIII/NADP(H), with alpha forming dI and beta forming dIII. The figure is a homology model, not an experimental E. coli complex structure.

    Source locationXPath /article/body/sec[1]/p[3] | /article/body/sec[1]/fig/caption/p[1]
NAD(P) transhydrogenase subunit beta
UniProtKB:P0AB67
located_in

The issuing subcellular-location annotation places this reference PntAB subunit in the inner membrane as a multi-pass membrane protein.

plasma membrane
GO:0005886
  • UniProtKB:P0AB67

    Source assertion: The issuing subcellular-location annotation places this reference PntAB subunit in the inner membrane as a multi-pass membrane protein.

    Source locationentry[primaryAccession='P0AB67'].comments[commentType='SUBCELLULAR LOCATION']
  • UniProtKB:P0AB67

    Source assertion: The separate issuing topological-domain features locate the alpha N-terminal or beta C-terminal soluble domain on the cytoplasmic side; these are annotation-based topology assignments.

    Source locationentry[primaryAccession='P0AB67'].features[type='Topological domain']
  • PMID:34707181

    Source assertion: The2021 Introduction and Figure1 explain cytoplasmic dI/NAD(H) and dIII/NADP(H), with alpha forming dI and beta forming dIII. The figure is a homology model, not an experimental E. coli complex structure.

    Source locationXPath /article/body/sec[1]/p[3] | /article/body/sec[1]/fig/caption/p[1]
1,3-dicyclohexylcarbodiimide
CHEBI:53090
inhibits

The exact native regulation identifies the reagent, a negative sign and the PntAB enzymatic reaction.

PntAB
EcoCyc:PYRNUTRANSHYDROGEN-CPLX

experimental construct: Historical purified E. coli transhydrogenase assays; full older bodies unavailable. The primary abstract and exact native regulation support inhibition, with preparation, cysteine variants and nucleotide-dependent protection retained separately.

Qualification evidence
  • PMID:3891338

    Source assertion: The primary abstract reports inhibition of E. coli transhydrogenase by the named reagent; this is abstract-level preparation evidence, not access to full Methods.

    Source locationresultList.result[id='3891338' and source='MED'].abstractText
  • EcoCyc:REG0-8848

    Source assertion: The exact native regulation identifies the reagent, a negative sign and the PntAB enzymatic reaction.

    Source locationXPath /ptools-xml/Regulation/regulator | /ptools-xml/Regulation/mode | /ptools-xml/Regulation/regulated-entity
  • PMID:3891338

    Source assertion: DCCD inhibits transhydrogenation and proton pumping; NADH protects, whereas NADP and less strongly NADPH accelerate inhibition.

    Source locationresultList.result[id='3891338' and source='MED'].abstractText
4-chloro-7-nitrobenzofurazan
CHEBI:78878
inhibits

The exact native regulation identifies the reagent, a negative sign and the PntAB enzymatic reaction.

PntAB
EcoCyc:PYRNUTRANSHYDROGEN-CPLX

experimental construct: Historical purified E. coli transhydrogenase assays; full older bodies unavailable. The primary abstract and exact native regulation support inhibition, with preparation, cysteine variants and nucleotide-dependent protection retained separately.

Qualification evidence
  • PMID:10556628

    Source assertion: The primary abstract reports inhibition of E. coli transhydrogenase by the named reagent; this is abstract-level preparation evidence, not access to full Methods.

    Source locationresultList.result[id='10556628' and source='MED'].abstractText
  • EcoCyc:REG0-9666

    Source assertion: The exact native regulation identifies the reagent, a negative sign and the PntAB enzymatic reaction.

    Source locationXPath /ptools-xml/Regulation/regulator | /ptools-xml/Regulation/mode | /ptools-xml/Regulation/regulated-entity
  • PMID:10556628

    Source assertion: NBD chloride inhibits transhydrogenation by several modifications. NADPH protects domain2/3 modification, but the NBD–NADPH reaction product is itself strongly inhibitory.

    Source locationresultList.result[id='10556628' and source='MED'].abstractText
soluble pyridine nucleotide transhydrogenase
EcoCyc:UDHA-CPLX

experimental construct: 2022 K12 sthA in pBXC3H_SthA, C-terminal His10, expressed in MC1061; FAD added during lysis, affinity plus SEC purification. Wild-type sequence construct is distinct from C45A/T50C and the AF-B7M718-F1 structural model.

Qualification evidence
  • PMID:35933012

    Source assertion: Results specify C-terminal His10 and Methods the MC1061 expression/purification with FAD-containing lysis buffer.

    Source locationXPath /article/body/sec[1]/sec[1]/p[1] | /article/body/sec[3]/sec[2]/p
has_part

SEC and DLS support an approximately440-kDa octamer for the purified2022 construct; this does not establish filamentous assemblies reported for other species.

Soluble pyridine nucleotide transhydrogenase
UniProtKB:P27306
  • PMID:35933012

    Source assertion: SEC and DLS support an approximately440-kDa octamer for the purified2022 construct; this does not establish filamentous assemblies reported for other species.

    Source locationXPath /article/body/sec[1]/sec[1]/p[2]
Soluble pyridine nucleotide transhydrogenase
UniProtKB:P27306
has_cofactor

The issuing SthA annotation identifies one FAD per subunit as cofactor capacity.

FAD(3-)
CHEBI:57692
  • UniProtKB:P27306

    Source assertion: The issuing SthA annotation identifies one FAD per subunit as cofactor capacity.

    Source locationentry[primaryAccession='P27306'].comments[commentType='COFACTOR']
  • EcoCyc:UDHA-ENZRXN

    Source assertion: The native historical enzyme comment reports0.76mol FAD per subunit; this observed occupancy is distinct from reference binding capacity.

    Source locationXPath /ptools-xml/Enzymatic-Reaction/comment
  • PMID:35933012

    Source assertion: Purified2022 SthA is predominantly holoenzyme, with a small FAD loss during SEC; occupancy depends on preparation.

    Source locationXPath /article/body/sec[1]/sec[1]/p[1]
Soluble pyridine nucleotide transhydrogenase
UniProtKB:P27306
located_in

The issuing reference places soluble SthA in the cytoplasm; unlike PntAB its redox reaction is not coupled to membrane proton translocation.

cytosol
GO:0005829
  • UniProtKB:P27306

    Source assertion: The issuing reference places soluble SthA in the cytoplasm; unlike PntAB its redox reaction is not coupled to membrane proton translocation.

    Source locationentry[primaryAccession='P27306'].comments[commentType='SUBCELLULAR LOCATION']
adenosine 5'-monophosphate(2-)
CHEBI:456215
activates

At5mM, AMP increases the rate of NADH/thioNADP transhydrogenation by the2022 construct; this is an assay activation, not an additional phosphoryl donor.

soluble pyridine nucleotide transhydrogenase
EcoCyc:UDHA-CPLX

experimental construct: 2022 K12 sthA in pBXC3H_SthA, C-terminal His10, expressed in MC1061; FAD added during lysis, affinity plus SEC purification. Wild-type sequence construct is distinct from C45A/T50C and the AF-B7M718-F1 structural model.

Qualification evidence
  • PMID:35933012

    Source assertion: Results specify C-terminal His10 and Methods the MC1061 expression/purification with FAD-containing lysis buffer.

    Source locationXPath /article/body/sec[1]/sec[1]/p[1] | /article/body/sec[3]/sec[2]/p
  • PMID:35933012

    Source assertion: At5mM, AMP increases the rate of NADH/thioNADP transhydrogenation by the2022 construct; this is an assay activation, not an additional phosphoryl donor.

    Source locationXPath /article/body/sec[1]/sec[2]/p[3] | /article/body/sec[3]/sec[5]/p[4]
  • DOI:10.1016/j.jbc.2022.102304

    Source assertion: Supplemental Table1 reports WT activity 160.7±2.9% with AMP, normalized to WT without adenylate. Mutant percentages have their own lower baselines.

    Source locationword/document.xml XPath /w:document/w:body/w:tbl[1]/w:tr[2] | /w:document/w:body/w:tbl[1]/w:tr[3]/w:tc[3] | /w:document/w:body/w:p[60]
ADP(3-)
CHEBI:456216
activates

At5mM, ADP increases the rate of NADH/thioNADP transhydrogenation by the2022 construct; this is an assay activation, not an additional phosphoryl donor.

soluble pyridine nucleotide transhydrogenase
EcoCyc:UDHA-CPLX

experimental construct: 2022 K12 sthA in pBXC3H_SthA, C-terminal His10, expressed in MC1061; FAD added during lysis, affinity plus SEC purification. Wild-type sequence construct is distinct from C45A/T50C and the AF-B7M718-F1 structural model.

Qualification evidence
  • PMID:35933012

    Source assertion: Results specify C-terminal His10 and Methods the MC1061 expression/purification with FAD-containing lysis buffer.

    Source locationXPath /article/body/sec[1]/sec[1]/p[1] | /article/body/sec[3]/sec[2]/p
  • PMID:35933012

    Source assertion: At5mM, ADP increases the rate of NADH/thioNADP transhydrogenation by the2022 construct; this is an assay activation, not an additional phosphoryl donor.

    Source locationXPath /article/body/sec[1]/sec[2]/p[3] | /article/body/sec[3]/sec[5]/p[4]
  • DOI:10.1016/j.jbc.2022.102304

    Source assertion: Supplemental Table1 reports WT activity 171.1±7.2% with ADP, normalized to WT without adenylate. Mutant percentages have their own lower baselines.

    Source locationword/document.xml XPath /w:document/w:body/w:tbl[1]/w:tr[2] | /w:document/w:body/w:tbl[1]/w:tr[3]/w:tc[4] | /w:document/w:body/w:p[60]
ATP(4-)
CHEBI:30616
activates

At5mM, ATP increases the rate of NADH/thioNADP transhydrogenation by the2022 construct; this is an assay activation, not an additional phosphoryl donor.

soluble pyridine nucleotide transhydrogenase
EcoCyc:UDHA-CPLX

experimental construct: 2022 K12 sthA in pBXC3H_SthA, C-terminal His10, expressed in MC1061; FAD added during lysis, affinity plus SEC purification. Wild-type sequence construct is distinct from C45A/T50C and the AF-B7M718-F1 structural model.

Qualification evidence
  • PMID:35933012

    Source assertion: Results specify C-terminal His10 and Methods the MC1061 expression/purification with FAD-containing lysis buffer.

    Source locationXPath /article/body/sec[1]/sec[1]/p[1] | /article/body/sec[3]/sec[2]/p
  • PMID:35933012

    Source assertion: At5mM, ATP increases the rate of NADH/thioNADP transhydrogenation by the2022 construct; this is an assay activation, not an additional phosphoryl donor.

    Source locationXPath /article/body/sec[1]/sec[2]/p[3] | /article/body/sec[3]/sec[5]/p[4]
  • DOI:10.1016/j.jbc.2022.102304

    Source assertion: Supplemental Table1 reports WT activity 148.2±8.9% with ATP, normalized to WT without adenylate. Mutant percentages have their own lower baselines.

    Source locationword/document.xml XPath /w:document/w:body/w:tbl[1]/w:tr[2] | /w:document/w:body/w:tbl[1]/w:tr[3]/w:tc[5] | /w:document/w:body/w:p[60]
hydrogenphosphate
CHEBI:43474
inhibits

Sodium and potassium phosphate suppress NADH/thioNADP activity, leveling off around50mM. The reference phosphate node represents the buffer species; exact assay protonation is not isolated.

soluble pyridine nucleotide transhydrogenase
EcoCyc:UDHA-CPLX

experimental construct: 2022 K12 sthA in pBXC3H_SthA, C-terminal His10, expressed in MC1061; FAD added during lysis, affinity plus SEC purification. Wild-type sequence construct is distinct from C45A/T50C and the AF-B7M718-F1 structural model.

Qualification evidence
  • PMID:35933012

    Source assertion: Results specify C-terminal His10 and Methods the MC1061 expression/purification with FAD-containing lysis buffer.

    Source locationXPath /article/body/sec[1]/sec[1]/p[1] | /article/body/sec[3]/sec[2]/p
  • PMID:35933012

    Source assertion: Sodium and potassium phosphate suppress NADH/thioNADP activity, leveling off around50mM. The reference phosphate node represents the buffer species; exact assay protonation is not isolated.

    Source locationXPath /article/body/sec[1]/sec[2]/p[1] | /article/body/sec[3]/sec[5]/p[4]
  • DOI:10.1016/j.jbc.2022.102304

    Source assertion: The salt control shows no significant change up to50mM NaCl/KCl, but500mM leaves about70%/40% activity, so high ionic strength is not universally inert.

    Source locationword/document.xml XPath /w:document/w:body/w:p[32]
NADH(2-)
CHEBI:57945
inhibits

With thioNADP fixed at0.5mM, NADH above7mM causes substrate inhibition; fitted KI12.1±2.0mM. This is not inhibition at every NADH concentration.

soluble pyridine nucleotide transhydrogenase
EcoCyc:UDHA-CPLX

experimental construct: 2022 K12 sthA in pBXC3H_SthA, C-terminal His10, expressed in MC1061; FAD added during lysis, affinity plus SEC purification. Wild-type sequence construct is distinct from C45A/T50C and the AF-B7M718-F1 structural model.

Qualification evidence
  • PMID:35933012

    Source assertion: Results specify C-terminal His10 and Methods the MC1061 expression/purification with FAD-containing lysis buffer.

    Source locationXPath /article/body/sec[1]/sec[1]/p[1] | /article/body/sec[3]/sec[2]/p
  • PMID:35933012

    Source assertion: With thioNADP fixed at0.5mM, NADH above7mM causes substrate inhibition; fitted KI12.1±2.0mM. This is not inhibition at every NADH concentration.

    Source locationXPath /article/body/sec[1]/sec[2]/p[2] | /article/body/sec[3]/sec[5]/p[1]
manganese(2+)
CHEBI:29035
inhibits

Mn2+ inhibits the2011 fused-SthA assay. After30min preincubation only Zn2+, Ni2+ and Cu2+ retain strong inhibition; exact metal salt and full experimental details were unavailable.

soluble pyridine nucleotide transhydrogenase
EcoCyc:UDHA-CPLX

experimental construct: 2011 purified fused E. coli STH; exact fusion sequence and full Methods were unavailable. The primary abstract measures NADPH/thio-NAD activity and reports time-dependent metal effects; this is distinct from2022 C-terminal His10 SthA.

Qualification evidence
  • PMID:21545646

    Source assertion: The primary abstract specifies a fused purified EcSTH protein, NADPH/thio-NAD kinetics and time-dependent divalent-metal effects.

    Source locationresultList.result[id='21545646' and source='MED'].abstractText
  • PMID:21545646

    Source assertion: Mn2+ inhibits the2011 fused-SthA assay. After30min preincubation only Zn2+, Ni2+ and Cu2+ retain strong inhibition; exact metal salt and full experimental details were unavailable.

    Source locationresultList.result[id='21545646' and source='MED'].abstractText
cobalt(2+)
CHEBI:48828
inhibits

Co2+ inhibits the2011 fused-SthA assay. After30min preincubation only Zn2+, Ni2+ and Cu2+ retain strong inhibition; exact metal salt and full experimental details were unavailable.

soluble pyridine nucleotide transhydrogenase
EcoCyc:UDHA-CPLX

experimental construct: 2011 purified fused E. coli STH; exact fusion sequence and full Methods were unavailable. The primary abstract measures NADPH/thio-NAD activity and reports time-dependent metal effects; this is distinct from2022 C-terminal His10 SthA.

Qualification evidence
  • PMID:21545646

    Source assertion: The primary abstract specifies a fused purified EcSTH protein, NADPH/thio-NAD kinetics and time-dependent divalent-metal effects.

    Source locationresultList.result[id='21545646' and source='MED'].abstractText
  • PMID:21545646

    Source assertion: Co2+ inhibits the2011 fused-SthA assay. After30min preincubation only Zn2+, Ni2+ and Cu2+ retain strong inhibition; exact metal salt and full experimental details were unavailable.

    Source locationresultList.result[id='21545646' and source='MED'].abstractText
zinc(2+)
CHEBI:29105
inhibits

Zn2+ inhibits the2011 fused-SthA assay. After30min preincubation only Zn2+, Ni2+ and Cu2+ retain strong inhibition; exact metal salt and full experimental details were unavailable.

soluble pyridine nucleotide transhydrogenase
EcoCyc:UDHA-CPLX

experimental construct: 2011 purified fused E. coli STH; exact fusion sequence and full Methods were unavailable. The primary abstract measures NADPH/thio-NAD activity and reports time-dependent metal effects; this is distinct from2022 C-terminal His10 SthA.

Qualification evidence
  • PMID:21545646

    Source assertion: The primary abstract specifies a fused purified EcSTH protein, NADPH/thio-NAD kinetics and time-dependent divalent-metal effects.

    Source locationresultList.result[id='21545646' and source='MED'].abstractText
  • PMID:21545646

    Source assertion: Zn2+ inhibits the2011 fused-SthA assay. After30min preincubation only Zn2+, Ni2+ and Cu2+ retain strong inhibition; exact metal salt and full experimental details were unavailable.

    Source locationresultList.result[id='21545646' and source='MED'].abstractText
nickel(2+)
CHEBI:49786
inhibits

Ni2+ inhibits the2011 fused-SthA assay. After30min preincubation only Zn2+, Ni2+ and Cu2+ retain strong inhibition; exact metal salt and full experimental details were unavailable.

soluble pyridine nucleotide transhydrogenase
EcoCyc:UDHA-CPLX

experimental construct: 2011 purified fused E. coli STH; exact fusion sequence and full Methods were unavailable. The primary abstract measures NADPH/thio-NAD activity and reports time-dependent metal effects; this is distinct from2022 C-terminal His10 SthA.

Qualification evidence
  • PMID:21545646

    Source assertion: The primary abstract specifies a fused purified EcSTH protein, NADPH/thio-NAD kinetics and time-dependent divalent-metal effects.

    Source locationresultList.result[id='21545646' and source='MED'].abstractText
  • PMID:21545646

    Source assertion: Ni2+ inhibits the2011 fused-SthA assay. After30min preincubation only Zn2+, Ni2+ and Cu2+ retain strong inhibition; exact metal salt and full experimental details were unavailable.

    Source locationresultList.result[id='21545646' and source='MED'].abstractText
copper(2+)
CHEBI:29036
inhibits

Cu2+ inhibits the2011 fused-SthA assay. After30min preincubation only Zn2+, Ni2+ and Cu2+ retain strong inhibition; exact metal salt and full experimental details were unavailable.

soluble pyridine nucleotide transhydrogenase
EcoCyc:UDHA-CPLX

experimental construct: 2011 purified fused E. coli STH; exact fusion sequence and full Methods were unavailable. The primary abstract measures NADPH/thio-NAD activity and reports time-dependent metal effects; this is distinct from2022 C-terminal His10 SthA.

Qualification evidence
  • PMID:21545646

    Source assertion: The primary abstract specifies a fused purified EcSTH protein, NADPH/thio-NAD kinetics and time-dependent divalent-metal effects.

    Source locationresultList.result[id='21545646' and source='MED'].abstractText
  • PMID:21545646

    Source assertion: Cu2+ inhibits the2011 fused-SthA assay. After30min preincubation only Zn2+, Ni2+ and Cu2+ retain strong inhibition; exact metal salt and full experimental details were unavailable.

    Source locationresultList.result[id='21545646' and source='MED'].abstractText
DNA-binding transcriptional dual regulator IHF
EcoCyc:PC00027
has_part

The native IHF complex contains the stated chain; native component slots give no coefficient, while the reviewed chain describes the alpha/beta heterodimer.

Integration host factor subunit alpha
UniProtKB:P0A6X7
  • EcoCyc:PC00027

    Source assertion: The native IHF complex contains the stated chain; native component slots give no coefficient, while the reviewed chain describes the alpha/beta heterodimer.

    Source locationXPath /ptools-xml/Protein/component
  • EcoCyc:PD00347

    Source assertion: The issuing native chain cross-reference identifies this exact IHF subunit.

    Source locationXPath /ptools-xml/Protein/dblink[dblink-db="UNIPROT"]
  • UniProtKB:P0A6X7

    Source assertion: The reviewed IHF chain annotation identifies a heterodimer of alpha and beta chains.

    Source locationentry[primaryAccession='P0A6X7'].comments[commentType='SUBUNIT']
DNA-binding transcriptional dual regulator IHF
EcoCyc:PC00027
has_part

The native IHF complex contains the stated chain; native component slots give no coefficient, while the reviewed chain describes the alpha/beta heterodimer.

Integration host factor subunit beta
UniProtKB:P0A6Y1
  • EcoCyc:PC00027

    Source assertion: The native IHF complex contains the stated chain; native component slots give no coefficient, while the reviewed chain describes the alpha/beta heterodimer.

    Source locationXPath /ptools-xml/Protein/component
  • EcoCyc:PD00348

    Source assertion: The issuing native chain cross-reference identifies this exact IHF subunit.

    Source locationXPath /ptools-xml/Protein/dblink[dblink-db="UNIPROT"]
  • UniProtKB:P0A6Y1

    Source assertion: The reviewed IHF chain annotation identifies a heterodimer of alpha and beta chains.

    Source locationentry[primaryAccession='P0A6Y1'].comments[commentType='SUBUNIT']
CRP-cyclic-AMP DNA-binding transcriptional dual regulator
EcoCyc:CPLX0-226
has_part

The native cAMP-bound CRP complex contains the exact PC00004 CRP assembly; native component slots give no coefficient.

DNA-binding transcriptional dual regulator CRP
EcoCyc:PC00004
  • EcoCyc:CPLX0-226

    Source assertion: The native cAMP-bound CRP complex contains the exact PC00004 CRP assembly; native component slots give no coefficient.

    Source locationXPath /ptools-xml/Protein/component[Protein]
CRP-cyclic-AMP DNA-binding transcriptional dual regulator
EcoCyc:CPLX0-226
has_part

The native complex contains CAMP; no ligand coefficient is given in this component slot.

3',5'-cyclic AMP(1-)
CHEBI:58165
  • EcoCyc:CPLX0-226

    Source assertion: The native complex contains CAMP; no ligand coefficient is given in this component slot.

    Source locationXPath /ptools-xml/Protein/component[Compound]
  • UniProtKB:P0ACJ8

    Source assertion: Issuing CRP binding features identify cAMP CHEBI:58165; this reference ligand mapping is distinct from the reporter assay.

    Source locationentry[primaryAccession='P0ACJ8'].features[type='Binding site']
DNA-binding transcriptional dual regulator CRP
EcoCyc:PC00004
has_part

The native CRP assembly contains its reference protein chain; stoichiometry is source-local.

DNA-binding transcriptional dual regulator CRP
UniProtKB:P0ACJ8
  • EcoCyc:PC00004

    Source assertion: The native CRP assembly contains its reference protein chain; stoichiometry is source-local.

    Source locationXPath /ptools-xml/Protein/component
  • UniProtKB:P0ACJ8

    Source assertion: The reviewed CRP reference is a homodimer able to bind DNA on cAMP binding.

    Source locationentry[primaryAccession='P0ACJ8'].comments[commentType='SUBUNIT']
  • UniProtKB:P0ACJ8

    Source assertion: The reference CRP accession and gene identity ground the native complex chain.

    Source locationentry[primaryAccession='P0ACJ8'].genes,organism,sequence
3',5'-cyclic AMP(1-)
CHEBI:58165
activates

cAMP binding stabilizes the active DNA-binding conformation of CRP. This general allosteric annotation alone does not establish binding to the pntA promoter.

DNA-binding transcriptional dual regulator CRP
UniProtKB:P0ACJ8
  • UniProtKB:P0ACJ8

    Source assertion: cAMP binding stabilizes the active DNA-binding conformation of CRP. This general allosteric annotation alone does not establish binding to the pntA promoter.

    Source locationentry[primaryAccession='P0ACJ8'].comments[commentType='ACTIVITY REGULATION']
DNA-binding transcriptional dual regulator IHF
EcoCyc:PC00027

experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein. IHF alpha deletion probes the heterodimer.

Qualification evidence
  • PMID:27488847

    Source assertion: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity.

    Source locationPDF 3,4; Methods: strain/growth, reporter construction and calculations
activates

Loss of IHF alpha reduces pntAB reporter activity on succinate, glycerol and glucose. The source infers IHF activation; direct promoter binding is not demonstrated by this reporter experiment.

pntA
Entrez:946628
  • PMID:27488847

    Source assertion: Loss of IHF alpha reduces pntAB reporter activity on succinate, glycerol and glucose. The source infers IHF activation; direct promoter binding is not demonstrated by this reporter experiment.

    Source locationPDF 5,7; Results; indicated reporter condition
  • Entrez:946628

    Source assertion: The exact MG1655 issuing Gene identity grounds this reference expression endpoint; the experiment itself used BW25113.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
Leucine-responsive regulatory protein
UniProtKB:P0ACJ0

experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein.

Qualification evidence
  • PMID:27488847

    Source assertion: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity.

    Source locationPDF 3,4; Methods: strain/growth, reporter construction and calculations
activates

Lrp deletion reduces pntAB promoter activity, with activation identified on glycerol and glucose; the full succinate result is retained in the supplementary screen.

pntA
Entrez:946628
  • PMID:27488847

    Source assertion: Lrp deletion reduces pntAB promoter activity, with activation identified on glycerol and glucose; the full succinate result is retained in the supplementary screen.

    Source locationPDF 5,7; Results; indicated reporter condition
  • Entrez:946628

    Source assertion: The exact MG1655 issuing Gene identity grounds this reference expression endpoint; the experiment itself used BW25113.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
  • UniProtKB:P0ACJ0

    Source assertion: This issuing reference grounds the regulator identity; exact tested strain and protein state remain source-qualified.

    Source locationentry[primaryAccession='P0ACJ0'].genes,organism,sequence
  • UniProtKB:P0ACJ0

    Source assertion: The reviewed Lrp reference has a homodimer annotation; condition-dependent higher oligomers are not resolved by this reporter experiment.

    Source locationentry[primaryAccession='P0ACJ0'].comments[commentType='SUBUNIT']
Leucine-responsive regulatory protein
UniProtKB:P0ACJ0

experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein.

Qualification evidence
  • PMID:27488847

    Source assertion: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity.

    Source locationPDF 3,4; Methods: strain/growth, reporter construction and calculations
inhibits

Lrp deletion increases sthA/udhA reporter activity on glycerol and glucose; this condition-specific repression is distinct from promoter occupancy.

sthA
Entrez:948461
  • PMID:27488847

    Source assertion: Lrp deletion increases sthA/udhA reporter activity on glycerol and glucose; this condition-specific repression is distinct from promoter occupancy.

    Source locationPDF 5,7; Results; indicated reporter condition
  • Entrez:948461

    Source assertion: The exact MG1655 issuing Gene identity grounds this reference expression endpoint; the experiment itself used BW25113.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
  • UniProtKB:P0ACJ0

    Source assertion: This issuing reference grounds the regulator identity; exact tested strain and protein state remain source-qualified.

    Source locationentry[primaryAccession='P0ACJ0'].genes,organism,sequence
HTH-type transcriptional regulator ArgP
UniProtKB:P0A8S1

experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein.

Qualification evidence
  • PMID:27488847

    Source assertion: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity.

    Source locationPDF 3,4; Methods: strain/growth, reporter construction and calculations
activates

ArgP deletion lowers pntAB reporter activity on glucose. Direct promoter binding remains unshown in this study.

pntA
Entrez:946628
  • PMID:27488847

    Source assertion: ArgP deletion lowers pntAB reporter activity on glucose. Direct promoter binding remains unshown in this study.

    Source locationPDF 5,7; Results; indicated reporter condition
  • Entrez:946628

    Source assertion: The exact MG1655 issuing Gene identity grounds this reference expression endpoint; the experiment itself used BW25113.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
  • UniProtKB:P0A8S1

    Source assertion: This issuing reference grounds the regulator identity; exact tested strain and protein state remain source-qualified.

    Source locationentry[primaryAccession='P0A8S1'].genes,organism,sequence
  • UniProtKB:P0A8S1

    Source assertion: The issuing ArgP reference is homodimeric; the reporter screen does not isolate an active monomer.

    Source locationentry[primaryAccession='P0A8S1'].comments[commentType='SUBUNIT']
Ferric uptake regulation protein
UniProtKB:P0A9A9

experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein.

Qualification evidence
  • PMID:27488847

    Source assertion: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity.

    Source locationPDF 3,4; Methods: strain/growth, reporter construction and calculations
activates

Fur deletion lowers pntAB reporter activity on succinate. This is a condition-limited expression inference, without direct promoter binding or measured Fur metal occupancy.

pntA
Entrez:946628
  • PMID:27488847

    Source assertion: Fur deletion lowers pntAB reporter activity on succinate. This is a condition-limited expression inference, without direct promoter binding or measured Fur metal occupancy.

    Source locationPDF 5,7; Results; indicated reporter condition
  • Entrez:946628

    Source assertion: The exact MG1655 issuing Gene identity grounds this reference expression endpoint; the experiment itself used BW25113.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
  • UniProtKB:P0A9A9

    Source assertion: This issuing reference grounds the regulator identity; exact tested strain and protein state remain source-qualified.

    Source locationentry[primaryAccession='P0A9A9'].genes,organism,sequence
  • UniProtKB:P0A9A9

    Source assertion: The issuing Fur homodimer annotation is by similarity; its oligomer and metal state were not measured in this reporter screen.

    Source locationentry[primaryAccession='P0A9A9'].comments[commentType='SUBUNIT']
Aerobic respiration control protein ArcA
UniProtKB:P0A9Q1

experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein.

Qualification evidence
  • PMID:27488847

    Source assertion: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity.

    Source locationPDF 3,4; Methods: strain/growth, reporter construction and calculations
inhibits

ArcA deletion increases sthA/udhA reporter activity on glucose. The study detects no ArcA activation of pntAB in its aerobic conditions; phosphorylation state is not directly measured here.

sthA
Entrez:948461
  • PMID:27488847

    Source assertion: ArcA deletion increases sthA/udhA reporter activity on glucose. The study detects no ArcA activation of pntAB in its aerobic conditions; phosphorylation state is not directly measured here.

    Source locationPDF 5,7; Results; indicated reporter condition
  • Entrez:948461

    Source assertion: The exact MG1655 issuing Gene identity grounds this reference expression endpoint; the experiment itself used BW25113.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
  • UniProtKB:P0A9Q1

    Source assertion: This issuing reference grounds the regulator identity; exact tested strain and protein state remain source-qualified.

    Source locationentry[primaryAccession='P0A9Q1'].genes,organism,sequence
DNA-binding protein H-NS
UniProtKB:P0ACF8

experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein.

Qualification evidence
  • PMID:27488847

    Source assertion: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity.

    Source locationPDF 3,4; Methods: strain/growth, reporter construction and calculations
inhibits

H-NS deletion increases pntAB promoter activity in glucose plus20 amino acids. Basal-medium outcomes differ; this is conditional repression without a demonstrated direct promoter interaction.

pntA
Entrez:946628
  • PMID:27488847

    Source assertion: H-NS deletion increases pntAB promoter activity in glucose plus20 amino acids. Basal-medium outcomes differ; this is conditional repression without a demonstrated direct promoter interaction.

    Source locationPDF 6,7; Results; indicated reporter condition
  • Entrez:946628

    Source assertion: The exact MG1655 issuing Gene identity grounds this reference expression endpoint; the experiment itself used BW25113.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
  • UniProtKB:P0ACF8

    Source assertion: This issuing reference grounds the regulator identity; exact tested strain and protein state remain source-qualified.

    Source locationentry[primaryAccession='P0ACF8'].genes,organism,sequence
  • UniProtKB:P0ACF8

    Source assertion: H-NS forms dimers and higher oligomers; the exact complex at pntA is unmeasured.

    Source locationentry[primaryAccession='P0ACF8'].comments[commentType='SUBUNIT']
CRP-cyclic-AMP DNA-binding transcriptional dual regulator
EcoCyc:CPLX0-226

experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein. cAMP occupancy and stoichiometry were unmeasured.

Qualification evidence
  • PMID:27488847

    Source assertion: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity.

    Source locationPDF 3,4; Methods: strain/growth, reporter construction and calculations
inhibits

CRP deletion increases pntAB reporter activity with20 amino acids. The active cAMP-bound reference complex is inferred from known CRP biology; the study does not directly measure pntA promoter binding.

pntA
Entrez:946628
  • PMID:27488847

    Source assertion: CRP deletion increases pntAB reporter activity with20 amino acids. The active cAMP-bound reference complex is inferred from known CRP biology; the study does not directly measure pntA promoter binding.

    Source locationPDF 6,7; Results; indicated reporter condition
  • Entrez:946628

    Source assertion: The exact MG1655 issuing Gene identity grounds this reference expression endpoint; the experiment itself used BW25113.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
HTH-type transcriptional regulatory protein TyrR
UniProtKB:P07604

experimental construct: 2016 BW25113 versus isogenic Keio deletion, low-copy whole-intergenic gfpmut2 transcriptional reporter, M9 at37°C, mid-exponential growth. The endpoint is the reference regulator whose loss changes expression, not the deletion as an active protein.

Qualification evidence
  • PMID:27488847

    Source assertion: Methods specify BW25113/Keio strains, low-copy intergenic GFP fusions, M9 growth and mid-exponential OD-normalized promoter activity.

    Source locationPDF 3,4; Methods: strain/growth, reporter construction and calculations
activates

In the amino-acid mixture screen, deleting TyrR lowers sthA reporter activity. This supplementary observation is expression-level evidence; no direct binding or defined TyrR oligomer was established.

sthA
Entrez:948461
  • PMID:27488847

    Source assertion: In the amino-acid mixture screen, deleting TyrR lowers sthA reporter activity. This supplementary observation is expression-level evidence; no direct binding or defined TyrR oligomer was established.

    Source locationPDF 6; Results; indicated reporter condition
  • Entrez:948461

    Source assertion: The exact MG1655 issuing Gene identity grounds this reference expression endpoint; the experiment itself used BW25113.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
  • UniProtKB:P07604

    Source assertion: This issuing reference grounds the regulator identity; exact tested strain and protein state remain source-qualified.

    Source locationentry[primaryAccession='P07604'].genes,organism,sequence
  • DOI:10.1099/mic.0.000346

    Source assertion: TableS4 gives WT sthA activity801.20±167.35 and TyrR-deletion332.83±14.09 under glucose plus20 amino acids. These are absolute activities, not a reported fold change.

    Source locationSupplement PDF 16,18; TableS4, WT and TyrR rows
L-leucine zwitterion
CHEBI:57427
inhibits

Leucine addition reduces pntAB reporter activity. WT BW25113 received5mM single amino acid in M9 glucose; this is a reporter response, not direct chemical binding to the gene or proven action through one regulator.

pntA
Entrez:946628
  • PMID:27488847

    Source assertion: Leucine addition reduces pntAB reporter activity. WT BW25113 received5mM single amino acid in M9 glucose; this is a reporter response, not direct chemical binding to the gene or proven action through one regulator.

    Source locationPDF 3,6; Methods single-amino-acid additions; Figure4b and Results
  • Entrez:946628

    Source assertion: The issuing reference Gene ID grounds the corresponding reporter target locus.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
L-leucine zwitterion
CHEBI:57427
activates

Leucine addition increases sthA/udhA reporter activity. WT BW25113 received5mM single amino acid in M9 glucose; this is a reporter response, not direct chemical binding to the gene or proven action through one regulator.

sthA
Entrez:948461
  • PMID:27488847

    Source assertion: Leucine addition increases sthA/udhA reporter activity. WT BW25113 received5mM single amino acid in M9 glucose; this is a reporter response, not direct chemical binding to the gene or proven action through one regulator.

    Source locationPDF 3,6; Methods single-amino-acid additions; Figure4b and Results
  • Entrez:948461

    Source assertion: The issuing reference Gene ID grounds the corresponding reporter target locus.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
L-lysinium(1+)
CHEBI:32551
inhibits

Lysine addition reduces pntAB reporter activity. WT BW25113 received5mM single amino acid in M9 glucose; this is a reporter response, not direct chemical binding to the gene or proven action through one regulator.

pntA
Entrez:946628
  • PMID:27488847

    Source assertion: Lysine addition reduces pntAB reporter activity. WT BW25113 received5mM single amino acid in M9 glucose; this is a reporter response, not direct chemical binding to the gene or proven action through one regulator.

    Source locationPDF 3,6; Methods single-amino-acid additions; Figure4b and Results
  • Entrez:946628

    Source assertion: The issuing reference Gene ID grounds the corresponding reporter target locus.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
L-histidine zwitterion
CHEBI:57595
inhibits

Histidine addition reduces pntAB reporter activity. WT BW25113 received5mM single amino acid in M9 glucose; this is a reporter response, not direct chemical binding to the gene or proven action through one regulator.

pntA
Entrez:946628
  • PMID:27488847

    Source assertion: Histidine addition reduces pntAB reporter activity. WT BW25113 received5mM single amino acid in M9 glucose; this is a reporter response, not direct chemical binding to the gene or proven action through one regulator.

    Source locationPDF 3,6; Methods single-amino-acid additions; Figure4b and Results
  • Entrez:946628

    Source assertion: The issuing reference Gene ID grounds the corresponding reporter target locus.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
L-methionine zwitterion
CHEBI:57844
activates

Methionine addition increases sthA/udhA reporter activity. WT BW25113 received5mM single amino acid in M9 glucose; this is a reporter response, not direct chemical binding to the gene or proven action through one regulator.

sthA
Entrez:948461
  • PMID:27488847

    Source assertion: Methionine addition increases sthA/udhA reporter activity. WT BW25113 received5mM single amino acid in M9 glucose; this is a reporter response, not direct chemical binding to the gene or proven action through one regulator.

    Source locationPDF 3,6; Methods single-amino-acid additions; Figure4b and Results
  • Entrez:948461

    Source assertion: The issuing reference Gene ID grounds the corresponding reporter target locus.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
3',5'-cyclic AMP(1-)
CHEBI:58165
inhibits

Extracellular cAMP lowers pntAB promoter activity after normalization to two constitutive reporters; growth effects are controlled and CRP activity rises. This does not demonstrate direct pntA promoter binding.

pntA
Entrez:946628
  • PMID:27488847

    Source assertion: Extracellular cAMP lowers pntAB promoter activity after normalization to two constitutive reporters; growth effects are controlled and CRP activity rises. This does not demonstrate direct pntA promoter binding.

    Source locationPDF 3,6,7; Methods reporter controls; Figure5
Leucine-responsive regulatory protein
UniProtKB:P0ACJ0

experimental construct: 2019 native Lrp in MG1655 ATCC47076 versus lrp::kan, MOPS0.2% glycerol,37°C,200rpm; MIN transition, OD6001.8–2.2. The antibody preparation is not a His tag on cellular Lrp. Exact per-gene supplementary data were unavailable; the target claim uses native annotation.

Qualification evidence
  • PMID:30420454

    Source assertion: Methods specify MG1655 ATCC47076, lrp::kan, MIN medium, phase-specific harvest and antibody-based ChIP/RNA-seq.

    Source locationPDF 16,17; Materials and methods
activates

The exact native regulation reports this sign and gene target under the stated2019 phase-specific condition. This is a located curated assertion, not a claim to have read unavailable target supplementary rows.

phoA
Entrez:945041
  • EcoCyc:REG0-15526

    Source assertion: The exact native regulation reports this sign and gene target under the stated2019 phase-specific condition. This is a located curated assertion, not a claim to have read unavailable target supplementary rows.

    Source locationXPath /ptools-xml/Regulation/mode | /ptools-xml/Regulation/regulator | /ptools-xml/Regulation/regulated-entity | /ptools-xml/Regulation/comment
  • EcoCyc:PD00353

    Source assertion: The native Lrp regulator chain unifies to UniProtKB:P0ACJ0.

    Source locationXPath /ptools-xml/Protein/dblink[dblink-db="UNIPROT"]
  • Entrez:945041

    Source assertion: The exact issuing Gene ID grounds this regulatory object.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
Leucine-responsive regulatory protein
UniProtKB:P0ACJ0

experimental construct: 2019 native Lrp in MG1655 ATCC47076 versus lrp::kan, MOPS0.2% glycerol,37°C,200rpm; MIN log, OD6000.15–0.25. The antibody preparation is not a His tag on cellular Lrp. Exact per-gene supplementary data were unavailable; the target claim uses native annotation.

Qualification evidence
  • PMID:30420454

    Source assertion: Methods specify MG1655 ATCC47076, lrp::kan, MIN medium, phase-specific harvest and antibody-based ChIP/RNA-seq.

    Source locationPDF 16,17; Materials and methods
activates

The exact native regulation reports this sign and gene target under the stated2019 phase-specific condition. This is a located curated assertion, not a claim to have read unavailable target supplementary rows.

pntA
Entrez:946628
  • EcoCyc:REG0-15529

    Source assertion: The exact native regulation reports this sign and gene target under the stated2019 phase-specific condition. This is a located curated assertion, not a claim to have read unavailable target supplementary rows.

    Source locationXPath /ptools-xml/Regulation/mode | /ptools-xml/Regulation/regulator | /ptools-xml/Regulation/regulated-entity | /ptools-xml/Regulation/comment
  • EcoCyc:PD00353

    Source assertion: The native Lrp regulator chain unifies to UniProtKB:P0ACJ0.

    Source locationXPath /ptools-xml/Protein/dblink[dblink-db="UNIPROT"]
  • Entrez:946628

    Source assertion: The exact issuing Gene ID grounds this regulatory object.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
Leucine-responsive regulatory protein
UniProtKB:P0ACJ0

experimental construct: 2019 native Lrp in MG1655 ATCC47076 versus lrp::kan, MOPS0.2% glycerol,37°C,200rpm; MIN log, OD6000.15–0.25. The antibody preparation is not a His tag on cellular Lrp. Exact per-gene supplementary data were unavailable; the target claim uses native annotation.

Qualification evidence
  • PMID:30420454

    Source assertion: Methods specify MG1655 ATCC47076, lrp::kan, MIN medium, phase-specific harvest and antibody-based ChIP/RNA-seq.

    Source locationPDF 16,17; Materials and methods
inhibits

The exact native regulation reports this sign and gene target under the stated2019 phase-specific condition. This is a located curated assertion, not a claim to have read unavailable target supplementary rows.

sthA
Entrez:948461
  • EcoCyc:REG0-15570

    Source assertion: The exact native regulation reports this sign and gene target under the stated2019 phase-specific condition. This is a located curated assertion, not a claim to have read unavailable target supplementary rows.

    Source locationXPath /ptools-xml/Regulation/mode | /ptools-xml/Regulation/regulator | /ptools-xml/Regulation/regulated-entity | /ptools-xml/Regulation/comment
  • EcoCyc:PD00353

    Source assertion: The native Lrp regulator chain unifies to UniProtKB:P0ACJ0.

    Source locationXPath /ptools-xml/Protein/dblink[dblink-db="UNIPROT"]
  • Entrez:948461

    Source assertion: The exact issuing Gene ID grounds this regulatory object.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
Aerobic respiration control protein ArcA
UniProtKB:P0A9Q1

molecular state: Phosphorylated ArcA (native PHOSPHO-ARCA), mapped to reference P0A9Q1. The2014 binding preparation is ArcA-8myc in MG1655; expression comparisons use ΔarcA in anaerobic M9 glucose/ammonium±20mmol KNO3 at37°C. No active deletion protein is asserted.

Qualification evidence
  • EcoCyc:PHOSPHO-ARCA

    Source assertion: The exact source state points to unmodified ARCA-MONOMER; state identity remains explicit rather than being treated as unmodified reference protein.

    Source locationXPath /ptools-xml/Protein/unmodified-form
  • PMID:24699140

    Source assertion: Methods specify ArcA-8myc, MG1655 derivatives, ΔarcA and anaerobic media with/without nitrate.

    Source locationXPath /article/body/sec[4]/sec[1]/p
  • UniProtKB:P0A9Q1

    Source assertion: The issuing ArcA reference has phosphoaspartate54; the active modified state is distinguished from the unmodified reference sequence.

    Source locationentry[primaryAccession='P0A9Q1'].features[type='Modified residue']
  • UniProtKB:P0A9Q1

    Source assertion: The issuing ArcA reference has phosphoaspartate54; the active modified state is distinguished from the unmodified reference sequence.

    Source locationentry[primaryAccession='P0A9Q1'].features[type='Modified residue']
activates

The native ArcA regulation records the exact sign, PHOSPHO-ARCA regulator and target gene under anaerobic source conditions.

pntA
Entrez:946628
  • EcoCyc:REG0-14088

    Source assertion: The native ArcA regulation records the exact sign, PHOSPHO-ARCA regulator and target gene under anaerobic source conditions.

    Source locationXPath /ptools-xml/Regulation/mode | /ptools-xml/Regulation/regulator | /ptools-xml/Regulation/regulated-entity | /ptools-xml/Regulation/comment
  • EcoCyc:REG0-14089

    Source assertion: The native ArcA regulation records the exact sign, PHOSPHO-ARCA regulator and target gene under anaerobic source conditions.

    Source locationXPath /ptools-xml/Regulation/mode | /ptools-xml/Regulation/regulator | /ptools-xml/Regulation/regulated-entity | /ptools-xml/Regulation/comment
  • PMID:24699140

    Source assertion: The primary Results report ArcA activation of pntAB and repression of sthA in the studied redox conditions.

    Source locationXPath /article/body/sec[2]/sec[3]/p[3]
  • EcoCyc:ARCA-MONOMER

    Source assertion: The unmodified native ArcA chain unifies to the exact UniProt reference; phosphorylation is carried in the endpoint qualifier.

    Source locationXPath /ptools-xml/Protein/dblink[dblink-db="UNIPROT"]
  • Entrez:946628

    Source assertion: The exact Gene ID grounds this regulatory object.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
  • DOI:10.1371/journal.pgen.1004264.s009

    Source assertion: The original ArcA table reports peak1675896–1676296; occupancy3.44; activation. Coordinates and log2 occupancy are source-specific, not modern remapped loci.

    Source locationPDF 1,3; pntA operon row
  • DOI:10.1371/journal.pgen.1004264.s010

    Source assertion: The original ArcA table reports peak1675706–1676221; occupancy7.42; activation. Coordinates and log2 occupancy are source-specific, not modern remapped loci.

    Source locationPDF 2,3; pntA operon row
Aerobic respiration control protein ArcA
UniProtKB:P0A9Q1

molecular state: Phosphorylated ArcA (native PHOSPHO-ARCA), mapped to reference P0A9Q1. The2014 binding preparation is ArcA-8myc in MG1655; expression comparisons use ΔarcA in anaerobic M9 glucose/ammonium±20mmol KNO3 at37°C. No active deletion protein is asserted.

Qualification evidence
  • EcoCyc:PHOSPHO-ARCA

    Source assertion: The exact source state points to unmodified ARCA-MONOMER; state identity remains explicit rather than being treated as unmodified reference protein.

    Source locationXPath /ptools-xml/Protein/unmodified-form
  • PMID:24699140

    Source assertion: Methods specify ArcA-8myc, MG1655 derivatives, ΔarcA and anaerobic media with/without nitrate.

    Source locationXPath /article/body/sec[4]/sec[1]/p
  • UniProtKB:P0A9Q1

    Source assertion: The issuing ArcA reference has phosphoaspartate54; the active modified state is distinguished from the unmodified reference sequence.

    Source locationentry[primaryAccession='P0A9Q1'].features[type='Modified residue']
  • UniProtKB:P0A9Q1

    Source assertion: The issuing ArcA reference has phosphoaspartate54; the active modified state is distinguished from the unmodified reference sequence.

    Source locationentry[primaryAccession='P0A9Q1'].features[type='Modified residue']
inhibits

The native ArcA regulation records the exact sign, PHOSPHO-ARCA regulator and target gene under anaerobic source conditions.

sthA
Entrez:948461
  • EcoCyc:REG0-14101

    Source assertion: The native ArcA regulation records the exact sign, PHOSPHO-ARCA regulator and target gene under anaerobic source conditions.

    Source locationXPath /ptools-xml/Regulation/mode | /ptools-xml/Regulation/regulator | /ptools-xml/Regulation/regulated-entity | /ptools-xml/Regulation/comment
  • EcoCyc:REG0-14102

    Source assertion: The native ArcA regulation records the exact sign, PHOSPHO-ARCA regulator and target gene under anaerobic source conditions.

    Source locationXPath /ptools-xml/Regulation/mode | /ptools-xml/Regulation/regulator | /ptools-xml/Regulation/regulated-entity | /ptools-xml/Regulation/comment
  • EcoCyc:REG0-14103

    Source assertion: The native ArcA regulation records the exact sign, PHOSPHO-ARCA regulator and target gene under anaerobic source conditions.

    Source locationXPath /ptools-xml/Regulation/mode | /ptools-xml/Regulation/regulator | /ptools-xml/Regulation/regulated-entity | /ptools-xml/Regulation/comment
  • PMID:24699140

    Source assertion: The primary Results report ArcA activation of pntAB and repression of sthA in the studied redox conditions.

    Source locationXPath /article/body/sec[2]/sec[3]/p[3]
  • EcoCyc:ARCA-MONOMER

    Source assertion: The unmodified native ArcA chain unifies to the exact UniProt reference; phosphorylation is carried in the endpoint qualifier.

    Source locationXPath /ptools-xml/Protein/dblink[dblink-db="UNIPROT"]
  • Entrez:948461

    Source assertion: The exact Gene ID grounds this regulatory object.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
  • DOI:10.1371/journal.pgen.1004264.s009

    Source assertion: The original ArcA table reports peak4158619–4159036; occupancy9.69; repression. Coordinates and log2 occupancy are source-specific, not modern remapped loci.

    Source locationPDF 1,3; sthA operon row
  • DOI:10.1371/journal.pgen.1004264.s010

    Source assertion: The original ArcA table reports peak4158474–4159090; occupancy10.7; repression. Coordinates and log2 occupancy are source-specific, not modern remapped loci.

    Source locationPDF 2,3; sthA operon row
Nitrogen assimilation regulatory protein nac
UniProtKB:Q47005

experimental construct: 2017 pT7-FLAG-4 inducible FLAG-Nac in MG1655, LB,1mM IPTG for2h from OD6000.2; ChIP-seq and RNA-seq. The30°C nitrogen-depletion validation was separate and does not define these pntA/cysQ rows.

Qualification evidence
  • PMID:28061857

    Source assertion: Primary Methods specify the inducible FLAG construct, host, LB induction and matched RNA-seq experiment.

    Source locationXPath /article/body/sec[2]/sec[2]/p | /article/body/sec[2]/sec[4]/p
inhibits

Nac-bound pntA row: peak1675942, coverage45, distance−15, published normalized FC0.372191; raw4.3/13.24 is not that normalized value.

pntA
Entrez:946628
  • DOI:10.1186/s12918-016-0376-y

    Source assertion: Nac-bound pntA row: peak1675942, coverage45, distance−15, published normalized FC0.372191; raw4.3/13.24 is not that normalized value.

    Source locationZIP member 12918_2016_376_MOESM3_ESM.xlsx; worksheet 'Nac Binding and RNA-Seq', row238
  • EcoCyc:G7072-MONOMER

    Source assertion: The exact native Nac chain cross-reference identifies Q47005.

    Source locationXPath /ptools-xml/Protein/dblink[dblink-db="UNIPROT"]
  • Entrez:946628

    Source assertion: The issuing reference gene grounds the expression object, distinct from the regulator chain.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
Nitrogen assimilation regulatory protein nac
UniProtKB:Q47005

experimental construct: 2017 pT7-FLAG-4 inducible FLAG-Nac in MG1655, LB,1mM IPTG for2h from OD6000.2; ChIP-seq and RNA-seq. The30°C nitrogen-depletion validation was separate and does not define these pntA/cysQ rows.

Qualification evidence
  • PMID:28061857

    Source assertion: Primary Methods specify the inducible FLAG construct, host, LB induction and matched RNA-seq experiment.

    Source locationXPath /article/body/sec[2]/sec[2]/p | /article/body/sec[2]/sec[4]/p
activates

Nac-bound cysQ row: peak4434633, coverage22, distance−145, published normalized FC2.176844. The row supports a condition-qualified binding/expression join.

cysQ
Entrez:948728
  • DOI:10.1186/s12918-016-0376-y

    Source assertion: Nac-bound cysQ row: peak4434633, coverage22, distance−145, published normalized FC2.176844. The row supports a condition-qualified binding/expression join.

    Source locationZIP member 12918_2016_376_MOESM3_ESM.xlsx; worksheet 'Nac Binding and RNA-Seq', row62
  • EcoCyc:G7072-MONOMER

    Source assertion: The exact native Nac chain cross-reference identifies Q47005.

    Source locationXPath /ptools-xml/Protein/dblink[dblink-db="UNIPROT"]
  • Entrez:948728

    Source assertion: The issuing reference gene grounds the expression object, distinct from the regulator chain.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
small regulatory RNA Spot 42
EcoCyc:SPF-RNA
inhibits

Spot42 represses sthA mRNA/translation in MG1655-derived NM525Δspf GS0433 Northern and PM1205Δspf GS0434 pBAD sthA-lacZ experiments. The fusion spans the TSS through9–15 codons;0.2% arabinose±1mM IPTG for1h, with regionIII and compensatory target mutants. This RNA construct context is explicit prose because endpoint qualifiers are restricted to proteins/complexes.

sthA
Entrez:948461
  • EcoCyc:REG0-11863

    Source assertion: The native source records negative Spot42 regulation of EG11428/sthA with expression and site-mutation evidence.

    Source locationXPath /ptools-xml/Regulation/mode | /ptools-xml/Regulation/regulator | /ptools-xml/Regulation/regulated-entity | /ptools-xml/Regulation/evidence
  • PMID:21292161

    Source assertion: Compensatory Spot42/target mutations restore sthA fusion repression, supporting direct RNA pairing rather than mere expression correlation.

    Source locationHTML XPath /html/body/div[2]/div[2]/div/div[1]/div/div[2]/main/article/section[2]/section/section[3]/section[2]/p[4]
  • PMID:21292161

    Source assertion: Northern assays used NM525Δspf GS0433 with IPTG-induced pSpot42; fusion assays used PM1205Δspf GS0434 and pBAD sthA-lacZ.

    Source locationHTML XPath /html/body/div[2]/div[2]/div/div[1]/div/div[2]/main/article/section[2]/section/section[3]/section[1]/figure/figcaption/p | /html/body/div[2]/div[2]/div/div[1]/div/div[2]/main/article/section[2]/section/section[3]/section[2]/figure[2]/figcaption/p | /html/body/div[2]/div[2]/div/div[1]/div/div[2]/main/article/section[2]/section/section[3]/section[3]/figure/figcaption/p | /html/body/div[2]/div[2]/div/div[1]/div/div[2]/main/article/section[2]/section/section[5]/section[4]/p | /html/body/div[2]/div[2]/div/div[1]/div/div[2]/main/article/section[2]/section/section[7]/p
  • Entrez:948461

    Source assertion: The reference sthA Gene ID grounds the transcript target; RNA pairing does not mean binding of Spot42 to the encoded enzyme.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
Phosphate regulon transcriptional regulatory protein PhoB
UniProtKB:P0AFJ5

molecular state: Phosphorylated PhoB (native PHOSPHO-PHOB), mapped to P0AFJ5 reference chain; phosphorylation-dependent dimer orientation is required for the active DNA-binding state. It is not an unmodified monomer or a synthetic-promoter preparation.

Qualification evidence
  • EcoCyc:PHOSPHO-PHOB

    Source assertion: The native state identifies unmodified PHOB-MONOMER and explains phosphorylation-dependent dimer orientation and activation.

    Source locationXPath /ptools-xml/Protein/unmodified-form | /ptools-xml/Protein/comment
  • UniProtKB:P0AFJ5

    Source assertion: The issuing PhoB reference has phosphoaspartate53, supporting the stated phosphorylated endpoint; this is not an unmodified chain.

    Source locationentry[primaryAccession='P0AFJ5'].features[type='Modified residue']
activates

The native regulation identifies phosphorylated PhoB activating PM00071.

phoA
Entrez:945041
  • EcoCyc:REG0-4617

    Source assertion: The native regulation identifies phosphorylated PhoB activating PM00071.

    Source locationXPath /ptools-xml/Regulation/mode | /ptools-xml/Regulation/regulator | /ptools-xml/Regulation/regulated-entity
  • EcoCyc:PM00071

    Source assertion: The exact native promoter is a component of TU00052.

    Source locationXPath /ptools-xml/Promoter/component-of
  • EcoCyc:TU00052

    Source assertion: The native transcription unit contains the phoA gene EG10727.

    Source locationXPath /ptools-xml/Transcription-Unit/component[Gene[@frameid="EG10727"]]
  • EcoCyc:PHOB-MONOMER

    Source assertion: The native unmodified PhoB chain unifies to P0AFJ5; the active modified state is retained in the qualifier.

    Source locationXPath /ptools-xml/Protein/dblink[dblink-db="UNIPROT"]
  • Entrez:945041

    Source assertion: The issuing Gene ID grounds the phoA expression endpoint.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
  • UniProtKB:P0AFJ5

    Source assertion: The exact PhoB reference is P0AFJ5, phoB/b0399,229residues in E. coli K12. P0A9I3 is GcvR and is rejected for this role.

    Source locationentry[primaryAccession='P0AFJ5'].genes,organism,sequence
NAD kinase
UniProtKB:P0A7B3
located_in

The issuing NadK annotation places the reference protein in the cytoplasm, by rule-based inference rather than direct localization of every historical preparation.

cytosol
GO:0005829
  • UniProtKB:P0A7B3

    Source assertion: The issuing NadK annotation places the reference protein in the cytoplasm, by rule-based inference rather than direct localization of every historical preparation.

    Source locationentry[primaryAccession='P0A7B3'].comments[commentType='SUBCELLULAR LOCATION']
3'(2'),5'-bisphosphate nucleotidase CysQ
UniProtKB:P22255
located_in

The issuing CysQ annotation describes a peripheral inner-membrane protein on the cytoplasmic side. This reference localization does not establish physiological NADP phosphatase function.

plasma membrane
GO:0005886
  • UniProtKB:P22255

    Source assertion: The issuing CysQ annotation describes a peripheral inner-membrane protein on the cytoplasmic side. This reference localization does not establish physiological NADP phosphatase function.

    Source locationentry[primaryAccession='P22255'].comments[commentType='SUBCELLULAR LOCATION']
calcium(2+)
CHEBI:29108
inhibits

The reviewed CysQ annotation reports calcium inhibition from the2006 bisphosphate-nucleotidase study. This is general enzyme context, not a measured calcium effect on the2007 NADP assay.

3'(2'),5'-bisphosphate nucleotidase CysQ
UniProtKB:P22255
  • UniProtKB:P22255

    Source assertion: The reviewed CysQ annotation reports calcium inhibition from the2006 bisphosphate-nucleotidase study. This is general enzyme context, not a measured calcium effect on the2007 NADP assay.

    Source locationentry[primaryAccession='P22255'].comments[commentType='ACTIVITY REGULATION']
HTH-type transcriptional repressor GlaR
UniProtKB:P37338

experimental construct: 2017 pT7-FLAG-4 induced CsiR in MG1655, LB,1mM IPTG for2h from OD6000.2. These RNA-seq rows are expression-only; neither pntA nor pntB occurs in the bound-target sheet. The current reference is GlaR/P37338.

Qualification evidence
  • PMID:28061857

    Source assertion: The primary Methods identify FLAG-tagged inducible regulators and paired transcript measurements.

    Source locationXPath /article/body/sec[2]/sec[2]/p | /article/body/sec[2]/sec[4]/p
activates

Induced CsiR gives pntA normalized FC2.793539; no pntA bound-target row was found. The edge denotes a potentially indirect expression response.

pntA
Entrez:946628
  • DOI:10.1186/s12918-016-0376-y

    Source assertion: Induced CsiR gives pntA normalized FC2.793539; no pntA bound-target row was found. The edge denotes a potentially indirect expression response.

    Source locationZIP member 12918_2016_376_MOESM2_ESM.xlsx; worksheet 'All CsiR RNA-Seq', row2451
  • UniProtKB:P37338

    Source assertion: Issuing P37338 identifies glaR with the historical csiR alias; the induced paper construct and modern reference are not assumed sequence-identical.

    Source locationentry[primaryAccession='P37338'].genes,organism,sequence
  • Entrez:946628

    Source assertion: The exact issuing Gene record grounds the expression object, independently of the regulator identity.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source
HTH-type transcriptional repressor GlaR
UniProtKB:P37338

experimental construct: 2017 pT7-FLAG-4 induced CsiR in MG1655, LB,1mM IPTG for2h from OD6000.2. These RNA-seq rows are expression-only; neither pntA nor pntB occurs in the bound-target sheet. The current reference is GlaR/P37338.

Qualification evidence
  • PMID:28061857

    Source assertion: The primary Methods identify FLAG-tagged inducible regulators and paired transcript measurements.

    Source locationXPath /article/body/sec[2]/sec[2]/p | /article/body/sec[2]/sec[4]/p
inhibits

Induced CsiR gives pntB normalized FC0.440537, opposite to pntA; no pntB bound-target row was found. The edge denotes a potentially indirect expression response.

pntB
Entrez:946144
  • DOI:10.1186/s12918-016-0376-y

    Source assertion: Induced CsiR gives pntB normalized FC0.440537, opposite to pntA; no pntB bound-target row was found. The edge denotes a potentially indirect expression response.

    Source locationZIP member 12918_2016_376_MOESM2_ESM.xlsx; worksheet 'All CsiR RNA-Seq', row2452
  • UniProtKB:P37338

    Source assertion: Issuing P37338 identifies glaR with the historical csiR alias; the induced paper construct and modern reference are not assumed sequence-identical.

    Source locationentry[primaryAccession='P37338'].genes,organism,sequence
  • Entrez:946144

    Source assertion: The exact issuing Gene record grounds the expression object, independently of the regulator identity.

    Source locationXPath /Entrezgene-Set/Entrezgene/Entrezgene_gene | /Entrezgene-Set/Entrezgene/Entrezgene_source

References

Curation history